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Citrobacter rodentium is a gut pathogen, which infects the distal colon of mice.   It has 
many similarities to human Enteropathogenic and Enterohemorrhagic E.coli in terms of 
mechanisms of pathogenicity and methods of transmission. Like many other gram 
negative bacteria, C. rodentium has developed a complex and highly specialised protein 
secretion system, known as type three (T3SS), to deliver bacterial proteins into 
eukaryotic cells.  By injecting effector proteins into host cell cytoplasm, the pathogens 
are able to modulate host cellular functions to facilitate their own survival and 
replication.  
There is growing evidence that Attaching Effacing (AE) pathogens can inject effector 
proteins into gut epithelial cells, which dampen pro-inflammatory responses. There is 
also evidence that EPEC, Yersinia and Shigella can inject effectors into immune cells 
and also modulate their function.  The objective of this work was to visualise and 
identify the host cells targeted for type III secretion by C. rodentium, and consequently 
determine the effect on host immune responses. The method chosen to detect cells 
targeted for effector protein delivery was the β-lactamase reporter system, where cells 
loaded with the fluorogenic substrate CCF2-AM emit a green FRET signal upon 
excitation by UV light, but emit a blue signal when cleaved by β-lactamase.   
By creating reporter strain of C.rodentium expressing fusion proteins between NleD 
effector and β-lactamase, I was able to show that C.rodentium is capable of injecting 
NleD in a wide variety of murine cell lines including Swiss 3T3 fibroblasts, J774 
macrophages, CMT93 epithelial cells and BW715 T cells in a dose and time dependent 
manner in vitro. In addition, I found that C.rodentium has the ability to inject proteins 
into the cytoplasm of immune cells isolated from mouse lymphoid tissues including the 
spleen, mesenteric lymph nodes and Peyer’s patches. Detailed analysis of the types of 
cells injected with effectors in vitro showed that NleD- injected cells represented B 
cells, dendritic cells and T cells.  
After inoculation of mice with the reporter strain of CitropACYCnleD, the plasmid 
encoded reporter fusion remained stable throughout infection and was able to inject 
cells in vitro after passage through the mouse gut. Unfortunately under the conditions 
described in this study, we were unable to visualise any gut cells targeted for protein 




pathogen relationships in the gut. Although there is a need to develop better strategies to 
visualise effector translocation in vivo, our study has demonstrated, for the first time, 
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1. General Introduction 
 
1.1 Intestinal immune system 
The human gastrointestinal tract, with an approximate surface area of 400m2, is the 
largest mucosal surface of the body. It is organised into millions of crypts and villi 
and is lined by a continuous row of intestinal epithelial cells, forming an epithelial 
barrier that separates the outside world from the internal host environment. The 
primary function of the gastrointestinal tract is the digestion of food and absorption 
of nutrients and water. However, the large surface area also makes the 
gastrointestinal tract particularly vulnerable to pathogens present in food and 
drinking water, which can damage the intestinal wall. In order to maintain barrier 
functions while enabling nutrient uptake, the gastrointestinal tract has developed an 
extensive network of organised gut associated lymphoid tissue (GALT) to protect 
against infectious microorganisms, such as pathogenic Escherichia coli (E. coli) and 
Citrobacter rodentium. Additionally, in the modern world, excessive immune 
responses to food and the microflora are responsible for hypersensitive conditions 
such as Coeliac disease and Crohn’s disease.  The intestinal epithelial barrier is thus 
at a crossroad between defence and nutrition (reviewed in MacDonald et al., 2011; 
Brandtzaeg, 2013; Peterson & Artis 2014). 
 
1.1.1 Intestinal epithelial cells  
The epithelial barrier (Fig. 1.1) is composed mainly of a single, continuous row of 
intestinal epithelial cells (IEC) (reviewed in Rescigno 2011a). IECs are polarised 
with a basolateral surface facing the lamina propria and an apical surface facing the 
intestinal lumen. Each IEC is columnar, 30µm thick, and covered with a microvillus 
brush border containing glycocalyx on the apical surface. Through various intimate 
associations between the epithelial cells – including tight junctions, adherens 
junctions and desmosomes – the intestinal epithelium forms a physical barrier 
against food and microorganisms in the gut lumen and prevents the uncontrolled 
entry of foreign antigens.  
Tight junctions are protein complexes, which form belt-like contacts between 
adjacent epithelial cells and seal the paracellular space (Turner et al 2009). They are 
made up of the transmembrane proteins claudin and occludin, as well as the 
peripheral membrane proteins zonula occludin1, which establish a diffusion barrier 
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between the apical and basolateral domains of the epithelium. This prevents the 
influx of luminal contents into the lamina propria (LP). In addition, tight junctions 
are associated with cytoplasmic actin and myosin networks that regulate intestinal 
permeability. The adherens junctions, made up of cadherin transmembrane proteins, 
‘glue’ the epithelial cells together.  Loss of adherens junctions results in cell-cell and 
cell-matrix contact disruption, ineffective epithelial cell polarisation, and apoptosis 
(Hermiston et al., 1995). Desmosomes are intracellular junctions that hold the 
epithelial sheet together. Desmosomes form extracellular bonds that are anchored at 
the cell surface to the intermediate filament-based cytoskeleton. Tight junctions, 
adherens junctions, and desmosomes thus work together to maintain the epithelial 
barrier integrity.  Any defects in these structures can lead to an increase in epithelial 
permeability and an altered composition of the microbiota, known as dysbiosis, 
resulting in inflammatory disorders, such as inflammatory bowel disease (IBD) 
(Peterson & Artis, 2014). 
Intestinal epithelial cells undergo continuous renewal from stem cell progenitors 
residing near the base of the intestinal crypts (Fig. 1.1) (Potten et al., 1997). As these 
cells migrate toward the tip of the crypts, they differentiate into one of four cell 
lineages (Yen and Wright, 2006). Although the majority of IECs lining the gut lumen 
are (1) absorptive epithelial cells (enterocytes), the epithelium also contains secretory 
epithelial cells, including (2) goblet cells, (3) Paneth cells, and (4) enterochromaffin 
cells (Peterson & Artis 2014). 
 
1.1.2 Goblet cells 
Overlaying the gut epithelium is a thick layer of mucus (Fig.1.1), produced by goblet 
cells, which provides the first line of defence against luminal microbes (reviewed in 
McGuckin 2011). Mucus is a complex fluid rich in mucin glycoproteins and 
antimicrobial molecules. It varies in thickness between 150µm in the stomach, 
300µm in the small intestine, and 700µm in the large intestine (Atuma et al., 2001). 
The thickness of the mucus layer depends on the presence of the microbiota, where 
goblet cells constitute 10% of IECs in the upper small intestine compared to 25% in 
the distal colon (Rescigno et al., 2011a; Mowat and Agace, 2014). The small 
intestine is covered by a single layer of mucus (Johansson et al., 2011), in contrast to 
the large intestine, which is coated by two mucus barriers consisting of a thin, dense, 
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inner layer – that is attached to the epithelial surface and impermeable to bacteria – 
and a thicker outer layer which contains bacteria (Johansson et al., 2011). The 
resulting mucucs layer forms a highly charged gel that physically separates luminal 
bacteria from the epithelial cell surface and is also composed of mucin glycoproteins 
that is directly toxic to many bacteria. In addition, the mucus layer provides an 
attachment site to antimicrobial peptides (AMP) and IgA antibodies (discussed later), 
which further strengthens the barrier properties (Mowat and Agace, 2014).  
Defects in mucus production have been linked with increased infiltration of 
commensal bacteria into the LP and an increased susceptibility to colitis and colon 
cancer. For example, mice lacking mucin-specific genes developed spontaneous 
colitis (Heazlewood et al., 2008) and mice deficient in mucin 1 are more susceptible 
to infection with Helicobacter pylori and Campylobacter jejuni (McGuckin et al., 
2007; McAuley et al., 2007). In addition, mice deficient in the mucin 2 gene show a 
reduced inner mucus layer, resulting in the direct contact of epithelial cells with the 
microbiota, (Hansson and Johansson, 2010) leading to inflammation, spontaneous 
colitis (Van der Sluis et al., 2006), and intestinal tumours (Velcich et al., 2002). The 
importance of mucus is further shown in Winnie mice, which have a missense 
mutation in the mucin 2 gene, display increased epithelial permeability, and develop 
an ulcerative colitis-like inflammation (Heazlewood et al., 2008). Taken together, 
these studies demonstrate the important role of mucus in the protection of the host 
against gut microorganisms.  
Cross-linking of mucin with trefoil factor 3 (TFF3) provides additional structural 
integrity to the mucus barrier (Peterson & Artis, 2014). Also secreted by goblet cells, 
TFF3 is upregulated around areas of epithelial cell damage and has been suggested to 
play a role in promoting epithelial cell migration and resistance to apoptosis, both of 
which are important for wound healing and intestinal repair (Wright et al., 1997; 
Peterson & Artis, 2014). TFF3-deficient mice show impaired mucosal healing that 
can lead to severe dextran sulphate sodium (DSS) induced colitis and death 
(Podolsky et al., 2009).  Conversely, the addition of TFF3 has been effective in 
treating colonic injury in both in vitro and in vivo models of colitis (Kindon et al., 
1995; Mashimo et al., 1996). 
Resistin-like molecule-ß (RELMß) is another product secreted by goblet cells that 
further reinforces the intestinal barrier functions. It plays an important role in 
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promoting mucin 2 secretion and in the regulation of macrophage and T cell 
responses during inflammation (Peterson & Artis, 2014). RELMß was also shown to 
provide protection against parasitic helminths that reside in the intestinal lumen by 
directly inhibiting parasite chemotaxis and the ability of the worms to feed on host 
tissue (Herbert et al., 2009; Peterson & Artis, 2014). 
Recently, 2-photon time lapse imaging was used to demonstrate an important role for 
goblet cells in delivering luminal antigens to dendritic cells (DCs) in the LP (McDole 
et al., 2012). In addition to the trans-epithelial dendrite (TED) formation by DCs 
(discussed later), this new source of luminal antigens for small intestinal DCs is 
known as a ‘goblet cell-associated antigen passage’ (GAP). According to the study 
by McDole et al. (2012), GAP formation occurred either through stable contacts with 
DCs, which slowly collected antigens over several minutes, or when DCs actively 
probed GAPs and captured antigen clumps. The luminal antigens were captured 
preferentially by the tolerogenic CD103+DCs, which promoted the development of 
regulatory T cells. Such findings suggest that goblet cells, through the GAP 
mechanism, play an important role in promoting intestinal immune homeostasis 
(McDole et al., 2012).  
 
1.1.3 Paneth cells 
The secretion of antimicrobial peptides (AMPs) by Paneth cells strengthens the 
regulation of a physical barrier in the intestine. Paneth cells are found in the small 
intestine and, unlike the rest of the IECs, migrate downward toward the base of the 
crypts after differentiating from stem cells (Fig.1.1) (Mowat and Agace, 2014). 
These cells are specialised to secrete a wide variety of AMPs, including defensins, 
lysozymes, cathelicidins, and regenerating islet-derived protein (REG) III lectins 
(McGuckin et al., 2011; Peterson & Artis et al., 2014). 
These AMPS display antimicrobial activity against bacteria, fungi, and viruses. For 
example, cathelicidins and pore forming defensins target bacterial surface 
membranes, while C-type lectins target gram-positive cell wall peptidoglycans 
(Gallo and Hooper, 2012; Mukherjee et al., 2014). Knockout mice that are deficient 
in active defensins display an impaired ability to clear Escherichia coli (E.coli) 
infection and show an increased susceptibility to Salmonella typhimurium 
(S.typhimurium) infection following oral inoculation of mice with these pathogens 
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(Wilson et al., 1999). In addition, transgenic mice over-expressing α defensins show 
increased resistance to S. typhimurium infection (Salzman et al., 2003).  
As well as providing resistance to invading pathogens, AMPs also play a role in 
shaping the microbiota composition. For instance, in comparison to wildtype mice, 
mice deficient in α-defensins display a completely altered microbiota, while mice 
over-expressing α-defensins show reduced colonisation by segmented filamentous 
bacteria (Salzman et al., 2010), which have been implicated in the protection of mice 
from C. rodentium infection (Ivanov and Littman, 2010). Furthermore, REGIIIγ 
produced by both Paneth cells and enterocytes have recently been shown to mediate 
host-microbial segregation in the gut. Similar to mucin 2 function in the colon, 
REGIIIγ helps to exclude bacteria from the epithelial surface of the small intestine, 
and interactions between REGIIIγ and mucins lead to increased antimicrobial 
activity at the epithelial surfaces (Vaishnava et al., 2011). In short, the combined 
effects of IEC-secreted products reinforce the epithelial barrier functions by limiting 
the diversity and quantity of bacteria that can access the epithelial surface and 








Figure 1.1: The intestinal epithelial cell barrier. The renewal of the epithelial cell 
layer is controlled by the intestinal epithelial stem cells, residing in the crypts, where 
differentiated IECs migrate up the crypt-villus axis. To exclude bacteria from the 
epithelial cell surface, goblet cells secrete mucus while Paneth cells secrete 
antimicrobial proteins (AMPs). Epithelial cells further contribute to this barrier 
function through transcytosis and luminal release of secretory IgA (SIgA). Luminal 
antigens and live bacteria are transported across the epithelial barrier by M cells, 
goblet cells, and intestine-resident macrophages (discussed later). (Taken from 




1.1.5 Microbial recognition by intestinal cells  
To maintain barrier functions and immune homeostasis, intestinal epithelial cells and 
immune cells are able to sense the presence of microbes and respond accordingly.    
This is done through the expression of pattern recognition receptors (PRR), which 
recognise microbe associated molecular patterns (MAMPs).  Members of the toll-
like receptor (TLR) and the nucleotide-binding oligomerisation domain (NOD)-like 
receptor (NLR) families mediate the recognition of microbial ligands or signals 
associated with enteropathogens (reviewed by Lavelle et al., 2010; Kawai & Akira, 
2011). PRR recognition can lead to the activation of downstream signalling cascades, 
including that of nuclear factor kappa B (NFκB), activator protein 1, and mitogen-
activated protein (MAP) kinases (Fig.1.2a) . These pathways promote the production 
of antimicrobial peptides and proinflammatory cytokines, which are important for 
antigen presentation and for inducing the proliferation of effector immune cell 
populations (Fig.1.2b). However, in addition to their role in initiating highly 
inflammatory cascades, the abundance of symbiotic commensals in the intestine 
make it necessary for the intestinal cells to maintain a state of epithelial homeostasis 
and immune tolerance upon microbial recognition of commensal bacteria (Lavelle et 
al., 2010; Petrson & Artis, 2014). 
 
1.1.5.1 Toll-like receptor (TLR) 
The number of TLRs identified so far total to 10 in humans and 13 in mice (Abreu, 
2010). TLR1,2,4, 5 and 6 are expressed on the cell surface (Fig.1.2) and mainly 
recognise microbial membrane components such as bacterial lipoproteins, 
peptidoglycans, lipopolysaccharides (LPS) and flagellin. In contrast, TLR3,7, 8 and 
9 are associated with intracellular vesicles (Fig.1.2) that recognise DNA and RNA 
from bacteria, virus, fungi and parasites (Abreu, 2010).  
 
TLR signalling through the myeloid differentiation factor (MyD)-88 adapter protein, 
is essential for driving resistance responses against enteric bacterial pathogens, partly 
by the production of antimicrobial peptides and lectins. Following infection of mice 
with Listeria monocytogenes, MyD88 signalling was shown to promote the 
production of microbicidal lectin RegIII by Paneth cells that can directly suppress the 
growth of L. monocytogenes (Brandl et al., 2007). Similarly, TLR2 signalling was 
shown to regulate the expression of RegIIIβ, without which animals were more 
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susceptible to infection with Yersinia pesudotuberculosis (Dessein et al., 2009). 
Similarly, mice deficient in TLR9 have decreased expression of α-defensin in the 
small intestine (Lee et al., 2006) while antibiotic treatment of mice decreased the 
expression of antimicrobial peptides (Brandl et al., 2008). Likewise, MyD88 
signalling was required for the control of pathogenic bacteria in a model of 
enterocolitis induced by S. typhimurium (Keestra et al., 2011).  
 
The importance of TLR mediated MyD88 signalling in the control of bacterial 
growth can be seen clearly in the C. rodentium model of mice infection. MyD88-/- 
mice infected with C. rodentium carried a bacterial burden up to 100-fold higher than 
wild type mice (Lebeis et al., 2007; Gibson et al., 2008b). As well as resulting in an 
abrogated production of TNFα and IL6 from macrophages, these MyD88-/-mice 
displayed an inability to recruit neutrophils and macrophages to the site of infection, 
which suggests that the control of bacterial burdens is related to the host 
inflammatory response. These mice were also unable to promote the proliferation 
and turnover of crypt epithelial cells, leading to bacterial invasion of colonic crypts 
(Gibson et al., 2008b). Moreover, MyD88-/- mice had defects in the MyD88-
dependent production of iNOS, which can contribute to the direct killing of C. 
rodentium (Vallance et al., 2004). Therefore, TLR-mediated MyD88 signalling 
proved essential in providing resistance against C. rodentium infection through direct 
killing, recruitment of phagocytes to the site of infection, and removal of infected 
epithelial cells (Bergstrom et al., 2012).  
As well as promoting resistance to invading pathogens, TLR activity is also 
associated with host responses that limit intestinal tissue damage. These TLRs drive 
processes that protect the host from pathogen-associated injury during bacterial 
infection. For example, mice deficient in MyD88 not only carried greater bacterial 
burden during C. rodentium infection but also suffered from severe necrosis in the 
colonic tissue (Lebeis et al., 2007; Bergstrom et al., 2012). In addition, studies in 
knockout mice show that, in the absence of TLR-mediated NFκB activation, 
epithelial cells undergo apoptosis, increased epithelial permeability, and 
translocation of microorganisms across the epithelium, which lead to the 
development of chronic intestinal inflammation (Nenci et al., 2007). TLR signalling 
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is therefore crucial in the maintenance of intestinal homeostasis, especially during 
gut infections. 
TLR-mediated protection from epithelial cell injury was also reported in mice with 
chemically-induced colitis. In the absence of TLR2 mediated expression of TFF3 by 
goblet cells and IECs, mice displayed an increase in apoptosis and susceptibility to 
DSS-induced colitis. Similar effects were seen in wild-type mice induced with colitis 
following treatment with antibiotics. Mice that are deficient in; MyD88 adapter 
protein, TLR4 (which recognises bacterial LPS), TLR5 (which recognises flagellin) 
and TLR2 (which recognises bacterial glycolipids) also displayed increased 
susceptibility to DSS colitis (Rakoff-Nahoum et al., 2004; Fukata et al., 2005; Vijay-
Kumar et al., 2007b; Araki et al., 2005). Conversely, the administration of flagellin 
(Vijay-Kumar et al., 2008), TLR2 ligand (Cario et al., 2007), TLR3 ligand (Vijay-
Kumar et al., 2007a), and TLR9 ligand (Rachmilewitz et al., 2004) in DSS induced 
mice conferred protection against DSS-induced injury by decreasing apoptosis, 
dampening proinflammatory cytokines, and increasing epithelial cell proliferation. 
Such data establish the role of TLR signalling in the maintenance of epithelial cell 
proliferation and repair of colitis-damaged gut.  
TLR signalling in response to bacterial antigens is also associated with expression of 
tight junction proteins by epithelial cells. In a model epithelium, TLR2 activation led 
to the reorganisation of tight junction associated proteins (Cario et al., 2004), which 
provided protection against colitis induced by C. rodentium (Gibson et al., 2008a). 
Similarly, treatment of IEC with TLR2 ligands resulted in a decrease in epithelial 
cell apoptosis and enhanced tight junction function through reorganisation of tight 
junction associated proteins in mice with DSS-induced colitis (Cario et al., 2007). 
Thus, TLR signalling can contribute to minimising intestinal damage by tightening 
the barrier formed by the epithelial cells.  
TLR signalling in IECs can enable antibody class switching to IgA since TLR 
activation of human IECs induces the secretion of a B cell stimulating factor known 
as proliferation-inducing ligand (APRIL) (He et al., 2007). APRIL binds to 
transmembrane activator TACI on B cells to induce plasma cell survival and class 
switching (Castigli et al., 2005). In mice where TLR4 is constitutively expressed, 
there is a higher number of IgA-producing plasma cells in the LP, higher expression 
of APRIL in the epithelium, and increased IgA in the faeces relative to control mice 
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(Shang et al., 2008). Therefore, TLR signalling in the epithelium is necessary for 
inducing IgA responses in the intestine.  
Despite the protective role of TLR signalling, contradictory evidence indicates a 
pathogenic role for TLRs in the development of inflammatory disorders. Evidence 
from genome-wide association studies suggests that TLR4 polymorphisms may be 
associated with Crohn’s disease and ulcerative colitis (Franchimont et al., 2004). In 
addition, studies of epithelial cells show higher expression of TLR4 in IBD patients 
than in control individuals (Cario and Podolsky et al., 2000). However, it is difficult 
to conclude whether this is a cause or an effect of IBD, since the presence of  
proinflammatory cytokines such as IFNγ and TNFα can also induce the transcription 
of TLR4 (Suzuki & Podolsky et al., 2003; Vamadevan et al., 2010). Even so, 
additional studies confirm that TLR4 expression by epithelial cells was responsible 
for neoplasia seen in mice induced with carcinogen azoxymethane and DSS (Fukata 
et al., 2009), where mice deficient in TLR4 were protected from neoplasia (Fukata et 
al., 2007). This is supported by further studies in mice lacking MyD88, which did not 
develop colitis after Helicobacter hepaticus infection (Asquith 2010), and in mice 
lacking a negative regulator of NFκB, which showed elevated levels of inflammatory 
cytokines and reduced barrier permeability (Zhou et al., 2009). Not only do such 
findings reveal a ‘darker side’ to TLR signalling – despite its well-established role in 
providing protection in the intestinal mucosa – but also highlights the complexity of 
TLR-induced effects in the mucosa.  
The complexity of TLR-induced effects is further demonstrated by the co-activation 
of TLR2 and TLR4 signalling during C. rodentium infection in mice (Khan et al., 
2006; Gibson et al., 2008a). Although TLR2 and TLR4 signalling can have different 
effects during a C.rodentium infection, they can also cooperate to provide host 
defence. Mice deficient in TLR4 displayed a delay in C. rodentium colonisation, 
with a marked reduction in bacterial burden in the first week of infection, followed 
by an impaired host response that included a reduced expression of chemokines and 
limited tissue infiltration of phagocytes. Although C. rodentium was eventually able 
to colonise and cause inflammation in the absence of TLR4, these mice suffered little 
tissue damage and were able to clear the infection. This suggests that TLR4 is 
responsible for much of the mucosal damage that occurs during a bacterial infection. 
However, it has also been suggested that this pro-inflammatory role may actually 
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promote C. rodentium colonisation, perhaps by helping to remove competing 
commensals during the initial stages of an infection (Lupp et al., 2007).  
In contrast, TLR2-deficient mice are highly susceptible to C. rodentium infection. 
These mice displayed severe ulceration in the colon, which led to rapid weight loss 
and high mortality within the first two weeks of infection (Gibson et al., 2008a). The 
colonisation of C. rodentium in TLR2 deficient mice is the same as wild-type mice, 
indicating that bacterial burden does not account for the severe disease pathogenesis. 
Instead, TLR2 deficient mice displayed a reduced production of IL-6, which resulted 
in exaggerated epithelial cell apoptosis during infection. The presence of further 
defects in the epithelial barrier in addition to the abnormal distribution of tight 
junction proteins in the absence of TLR2, suggest that TLR2 signalling promotes 
intestinal homeostasis and protection of the epithelium following pathogen-induced 
injury (Bergstrom et al., 2012).  
Mice deficient in TLR 2 and TLR 4 (TLR2/4) show increased barrier dysfunction but 
little damage during C. rodentium infection. When reconstituted with TLR2-deficient 
– but not TLR4-deficient – bone marrow, the TLR2/4-deficient mice developed 
severe mucosal ulcerations (Gibson et al., 2010). It was further found that TLR2 
signalling leads to the production of IL-11 by sub-epithelial mesenchymal cells. IL-
11 is a cytoprotective cytokine that exerts its functions in colonic crypt epithelial 
cells and has been suggested to promote epithelial cell health and proliferation 
(Pickert et al., 2009). Taken together, these studies suggest that, during C. rodentium 
infection, TLR4 activation is responsible for pathogen-associated mucosal damage, 
while TLR2 activation results in the protection of the intestine from the TLR4 driven 
damage (Bergstrom et al., 2012). 
Finally, TLR signalling enables the epithelium to distinguish between harmless 
microflora and harmful pathogens. Inoculation of MyD88 deficient mice with E. coli 
K-12 resulted in an increased translocation of live bacteria into the spleen, indicating 
that TLR signalling is required to restrict the presence of microbiota in the lumen 
(Slack et al., 2009). In addition, the polarised nature of the intestinal epithelium 
enables spatial segregation of the PRRs. For example, TLR5 is expressed on the 
basolateral surface of the epithelial cells and is only activated when bacteria breach 
the epithelial barrier and invade the lamina propia. Similarly, the intracellular 
location of TLR3, 8, and 9 in the endosomal organelles ensures that only pathogenic 
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bacteria which enter and invade the epithelial cells are recognised, rather than 
bacteria residing on the apical surface (Kayama & Takeda, 2012). Furthermore, 
apical exposure of IECs to TLR9 ligands resulted in an inhibitory effect on the 
proinflammatory pathway, while the basolateral exposure of IECs to the same ligand 
resulted in the activation and translocation of NFκB (Fig.1.2a), demonstrating the 
existence of a differential response to microbial signals based on anatomical location 
(Peterson & Artis, 2014).  
 
1.1.5.2 NOD-like receptors (NLR) 
The NLR family of PRRs are primarily cytosolic and recognise intracellular MAMPs 
present in the cell cytosol (Kumar et al., 2009). NOD1 and NOD2 are well-
characterised NLR receptors that recognise components of the bacterial 
peptidoglycan. NOD1 is expressed by all adult cells and is upregulated in IECs in 
response to IFNγ (Inohara et al., 1999). In contrast, NOD 2 expression – restricted to 
leukocytes, DCs, and epithelial cells – is upregulated upon receiving stimuli from 
LPS, TNFα, and IFNγ (Rosenstiel et al., 2003). Activated ligands for both NOD1 
and NOD2 enter cells by endocytosis via clathrin-coated pits (Lee et al., 2009).  
Like TLR signalling, NOD signalling drives the downstream activation of MAPK 
and NFκB pathways, which upregulate the expression of proinflammatory cytokines 
and defensins responsible for antibacterial effects (Lavelle et al., 2010). Mice with 
NOD2 deficiency display abnormally large PP with increased numbers of M cells 
and CD4 T cells, resulting in the increased translocation of bacteria and yeast across 
the PP which leads to elevated levels of inflammatory cytokines TNFα, IFNγ, IL12, 
and IL4 in the LP (Barreau et al., 2007). Furthermore, NOD2-deficient mice are 
more susceptible to oral infection with Listeria monocytogenes, and have reduced 
cryptidin production by Paneth cells (Kobayashi et al., 2005) compared to NOD1 
deficient mice, which are highly susceptible to Helicobacter pylori infection (Viala 
et al., 2004).  
Genome-wide studies have revealed strong associations between NOD2 gene 
mutations and Crohn’s disease (Ogura et al., 2001). NOD2 mutations result in the 
inability to sense components of the bacterial peptidoglycan (Inohara et al., 2003), 
leading to a decrease in peptidoglycan-induced NFκB activity and impaired bacterial 
clearance (Netea et al., 2005). In vitro studies using epithelial cell lines expressing 
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mutations in the NOD2 gene, show impaired signalling in response to peptidoglycan 
from S. typhimurium, thereby indicating the role of NOD2 in the protection against 
intracellular bacteria (Hisamatsu et al., 2003). 
In the inflammatory disorder known as ‘Blau syndrome’, a NOD2 gain-of-function 
mutation causes constitutive activity of NOD2, which results in enhanced NFκB 
activation, increased apoptosis, and secretion of IL1B (Maeda et al., 2005). In 
addition, it was found that NOD2 mutations in Paneth cells resulted in the reduction 
of human defensin 5 and 6 levels (Grimm and Pavli, 2004) and that an α-defensin 
deficiency in Paneth cells contributed to the development of ileal Crohn’s disease 
(Wehkamp et al., 2005). Taken together, these studies establish a link between 
NOD2 mutations and Crohns disease susceptibility.  
NOD1 and NOD2 have also been implicated in the host defence to C. rodentium, 
despite the fact that it is an extracellular pathogen. In a recent study, a greater 
bacterial burden was observed in mice deficient in NOD2 compared to wild-type 
mice infected with C. rodentium (Kim et al., 2011). It was proposed that NOD2-
dependent production of CCL2 led to the recruitment of CD11c+ inflammatory 
monocytes to promote C. rodentium killing at the site of infection. However, mice 
deficient in NOD1/2 displayed more severe colitis in response to C. rodentium 
infection, which was associated with a higher bacterial load in the spleen (Geddes et 
al., 2011). According to the study, NOD1 and NOD2 play an important role in the 
protection against pathogen-induced damage by limiting pathogen translocation 
across the epithelium and promoting mucosal integrity. The protective effects of 
NOD1/2 are due to the early production of IL17A by a unique population of innate 
lymphocyte TH17 cells (Geddes et al., 2011). These cells presumably produce IL22 
and RegIIIy, which are protective molecules in this model (discussed later) (Zheng et 
al., 2008). Collectively, these studies implicate NOD signalling in promoting 
resistance to infection through chemokine production and inflammatory cell 
recruitment, as well as promoting tolerance through activation of novel TH17 cell 
responses.  
Other members of the NLR family, including NLRP3 and NLRP4, are involved in 
inflammasome formation (Ting et al., 2008). Inflammasomes are cytoplasmic multi-
protein complexes containing the apoptosis speck-like protein (ASC) adapter 
molecule, which control the recruitment and activation of caspase-1 required for the 
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maturation of proinflammatory cytokines IL1β and IL18 (Fig. 1.2a) (Bryant and 
Fitzgerald, 2009). NLR4 inflammasome formation occurs in response to the presence 
of flagellin, delivered by Salmonella type three secretion systems (T3SS, discussed 
later) into the cytosol of macrophages, resulting in the secretion of IL1β by these 
macrophages (Franchi et al., 2006). In addition, the activation of NLRP3 
inflammasome formation in response to stimuli from ATP, pore-forming toxins, uric 
acid (Ting et al., 2008), and TLR agonists (Sharp et al., 2009) has been shown to 
induce innate immune responses. ATP, produced in high concentrations by 
commensal bacteria (Atarashi et al., 2008), is able to induce NLRP3 inflammasomes 
to activate cytokines that in turn induce the differentiation of TH17 cells in the LP 
(Lavelle et al., 2010). TH17 cells have been implicated in the protection against 
bacterial pathogens such as C. rodentium (Mangan et al., 2006). Mice deficient in 
NLRP3 or Caspase 1 are more susceptible to DSS colitis and colitis-associated 
cancer. The increased susceptibility can be reduced by the addition of IL18, which 
suggests that part of the protective role of NLRP3 is mediated by IL18 (Zaki et al., 
2010; Allen et al., 2010). In addition, mutations in the NLRP3 gene have been 
associated with susceptibility to other inflammatory disorders, demonstrating the 
requirement for bacterial recognition by NLR-mediated inflammasome formation to 





Figure 1.2: Microbial recognition by intestinal epithelial cells. (A) Intestinal 
epithelial cells express TLRs, which recruit MyD88 signalling adaptor proteins to 
signal molecules via the NFκB and MAPK pathway. IECs also express NOD1 and 
NOD2, which activate NFκB and MAPK, as well as other NLRs including NLRP3 
that form inflammasome complexes with pro-caspase 1 for the cleavage and 
activation of IL-1β and IL18. (B) Microbial recognition by epithelial cells also 
promote barrier function (increased mucin and AMP production), cell survival and 
repair and immunoregulatory responses. (Taken from Peterson and Artis, 2014). 
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1.1.6 Gut-associated lymphoid tissue 
The gut-associated lymphoid tissue (GALT) is the inductive site of mucosal immune 
responses. GALTs sample antigens directly from the mucosal surface across the 
follicle-associated epithelium (FAE) and therefore do not require the afferent 
lymphatic supply of antigens (Brandtzaeg, 2010). The FAE forms the interface 
between the GALT and the gut lumen and contains specialised ‘microfold’ (M) cells 
which are able to transport bacteria and antigens to the underlying lymphoid tissue. 
This leads to the activation of a systemic immune response, including specific T cell 
responses that lead either to the generation of immunoglobulin A (IgA) or to immune 
cell tolerance. Studies show that mice which do not have M cells, or antigen 
sampling by M cells, have reduced antigen-specific T cell responses in the Peyer’s 
patches following oral inoculation with S. typhimurium (Mabott et al., 2013). GALT 
comprises the Peyer’s patches in the small bowel, isolated lymphoid follicles (ILF) 
in the colon and small intestine, and cryptopatches in mice and the appendix 
(Brandtzaeg 2011). The GALT contains up to 70% of the body’s immune cells, 
making it the largest lymphoid organ in the body (reviewed in Jung et al., 2010).  
 
1.1.6.1 Peyer’s patches 
The most well characterised GALT tissues are the macroscopically visible Peyer’s 
patches (PPs). PPs are lymphoid aggregates made up of 5 to 25 individual follicles. 
They are oval in shape and distributed irregularly along the anti-mesenteric side of 
the small intestine. In the distal ileum, however, there are about 300 PPs in an adult 
(Jung et al., 2010). 
In humans, PP development occurs during gestation and rapidly progresses after 
birth when the gut is exposed to commensal bacteria and antigens. Peyer’s patch 
numbers steadily increase through puberty, peak between the ages of 15 and 25, and 
then decline later in life (Jung et al., 2010). The embryonic steps of PP development 
have been studied extensively in mice, in which PP development is initiated by the 
expression of vascular cell adhesion molecule 1 (VCAM-1) on stromal cells (Jung et 
al., 2010; Pavert & Mebius 2010). Located on the anti-mesenteric side of the small 
intestine, distinct clusters of VCAM-1+ stromal cells express receptor tyrosine 
kinase (RET) ligands. RET ligands are encountered by RET+CD11c+ cells, which – 
following RET-dependent signalling – recruit haematopoietic cells. This initiates 
haematopoietic cell clustering which contains VCAM-1+ stromal cells, 
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RET+CD11c+ cells, and lymphoid tissue inducer (LTi) cells. Mice lacking RET, are 
unable to initiate haematopoietic cell clustering (Veiga-Fernandes et al., 2007).  
RET-dependent signalling also leads to the expression of lymphotoxins by CD11c+ 
cells, which interact with the lymphotoxin-ß receptor (LTßR) expressed by the 
VCAM-1+ stromal cells. This produces IL7 and homeostatic chemokines CXCL13 
and leads to further expression of surface lymphotoxin by LTi cells, resulting in the 
growth of PP (Yoshida et al., 2002). LTi cells are derived from common lymphoid 
progenitors, which are found in the foetal liver and give rise to all cells of the 
lymphoid lineage, including T cells, B cells, DCs, NK cells, and LTi cells (Mebius et 
al., 2001). The generation of LTi cells from common lymphoid progenitors require 
the expression of retinoic acid receptor-related orphan receptor-γt (RORγt) 
transcription factor (Eberl & Littman 2003). RORγt-deficient mice lacking LTi cells 
fail to develop PP, as well as lymph nodes and isolated lymphoid follicles (Eberl et 
al., 2004; Eberl et al., 2007). In contrast, very few CD11c+ cells are found in the 
developing lymph nodes (Van de Pavert et al., 2009) where the induction of 
lymphotoxin is fulfilled by receptor activator of nuclear factor κ B (RANK) 
signalling, a member of the tumour necrosis factor family (Kim et al., 2000). 
The PP contains numerous B cell lymphoid follicles, which are surrounded by 
smaller T cell areas. The presence of germinal centres on all PP structures is 
indicative of the continual immune stimulation that occurs in response to luminal 
antigens (Mowat & Agace 2014). Other macroscopic structures that also contain M 
cells are the caecal patches and colonic patches, distributed throughout the colon and 
the rectum (Owen et al., 1991). Recent studies suggest that the intestinal microbiota 
play a crucial role in the generation of IgA-producing plasma cells in the PP and 
caecal patches. While PPs seem to be the main source of IgA plasmablasts that are 
targeted to the small intestine, it is suggested that caecal patches may be the major 
site for IgA-producing plasma cells that migrate to the colon (Masahata et al., 2014; 





1.1.6.2 Cryptopatches and isolated lymphoid follicles 
The GALT also contains smaller lymphoid aggregates that can only be detected 
microscopically. These include the smaller cryptopatches (CPs) in mice and the more 
mature isolated lymphoid follicles (ILFs) (reviewed in Mowat & Agace, 2014). An 
ILF is a single B cell follicle, which has the capacity to develop a germinal centre 
following maturation (Knoop et al., 2011). ILFs are composed mainly of B cells 
surrounded by LTi or LTi-like cells, DCs, and stromal cells (Pearson et al., 2012). 
Like the PPs, ILFs are also covered by FAE-containing M cells, and therefore serve 
as an inductive site for IgA synthesis; however, unlike PPs, ILFs have no clear T cell 
zones and have been implicated as important sites for T cell-independent IgA class 
switching in mice. A single ILF can occupy the space of an entire villus, whereas 
CPs are smaller and found deep within the crypt LP. An adult mouse contains 
approximately 100-200 ILF in the small intestine and 50 in the colon. In comparison, 
1500 CPs are found in the small intestine and 150 in the colon (Hamada et al., 2002; 
Taylor & Williams, 2005; Knoop et al., 2011).  
Cryptopatches, which are yet to be identified in humans, develop postnatally within 
the first two weeks of life. They are present in germ-free mice and RAG-/- knockout 
mice lacking T and B cells. Cryptopatches contain DCs, common lymphoid 
progenitor cells and LTi-like cells (Pearson et al., 2012). In contrast, ILFs are absent 
in germ-free mice and in the foetus, and develop following re-colonization of mice 
gut with commensal bacteria. Hence, the development of ILFs in the small intestine 
requires stimulation from commensal microbiota. Such findings have led to the 
suggestion that the CP and ILF, rather than representing distinct types of intestinal 
lymphoid tissue, are two extremes on a continuum of solitary intestinal lymphoid 
tissue (SILT), whereby activated cryptopatches can develop into larger B cell 
follicles to form ILFs, which increase in size depending on the presence of 
microflora in the gut lumen (Pabst et al., 2006; Knoop et al., 2011; Eberl et al., 
2010). Indeed, it was recently shown, in a human-mouse chimeric model, that mouse 
cryptopatches can initiate human GALT genesis in which the resulting GALT 
structures first contain T cells, B cells, DCs, and macrophages, and secondly can 




1.1.6.3 Antigen uptake by intestinal cells 
Antigen uptake into the GALT is the first step required for the induction of the 
mucosal immune response. This can occur through several pathways involving M 
cells (direct and indirect mechanisms), epithelial cells, and DCs.  
 
1.1.6.3.1 M cells 
Within the FAE of GALT structures are specialised transcytotic epithelial cells 
known as microfold cells (M cells). M cells sample antigens directly from the gut 
lumen and transport them into the subepithelial dome region containing T cells, B 
cells, DCs, and macrophages (Neutra et al., 2001). Direct antigen uptake by an M 
cell occurs by various mechanisms, including phagocytosis, endocytosis, and 
macropinocytosis. Phagocytosis of whole bacteria can induce membrane ruffling and 
cytoskeletal rearrangements to form pseudopodia-like structures on the apical surface 
of the M cell (Borghesi, 1996). M cells also contain microfolds – instead of 
microvilli – on the apical surface that are rich in clathrin-coated pits, which mediate 
endocytosis of viruses and other particles (Acheson and Luccoili, 2004). 
Alternatively, non-adherent particles are internalised by fluid-phase endocytosis, 
known as macropinocytosis (Gebert & Bartels, 1995; Jung et al., 2010). In the small 
intestine, antigens are taken up by M cells in the FAE of the PP and ILF, whereas in 
the colon, the same antigen transport mechanism occur in the colonic ILF and caecal 
patches (Mowat & Agace 2014).  
Indirect antigen uptake through M cells in the FAE can also occur in the form of 
secretory immunoglobulin A (IgA) complexes. Secretory IgA complexes may consist 
of secretory IgA bound to soluble antigens, as well as secretory IgA-coated bacteria. 
Although the exact mechanism of secretory IgA-complex internalisation by M cells 
remain unknown, it is speculated that IgA binding to an antigen may induce 
conformational changes in the IgA complex that enable it to bind preferentially to M 
cells rather than to free secretory IgA (Schulz & Pabst, 2013). 
After internalisation, the particulate material is released into the M cell intraepithelial 
pockets. These are distinct subdomains in the M cell formed from deeply invaginated 
basolateral membrane (Neutra et al., 1996). Within these pockets, antigen-presenting 
cells – including B cells, macrophages, and DCs – internalise, process, and present 




1.1.6.3.2 Epithelial cells 
Antigen uptake can also occur in absorptive enterocytes lining the villous epithelium 
(Schulz & Pabst, 2013). Epithelial cells express neonatal Fc receptors (FcRn), which 
bind to IgG-antigen complexes for transport across the epithelium to underlying 
DCs. The FcRn expression is restricted to the neonatal period in mice, unlike in 
humans, who express it throughout life (Yoshida et al., 2004). Transgenic expression 
of the FcRn in mice promotes bidirectional transport of IgG across the epithelium 
and into the lumen, as well as the IgG-dependent sampling of luminal antigens across 
the epithelium (Yoshida et al, 2006). This bidirectional FcRn transport not only helps 
to sample the gut commensal microflora, but also inhibits colonisation of pathogenic 
bacteria by IgG secretion. This has been shown in mice infected with pathogenic 
bacteria including C. rodentium (Yoshida et al., 2006) or H. pylori (Ben Suleiman et 
al., 2012).  
 
1.1.6.3.3 Dendritic cells 
An alternative means of antigen entry is mediated by intestinal dendritic cells (DCs). 
These DCs are found in close association with the gut epithelium, as well as in the 
lamina propia. Rescigno et al (2001) first showed the in vitro uptake of non-
pathogenic E. coli and S. typhimurium by DCs through a monolayer of epithelial 
Caco-2 cells. These DCs were shown to extend dendrites in a paracellular manner 
between the epithelial cells by the formation of tight junction complexes, which did 
not disrupt the integrity of the epithelial barrier. These cells were subsequently 
shown to express the chemokine receptor CX3CR1 (Neiss et al., 2005). Upon oral 
administration of fluorescent E. coli or non-invasive S. typhymurium to CX3CR1-
deficient mice, there was an absence of transepithelial protrusions and reduced 
bacterial translocation to the MLN (Niess et al., 2005). Taken together, these studies 
confirm that CX3CR1+ cells express tight junction proteins which enable them to 
extend ‘trans-epithelial dendrites’ (TEDs) through the epithelial barrier to sample 
bacterial antigens in the gut lumen (Rescigno et al., 2001; Niess et al., 2005; Vallon- 
Eberhard et al., 2006).  
TED formation by CX3CR1+ cells is dependent on the presence of microbial 
products and TLR signalling in epithelial cells (Chieppa et al, 2006), since 
challenging mice with pathogenic bacteria or TLR ligands increased the number of 
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TEDs (Niess et al., 2005; Chieppa et al., 2006). In addition, DCs from germ-free 
mice, MyD88-deficient animals, and mice treated with antibiotics exhibit reduced 
numbers of TED processes (Niess et al., 2005; Niess & Adler, 2010). CD103+ DCs, 
another subset of DCs, have also been implicated in the capture of luminal antigens, 
upregulated expression of maturation markers, and migration to secondary lymphoid 
organs (Jaensson et al., 2008). This alternative route of antigen entry has important 
physiological relevance because the DCs, which are migratory cells, can transport 
pathogens/antigens directly to the MLN and spleen for induction of the systemic 
immune response.  
 
1.1.6.4 Antigen presentation and lymphocyte migration in the GALT 
Following entry into the GALT, antigens are processed by antigen presenting cells 
(APCs) located below the dome of the epithelium. These APCs then move to T cell 
areas or B cell follicles where they can interact with naïve lymphocytes. APC 
interaction with naïve CD4+ T cells generate T helper (Th) cell responses that lead to 
the activation of B cells within germinal centres of GALT follicles (Brandtzaeg, 
2009). In the follicles, B cells undergo immunoglobulin class switching from 
expression of IgM to IgA in the presence of TGFβ, IL10, microbial signals, and 
other cellular signals from DCs and T cells (Cerutti et al., 2008). Mice with reduced 
bacterial colonisation display PPs with smaller and fewer germinal centres, while a 
lack of the TLR-associated adapter protein MyD88 results in an altered IgA response 
(Fagarasan et al., 2010; Chorny et al., 2012).  
The primed lymphocytes exit the PP and enter the mesenteric lymph node (MLN) 
through the draining lymphatics, where they may undergo further differentiation. The 
cells then migrate to the bloodstream through the thoracic duct before homing back 
to the LP to carry out effector functions (Brandtzaeg, 2011). Lymphocytes primed in 
the GALT lose expression of L-selectin and specifically upregulate the expression of 
gut-homing markers. The interaction of the gut-homing receptors α4ß7 integrin and 
chemokines CCR9, with their corresponding ligands MAdCAM-1 and CCL25, 
respectively, facilitate lymphocyte migration to the LP (Mora, 2008). The addressin 
MAdCAM-1 and CCL25 are found on endothelial cells of the tissue post venules of 
the small and large bowel, while the gut-homing molecules α4ß7 and CCR9 are 
imprinted on activated T and B cells by gut-associated DCs (Mora, 2008; Cassani et 
al., 2012).  
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Gut-associated DCs express high levels of retinaldehyde dehydrogenase enzymes 
that enable them to metabolise retinoic acid from vitamin A (retinol) in the diet 
(Iwata et al., 2004). Vitamin A is essential for lymphocyte homing to the intestine, as 
retinoic acid upregulates the expression of gut-homing receptors (α4ß7 and CCR9) 
on lymphocytes while suppressing the expression of skin-homing markers (L-
selectin) on lymphocytes (Iwata et al., 2004). As well as lymphocyte homing, 
vitamin A enhances B cell class switch recombination (CSR) (Mora et al., 2006; 
Cerutti and Rescigno, 2008) and has been implicated in the modulation of Foxp3+ 
regulatory T cell (Treg) and Th17 cell differentiation (Kang et al., 2007; Wang et al., 
2010). Studies using vitamin A depleted mice demonstrate a reduction in the level of 
free retinol and retinyl esters, an absence of T cells and IgA secreting plasma cells in 
the small intestine, and an inability to induce gut tropic effector T cells (O’Byrne et 
al., 2005; Iwata et al., 2004; Mora et al., 2006; Hall et al., 2011).  
Activated effector lymphocytes primed in the GALT and expressing gut-homing 
markers enter the LP and epithelium effector sites. Here, they generate protective 
immune responses including cytotoxic T lymphocytes, cytokine secreting T helper 
(Th) cells, and mature B cells (plasma cells) that produce secretory IgA. These 
effector responses can lead to tolerance of food and commensals or rejection of 
pathogenic microbes, depending on the initial antigen encountered by the APCs in 
the GALT inductive sites. Adaptive mucosal immune responses result from T cell 
help, by either Th1 or Th2 cells, which support the development of IgA-producing 




1.2 Citrobacter rodentium  
C. rodentium infection in mice has been used extensively to study host mucosal 
immune response to enteric pathogens. Mice infected with C. rodentium display 
colonic inflammation (hyperplasia) accompanied by a Th1 immune response, making 
this model particularly relevant for the in vivo study of host inflammatory responses. 
In addition, since C. rodentium infection is limited to the intestinal mucosa, it is also 
used to model important human intestinal diseases such as Crohn’s disease, 
ulcerative colitis, and colon tumorigenesis. C. rodentium is host-adapted to 
laboratory mice, such that both the pathogen and the host can be genetically 
manipulated. Furthermore, the ability to quantify bacterial burden during C. 
rodentium infection, and the availability of the completed C. rodentium genome 
sequence, makes C. rodentium an ideal model system to study host-pathogen 
relationship in the gut.  
C. rodentium, a natural pathogen of mice, infects the distal colon and causes 
transmissible murine crypt hyperplasia (TMCH). C. rodentium is transmitted by the 
faecal-oral route, and disease severity varies depending on mice strain, age, genetic 
background, and the composition of the mice intestinal microbiota (Barthold et al, 
1978; Vallance et al, 2003; Collins et al, 2014). Infection of highly susceptible mice, 
such as young, inbred, genetically modified or C3H mice, can lead to severe 
inflammation and death. In contrast, resistant mice, including Balb/c, adult, or 
immunocompetent mice, display a self-limiting disease with minimal inflammation 
and tissue damage upon C. rodentium infection (Barthold et al, 1978; Mundy et al, 
2005; Vallance et al, 2003; Collins et al, 2014). Although C. rodentium is non-
invasive and colonises the surface of gut epithelial cells (Fig. 1.5), it can spread to 
systemic sites including the blood, spleen, and liver in mice in which the protective 
immune response is impaired (Collins et al, 2014). For infection studies, mice are 
usually orally gavaged with laboratory cultured C. rodentium whereby the course of 
infection can be monitored mainly through quantification of bacteria in the faecal 
shedding.  
 
1.2.1 Course of infection 
Following the oral gavage of mice with C.rodentium, bacteria colonise the caecum 
during the first day of infection and progress to the distal colon by day 2-3 post 
inoculation (p.i). Bacterial colonisation of the caecal patch, which is the largest 
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lymphoid structure in the caecum, is thought to facilitate the establishment of 
disease, as it is the site where bacteria adapt to the gastrointestinal environment and 
switch on virulence genes (Wiles et al, 2004; Wiles et al, 2006; Collins et al, 2013). 
Following bacterial colonisation of the distal colon and rectum, there is a peak of 
infection, during which bacterial shedding can release hyperinfectious bacteria into 
the environment and disease can be transmitted to uninfected mice via the faecal-oral 
route (Wiles et al, 2005; Bishop et al, 2007). Increased growth of C. rodentium in the 
colon leads to a reduction in the overall diversity of commensal microbiota (Lupp et 
al, 2007; Collins et al, 2014). Bacteria begin to clear from the caecum and the colon 
after the second week of infection, until complete clearance is seen at 3-4 weeks p.i 
















Figure 1.3 : C. rodentium colonisation of mouse intestinal epithelial cells (IEC) 
in vivo. Immunofluorescent staining of mouse colonic tissue at day 6 p.i using C. 
rodentium-specific anti-Tir antibody (green) and DAPI (blue) as a counterstain for 





1.2.2 Transmissible murine crypt hyperplasia (TMCH) 
The main pathological feature of C. rodentium infection is transmissible murine 
crypt hyperplasia (TMCH) (reviewed in Collins et al, 2014). TMCH is characterised 
by the elongation of colonic crypts and thickening of the mucosa (Fig 1.6). This 
occurs due to the induction of excessive intestinal epithelial repair processes, which 
include epithelial cell proliferation, epithelial cell turnover, and shedding of infected 
epithelial cells into the gut lumen (Luperchio and Schauer, 2001; Mundy et al, 2005; 
Bergstrom et al, 2012; Collins et al, 2014). Epithelial cell proliferation is triggered by 
the activation of specific signalling pathways in response to bacterial attachment to 
epithelial cells (Higgins et al, 1999; Collins et al, 2014). For example, the activation 
of host TLR4 and TLR2 in response to C. rodentium infection was shown to 
contribute to MyD88 signalling and the downstream activation of NFκB pathway 
required for the proliferative response of crypt epithelial cells (Lebeis et al, 2007; 
Khan et al, 2006; Gibson et al, 2008b; Collins et al, 2014). TMCH is also triggered 
by the loss of epithelial barrier integrity and the translocation of bacteria into the LP 
(Gibson et al, 2010).  
Although the initiation of TMCH does not depend on T or B cells, as indicated by 
the presence of TMCH in RAG-/- knockout mice, adaptive immunity is required for 
bacterial clearance and the resolution of TMCH (Vallance et al, 2003; Collins et al, 
2014). TMCH may be beneficial for C. rodentium infection as it provides increased 
surface area for bacterial adherence and enables reduction of commensal microbiota, 
resulting in a competitive advantage for C. rodentium colonisation. In addition, 
TMCH enhances the transmission of bacteria to other hosts through increased 
shedding of epithelial cells and C. rodentium into the gut lumen (Higgins et al, 
1999). However, increased epithelial cell shedding in TMCH can also contribute to 
host resistance, because it can facilitate the removal of infected cells and enhance 
bacterial clearance (Bergstrom et al, 2012).   
Another pathological feature of C. rodentium infection is goblet cell depletion in the 
colon of infected mice (Fig. 1.6) (Luperchio & Schauer, 2001). Although goblet cells 
are abundant in the colon and secrete Mucin 2, which has been shown to provide 
protection against C. rodentium (McGuckin et al, 2011; Bergstrom et al, 2010), the 
reduction in goblet cell numbers during C. rodentium infection can also be beneficial 
to the host (Chan et al, 2013). In a recent study by Chan et al (2013), C. rodentium 
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was observed to preferentially localise within crypts that were non-hyperplastic and 
contained numerous goblet cells, compared to hyperplastic, goblet cell-depleted 
crypts, which were protected from infection. In addition, goblet cell depletion 
appeared to be driven by IFNγ production from CD4+T cells, as mice lacking 
CD4+T cells did not exhibit goblet cell depletion (Bergstrom et al, 2008; Chan et al, 
2013). This suggests that goblet cell depletion is a protective host response against C. 
rodentium whereby the reduction in goblet cell numbers may reduce the surface area 




Figure 1.4: H &E stained colonic sections from C. rodentium infected mice. (A) 
Normal colonic architecture from uninfected mice (B) colon showing crypt 
hyperplasia, goblet cell depletion, and mild inflammation from 31-day old Swiss-




1.2.3 Host immune response to C. rodentium infection in mice 
The requirement for both innate and adaptive immunity for the clearance of C. 
rodentium (Appendix A) has been widely demonstrated in various genetically 
modified mice lacking specific components of the immune system (Appendix B). 
Due to space restrictions, I will be focusing on the role of pattern recognition 
receptors, innate lymphoid cells, and adaptive immunity in the resolution of C. 
rodentium-mediated disease (Fig. 1.7). 
 
1.2.3.1 Pattern recognition receptor signalling  
C. rodentium and its pathogen-associated molecular patterns (PAMPS)—including 
lipopolysaccharides (LPS), peptidoglycans, and the T3SS—are recognised by 
MyD88-dependent TLR signalling (Gobert 2005; Collins et al, 2014), which has 
been shown to be essential for host defences against C. rodentium (Fig. 1.7a). Mice 
deficient in MyD88 are unable to control C. rodentium growth in colonic tissue, fail 
to recruit neutrophils and macrophages to the site of infection, unable to produce 
iNOS that contribute to the direct killing of C. rodentium, and unable to promote 
epithelial cell turnover and repair (Vallance et al, 2004; Lebeis et al, 2007; Gibson et 
al, 2008b; Bergstrom et al, 2012). The main contributors to MyD88-mediated 
signalling during C. rodentium infection are TLR2 and TLR4 (Fig.1.7a), which have 
been shown to control the production of proinflammatory cytokines TNFα, IL6 and 
keratinocyte chemoattractant (KC) as well as the upregulation of iNOS (Gibson et al, 
2008a; Lebeis et al, 2007; Bergstrom et al, 2012; Collins et al, 2014). Although C. 
rodentium is extracellular, the intracellular Nod-like receptors NOD1 and NOD2 
have also been implicated in triggering innate host responses to C. rodentium (Fig. 
1.7) (Geddes et al, 2011). Mice deficient in NOD1 and NOD2 display high systemic 
loads of C. rodentium throughout the course of infection (Kim et al, 2011; Geddes et 
al, 2011). This is because NOD2 signalling results in the production of monocyte 
chemotactic protein 1 (MCP1) or CCL2, which is involved in the recruitment of 
CD11c+ inflammatory monocytes to the site of infection for bacterial killing (Kim et 
al, 2011; Geddes et al, 2011). NOD1 and NOD2 signalling also provide protection 
against pathogen-induced damage by stimulating the production of IL17 by innate 




1.2.3.2 Innate lymphoid cells 
The group 3 innate lymphoid cells (ILC3s), which are induced early during C. 
rodentium infection, belong to a newly identified group of innate lymphoid cells that 
produce T helper cell-associated cytokines but do not express a T cell receptor 
(Walker et al, 2013). These cells develop as a result of bacterial imprinting by the 
intestinal microbiota (Geddes et al, 2011). ILC3s are important producers of IL17 
and IL22 cytokines, which are both essential in the control of C. rodentium infection 
(Fig. 1.7b) (Collins et al, 2014).  
ILC3s are an important source of IL-22 production in the gut (Ahlfors et al, 2014). 
During the early stages of C. rodentium infection, IL22 is upregulated and provides 
protection by regulating the secretion of antimicrobial proteins (RegIII) from 
epithelial cells (Zheng et al, 2008). IL22 also maintains epithelial barrier integrity 
and prevents the dissemination of bacteria (Ahlfors et al, 2014). The fact that IL22 is 
produced from an innate cell source emerged from studies using RAG1-/- KO mice, 
in which IL22 maintained the epithelial barrier integrity and contained C. rodentium 
infection despite the absence of T and B lymphocytes (Vallance et al, 2002). 
However, these mice eventually died as a result of chronic inflammation. 
Furthermore, mice lacking the ILC3 subset failed to contain C. rodentium infection 
in the gut, and, like IL22-/- mice, exhibited an increased infiltration of inflammatory 
cells and mucosal hyperplasia (Zheng et al, 2008; Lee et al, 2012; Walker et al, 
2013). ILC3s therefore provide a rapid source of IL22 to strengthen the epithelial 
barrier in response to C. rodentium.  
The IL22 response to C. rodentium is dependent on a lymphotoxin pathway, since in 
the absence of lymphotoxin signalling, mice succumb to infection (Tumanov et al, 
2011). Lymphotoxin, expressed by the RORγt transcription factor, propagates a 
signal through the lymphotoxin receptor (LTβR) present on DCs, macrophages, and 
epithelial cells. This induces the production of IL23, which binds to and activates the 
IL23R on ILCs to produce IL22. IL22 signals via IL22R on intestinal epithelial cells 
to drive the expression of antibacterial proteins (RegIIIγ and RegIIIβ) and promote 
epithelial barrier integrity and epithelial cell generation. IL-22-dependent RegIIIγ 
secretion is crucial for protection against C. rodentium, as exogenously added 
RegIIIγ rescues IL-22-deficient mice from fatal infection (Zheng et al, 2008). In the 
later stages of C. rodentium infection, however, CD4+T cells (Th17) function as the 
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main source of IL22 that is dependent on IL6 (Basu et al, 2012). The production of 
IL22 from both ILC3s and Th17 cells is therefore required to provide complete 
protection against C. rodentium infection (Basu et al, 2012; Collins et al, 2014). 
 
1.2.3.3 Th17 cell response: 
Citrobacter rodentium induces a potent Th17 cell response, which is stronger than a 
IFNγ mediated Th1 response one week after oral inoculation of mice (Mangan et al, 
2006). During the peak of infection (Day 8 p.i), a higher frequency of colonic 
CD4+T cells express IL17 in comparison to a smaller fraction of cells expressing 
IFNγ (Mangan et al, 2006). Although host protection was previously associated with 
IFNγ mediated Th1 dependent IgG response (Simmons et al, 2003), the expression of 
IL17 and IL22 cytokines by Th17 cells appear to play an important role in 
controlling the severity of gut pathology and C. rodentium infection (Collins et al, 
2014). In particular, IL17 promotes the recruitment of neutrophils and other effector 
cells to the site of infection while IL22 activates epithelial cell defenses through the 
expression of antimicrobial peptides and mucus production (Chen et al, 2014; Wang 
et al, 2014). Deficiencies in any of the Th17 cell effector molecules or the IL17 
receptors including IL17A, IL17F, IL17RA or IL17RE, result in the reduction of 
neutrophil recruitment and expression of genes encoding antimicrobial peptides 
which in turn leads to the increase in bacterial burden, mucosal ulceration, bacterial 
dissemination and early mortality following C. rodentium infection (Geddes et al, 
2011; Song et al, 2011; Collins et al, 2014).  
During infection of mice with C. rodentium, the CD4+Th17 cell subset was observed 
to increase in the PP but not in the MLN (Li et al, 2014). Further studies revealed 
that IL6 is required for the differentiation of Th17 cells in the PP, since treatment 
with anti-IL6 neutralizing antibodies reduced the Th17 cell subset, resulting in 
increased susceptibility of mice to C. rodentium infection (Li et al, 2014). In addition 
to IL6, TGFβ contributes to the development of Th17 cells (Mangan et al, 2006). By 
actively suppressing the production of IFNγ (a potent inhibitor of Th17 development) 
TGFβ inhibits Th1 immune responses and promotes Th17 cell development. In the 
presence of IL23, TGFβ induces further suppression of IFNγ+ cells and increases the 
fractions of Th17+ cells. Mice deficient in IL23 failed to clear the high bacterial load 
and succumbed to infection (Mangan et al, 2006). 
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Furthermore, the generation of a Th17 cell response is influenced by the intestinal 
microbiota, since germ free mice have substantially fewer IL17 producing CD4+ T 
helper cells than specific pathogen free mice (Ivanov et al, 2008). Faecal microbiota 
transplantation (FMT) and cohousing studies reveal that mice that have higher Th17 
cell numbers, have higher levels of SFB in their microbiota, and the introduction of 
SFB into germ free mice or Th17 cell deficient mice induce the appearance of IL17 
and IL22 producing CD4+T helper cells in the lamina propia. SFB mediated Th17 
response is correlated with increased expression of genes associated with 
inflammation and anti microbial defenses resulting in enhanced resistance against C. 
rodentium (Ivanov et al, 2009). SFB typically adhere tightly to the epithelium in the 
ileum where they have been suggested to induce the production of serum amyloid A 
that act on lamina propia DCs to promote Th17 cell differentiation. SFB colonized 
mice that have been infected with C. rodentium, display reduced colon mucosal 
thickness, a decrease in bacterial titre recovered from the colon wall and an overall 
reduction in the growth and colonization of C. rodentium in mouse distal colon 
(Ivanov et al, 2009; Ivanov & Littman, 2010). 
 Recent studies suggest that adhesion of SFB to the intestinal epithelial cells is 
critical in the induction of a Th17 response (Atarashi et al, 2015). Similarly, strong 
adhesion of C. rodentium to intact epithelial cells was shown to stimulate the 
production of reactive oxygen species, which lead to the induction of a potent Th17 
response. Mice colonised with C. rodentium lacking intimin, a protein essential for 
epithelial cell adhesion, were unable to adhere to epithelial cells resulting in a weak 
Th17 cell response (Atarashi et al, 2015). 
Moreover the development of the Th17 cell response is associated with C. 
rodentium-induced apoptosis of IECs (Torchinsky et al, 2009, Collins et al, 2014).  
The phagocytosis of infected apoptotic IECs by innate immune cells, such as DCs, 
trigger the release of cytokines IL6 and TGFβ, which play an important role in the 
differentiation and proliferation of Th17 cells. Blocking apoptosis of IECs during C. 
rodentium infection impairs the development of the Th17 cell response in the lamina 
propia (Torchinsky et al, 2009). Phagocytosis of apoptotic cells in the absence of 
microbial signals induce the differentiation of regulatory T cells that are important 
for controlling autoimmunity. Effector Th17 cells produce IL17, IL10 and IL22 
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which are important for the clearance of C. rodentium as well as repair of the 
infection-damaged intestinal epithelium (Torchinsky et al, 2009). 
1.2.3.4 Adaptive immune cells 
Mice infected with C. rodentium elicit a T helper 1 (Th1) cell response, characterised 
by a large infiltrate of CD4+T cells in the LP and an increased production of IL12, 
TNFα, and IFNγ in the colonic tissue (Higgins et al, 1999). Many of the effector 
functions of CD4+T cells are mediated by IFNγ, as mice lacking CD4+T cells or 
IFNγ have increased susceptibilities to C. rodentium infection (Simmons et al, 2003; 
Bry & Brenner, 2004; Shiomi et al, 2010). IFNγ, amongst other functions, stimulates 
the activation of antigen-specific T helper cells that lead to the subsequent increase 
in B cell production of antigen-specific IgG (Shiomi et al, 2010). Mice lacking B 
cells show similar pathology and mortality in response to C. rodentium infection as 
mice lacking CD4+T cells. The administration of immune sera from wildtype mice 
that have recovered from infection protects B cell-deficient mice and CD4+T cell-
deficient mice from systemic infection and mortality (Simmons et al, 2003; Maaser 
et al, 2004; Bry et al, 2006; Belzer et al, 2011). Passive immunization with serum 
IgG is sufficient to protect CD4-deficient mice from fatal infection, while mice 
lacking secretory IgA, secretory IgM, or proteins required for their transport into the 
lumen (pIgR or J chain) clear C. rodentium normally (Bry and Brenner, 2004; 
Maaser et al, 2004; Uren et al, 2005).   
Although the mechanism of IgG entry into the gut lumen is unclear, studies suggest 
that FcRn-mediated epithelial transport may play a role (Bry et al, 2006; 
Spiekermann et al, 2002). Infection of C57Bl/6 mice with C. rodentium, generates 
high numbers of IgG2c and IgG2b, which enter the intestinal lumen (Bry et al, 2006) 
and bind to neutrophil Fcγ receptors for pathogen opsonization. These antigen-
associated IgG complexes can further activate the complement system since 
complement protein C3b and IgG isotypes were found coating the surface of C. 
rodentium bacteria shed in mice stool (Belzer et al, 2011). This suggests that C. 
rodentium opsonization with IgG and/or C3 molecules may enhance the uptake and 
killing of C. rodentium by neutrophils, while the activation of the complement 
cascade can have direct antimicrobial effects, including bacterial lysis and 
neutralisation of bacterial adhesins (Belzer et al, 2011).  
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Collectively, these studies show a dynamic interplay between components of the 
innate and adaptive immune system to initiate a well-coordinated host response 
against C. rodentium infection. Therefore, C. rodentium serves as an ideal model for 
the study of host-pathogen relationship in the gut. In addition, since C. rodentium 
possesses a type 3 secretion system (T3SS) and shares many of its virulence genes 
and disease strategies with pathogenic E. coli, it is also an excellent small-animal in 


















Figure 1.5: Immune response to C. rodentium infection. C. rodentium infection in mice 
triggers host inflammation through the recognition of lipopolysaccharide (LPS), the type III 
secretion system (T3SS), and peptidoglycans by host TLRs. (A) C. rodentium recognition 
by host TLR2, TLR4, and NOD proteins initiates MYD88 signalling, which results in the 
activation of NFκB and the production of the proinflammatory cytokines IL-6, IL-12, IL-
23, and TNF by innate immune cells, including dendritic cells, macrophages, and 
neutrophils. C. rodentium also induces IL-1β and IL-18 production by macrophages and 
dendritic cells via the caspase 1-dependent NLRP3 inflammasome. (B) C. rodentium 
infection induces TH1 and TH17cell responses, which drives host resistance to C. rodentium 
infection through the production of IL-17A (which recruits neutrophils) and IL-22 (which 
upregulates the expression of antimicrobial peptides, RegIIIβ and RegIIIγ in colonocytes). 
In the caecum, group 3 innate lymphoid cells (ILC3s), induced early during infection in a 
NOD-dependent manner, are an important source of IL-17 and IL-22 and contribute to the 



















Enteropathogens are specific gram-negative bacteria that have acquired sophisticated 
strategies to breach the intestinal barrier, exploit the mucosa to replicate and 
disseminate, and cause intestinal disease (reviewed in Sansonetti & Santo, 2007; 
Coburn et al, 2007). Many successful enteropathogens possess a specialized 
macromolecular export apparatus known as a type three secretion system (T3SS) to 
inject virulence proteins (effectors) directly into the cytoplasm of host cells (Cornelis 
2006; Coburn et al, 2007; Erhardt et al, 2010). Inside host cells, effectors target 
subcellular structures and components of the host cell machinery including tight 
junctions, cytoskeletal proteins, microtubules, mitochondria, Golgi, nucleus, and 
plasma membranes to regulate actin dynamics, subvert endocytic trafficking, block 
phagocytosis, modulate apoptotic pathways, and manipulate host inflammatory 
responses (Dean et al, 2011). Subversion of host cellular processes by the T3SS 
effectors enable the non-invasive enteropathogens to successfully attach to and 
colonise host intestinal epithelial cells while facilitating invasive enteropathogens to 
invade intestinal epithelial cells, survive intracellularly and disseminate to deeper 
tissues (reviewed in Reis & Horn, 2010; Raymond et al, 2013). 
The T3SS is the most complicated secretion system in bacteria (Cornelis et al, 2006; 
Coburn et al, 2007).  It is made up of approximately 25 proteins and delivers over 20 
effectors to the host target cell (Cornelis 2010). The T3SS enables bacteria to 
transport proteins directly across the bacterial cell wall and the eukaryotic cellular 
membranes (Pugsley, 1993; Galan et al, 1999; Coburn et al, 2007). It differs from 
other bacterial secretion systems because it requires host cell contact for activation of 
the T3SS pathway and the presence of chaperone proteins for effector translocation 
(Cornelis 2006). The T3SS apparatus is highly conserved among the different 
pathogens and shares a strong homology to components of the flagellar system 
(Blocker et al, 2003; Erhardt et al, 2010). Although the presence of the flagellar 
system in both gram-positive and gram-negative bacteria suggests that all T3SS may 
have evolved from the flagellum (Hueck 1998; Macnab 2004), phylogenetic studies 
indicate that the flagellum and the injectisome are both ancient and may share a 
common ancestor instead (Gophna et al, 2003; Cornelis 2006). The T3SS is present 
in over 25 species of gram-negative bacteria, including the causative agents of 
pneumonia (Pseudomonas), plague (Yersinia), typhoid fever (Salmonella), dysentery 
 
57 
(Shigella) and bloody diarrhoea (E. coli) (Dean et al, 2011). Due to space limitations, 
the focus here will be on the attaching effacing pathogens comprising of EPEC, 
EHEC, and C. rodentium for the purposes of this thesis.   
 
1.3.1 Attaching Effacing Pathogens 
Enteropathogenic E. coli (EPEC), enteroheamorrhagic E.coli (EHEC), and 
Citrobacter rodentium are gram-negative, non-invasive, extracellular bacteria that 
belong to the attaching and effacing (AE) group of pathogens. These 
enteropathogens are characterised by their ability to create AE lesions on mucosal 
surfaces of the host gastrointestinal tract (Fig. 1.9a -1.9b). Bacterial translocation of 
effectors into the host cell subverts host cytoskeletal pathways that lead to the 
formation of pedestal-like structures. These are raised surfaces of electron-dense 
material consisting mostly of polymerised actin filaments that protrude into the 
lumen on which the bacteria reside (Fig.1.9c – Fig.1.9d). Pedestal formation 
facilitates increased bacterial adherence (attachment) and the loss or destruction of 
the microvilli brush border (effacement) on the surface of enterocytes (Nataro & 
Kaper 1998; Wales et al, 2005; Clements et al, 2012; Lai et al, 2013).  
EPEC is a major cause of infectious diarrhoea in children worldwide, producing 
significant morbidity and mortality in developing countries. EPEC is transmitted by 
human carriers through the faecal-oral route, weaning fluids, and contaminated 
surfaces (Nataro & Kaper, 1998). The ingestion of contaminated food and water has 
been responsible for causing rare outbreaks amongst adults (Croxen et al, 2013). 
EPEC colonises the small bowel, resulting in diarrhoea accompanied by fever, 
vomiting, and dehydration in children under 2 years of age (reviewed in Nataro & 
Kaper, 1998; Croxen et al, 2013). EPEC is classified into “typical” and “atypical” 
subtypes based on the presence of an E. coli adherence factor (EAF) plasmid 
(Croxen et al, 2013). Humans are the only known reservoir for typical EPEC, while 
atypical EPEC has been isolated from human and animal sources, including dogs, 
rabbits, monkeys, and sheep (Swennes et al, 2012). The strain E2348/69 is a 
prototype of EPEC and is used widely in the laboratory to model AE pathogenesis.  
EHEC is a subset of Shiga toxin-producing E. coli (STEC) associated with 
haemorrhagic colitis (HC) and the fatal haemolytic-uremic syndrome (HUS) (Nataro 
& Kaper, 1998). EHEC colonizes the large bowel in humans and can cause mild to 
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bloody diarrhoea in both adults and children. It often causes outbreaks of severe 
gastroenteritis in developed countries, commonly by the EHEC serotype O157:H7 in 
contaminated food and water. Disease transmission usually occurs through the 
faecal-oral route and the infectious dose is very low. Cattle are widely known to be 
major reservoirs for EHEC because exposure to their faecal matter is an important 
source of human illness. EHEC virulence factors include Shiga toxin (also known as 
Vero toxin) and hemolysin, a pore-forming toxin that lyses erythrocytes (Croxen et 
al, 2013). 
C. rodentium is the only known AE lesion-forming pathogen to infect mice. The 
LEE of C. rodentium also shows striking similarity to that of EPEC and EHEC (Fig. 
1.8) (Deng et al, 2001) and is required to produce AE lesions in mouse intestinal 
cells (Schauer & Falkow 1993). Although C. rodentium infection results in colonic 
inflammation and hyperplasia (Barthold et al, 1978) rather than causing obvious 
diarrhoea, as is the case with EPEC and EHEC, mouse infection with C. rodentium 
has greatly improved our understanding of AE pathogenesis and virulence 
mechanisms in vivo. Attaching and effacing pathogenesis occurs in a sequential 
process, which in this thesis is described in 4 stages: adherence, assembly of the 






Figure 1.6: Virulence genes in EPEC and C. rodentium. Taken from Deng et al. 
(2001). The organisation of virulence genes between the AE pathogens are very 
similar. The LEE core region for both EPEC and C. rodentium is 36kb and contain 
41 open reading frames (ORFs) that are organised into 5 operons (LEE 1-5). The  
core region of C. rodentium LEE is 98% identical to that of EPEC.  
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Figure 1.7: Attaching effacing lesion and pedestal formation in AE pathogens. 
(A) Uninfected intestinal surface showing normal microvilli. (B) EPEC infected 
intestinal cell surface showing loss of microvilli. Taken from 
(www.staff.ncl.ac.uk/p.dean/body_index.html). (C) Transmission electron 
micrograph (TEM) showing A/E lesions induced by EHEC in the colon of a calf 
where the microvillus effacement and the raised electron-dense pedestals are clearly 
visible. Taken from Stevens and Frankel (2014). (D) Scanning electron microscope 
image of EPEC (purple) sitting on top of a pedestal (orange). Image originally 




The first stage in the AE lesion process involves the non-intimate adhesion of EPEC 
to host enterocytes in the small bowel. This is mediated by bundle-forming pili 
(BFP) encoded by the E.coli adherence factor (EAF) plasmid present in typical 
EPEC (Giron et al, 1991; Trabulsi et al, 2002). Bundle-forming pili (BFP), 
synthesised in response to bacterial contact with host cells, are rope-like filaments 
that can interact with receptors on the microvilli of host enterocytes (Hyland et al, 
2008).  Bundle-forming pilli also interact with other EPEC bacteria to produce 
localised adherence and form characteristic EPEC microcolonies. There is evidence 
that E. coli common pilus may also act in combination with the BFP to stabilize 
EPEC attachment to host cells (Saldana et al, 2009). Following BFP production, 
adhesion of typical EPEC to the epithelial cells activates the assembly of the T3SS. 
Atypical EPEC strains, however, do not possess the EAF plasmid and so do not 
produce BFP. Instead they form loose clusters of bacteria in a localised adherence-
like pattern that is slower to establish than localised adherence. In addition, EPEC 
encodes a lymphocyte inhibitory factor, a surface protein required for epithelial cell 
adherence in vitro and intestinal colonisation of mice by C. rodentium in vivo (Badea 
et al, 2003; Klapproth et al, 2005). Lymphocyte inhibitory factor, more commonly 
found in typical rather than atypical EPEC, has been identified as the largest effector 
to be secreted by T3 pathogens (Vieira et al, 2010). Although the initial attachment 
of EHEC to enterocytes in the colon is not well-defined, recent work has identified a 
role for haemorrhagic coli pilli, flagella, and the E. coli common pilli in the 
adherence of EHEC to host cells (Xicohtencatl-Cortes et al, 2009; Erdem et al, 2007; 
Rendon et al, 2007). The initial attachment of AE pathogens with host epithelial cells 
initiates the assembly of the T3SS injectisome.  
 
1.3.3 Assembly of the T3SS injectisome  
The T3SS injectisome is a supermolecular complex that is made up of the basal 
body, needle, and pore complex (Fig.1.10) (Sekiya et al, 2001; Cornellis 2006). The 
basal body of the injectisome spans the inner and outer membranes of the bacteria 
and is composed of scaffolding proteins, an export apparatus, and an ATPase 
complex. The needle extends from the basal body to the extracellular environment, 
and the needle tip is connected to the host cell by the pore complex in the host cell 
membrane. The complete injectisome, when docked onto a host cell, allows the 
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translocation of proteins directly from the bacteria to the host cell cytosol (Dewoody 
et al, 2013; Monjaras Feria et al, 2012)  
Assembly of the injectisome is a sequential, tightly regulated process (Cornelis, 
2006; Deane et al, 2010). In AE pathogens, basal body formation begins with the 
oligomerisation of EscC secretin, which forms a ring in the bacterial outer membrane 
(OM), followed by assembly of an inner membrane (IM) ring using proteins EscD 
and EscJ (Diepold et al, 2010; Gauthier & Finlay, 2003). Together these proteins 
create a scaffold anchored within the peptidoglycan, which serves as a base for the 
assembly of the remaining injectisome components.  
The export apparatus is localised in a patch of membrane within the inner membrane 
ring. This is made up of the integral membrane proteins EscR, EscS, EscT, EscU, 
and EscV, and its assembly is independent of the scaffolding proteins (Moraes, 2008; 
Wagner et al, 2010). The formation of the EscN ATPase occurs on the cytosolic face 
of the basal body (Andrade et al, 2007). This energizes the secretion process and also 
functions as a docking site for the chaperone-effector complexes present in the 
bacterium prior to secretion (Gauthier & Finlay 2003; Zarivach et al, 2007; Feria et 
al, 2012). The joining of the scaffold with the export apparatus and the ATPase 
complex completes the basal body formation, which is then capable of exporting 
secretion substrates. The protein substrates are secreted in 3 stages: early substrates 
(inner rods and needle subunits), middle substrates (translocators), and late substrates 
(effectors) (Deane et al, 2010; Buttner et al, 2012). This is summarised in Table 1.1. 
Upon completion of the basal body, the “early” substrates, necessary for needle 
assembly, are exported (Table 1.1). One of the first proteins to be translocated is the 
EscI protein, which polymerises to form the periplasmic inner rod of the T3SS basal 
complex (Sal-Man et al, 2012). Secreted through the inner rod are the EscF subunits, 
which polymerise to form the extracellular needle to an approximate length of 50 nm 
(Diepold et al, 2012; Wilson et al, 2001). Regulation of the needle length is carried 
out by “ruler” proteins, which are known as YscP in Yersinia, Spa32 in Shigella, 
InvJ in Salmonella, and, more recently, EscP in E. coli (Journet et al, 2003; Feria et 
al, 2012). Mutations in these genes result in the production of abnormally long 
needles and the inability of the T3SS to secrete “middle” and “late” substrates 
(Journet et al, 2003; Feria et al, 2012). 
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When the needle reaches full length, a substrate specificity switch is triggered, which 
arrests needle export. The substrate specificity switch is mediated by the interaction 
of EscP with EscU of the export apparatus, resulting in the autocleavage of EscU 
(Minamino et al, 2005). The substrate specificity switch also enables the secretion of 
the middle and late substrates (Thomassin et al, 2011; Feria et al, 2012). The middle 
substrates refer to proteins that make up the pore complex, while the late substrates 
refer to the effectors (Dewoody et al, 2013).  
During the initiation of the pore complex, a long helical homopolymeric filament—
generated by the polymerisation of EspA subunits—extends the needle, projecting 
from the bacteria to the intestinal cell surface (Knutton et al, 1998). Through this 
EspA filament, translocators EspB and EspD travel to and form a translocation pore 
in the enterocyte membrane (Munera 2010). The translocation pore creates an 
opening in the host cell membrane and promotes the entry of late substrates 
(effectors) (Table 1.1) into the host cell cytosol. To initiate the secretion of effectors, 
contact with host cell is required (Forsberg et al, 1991).  
 
 
Figure 1.8: The T3SS injectisome. A schematic representation of the T3SS encoded 
within the LEE of AE pathogens. The T3SS effectors leave bacteria through the 
export apparatus, travel through the needle filament and enter the host cell cytoplasm 
through the translocation pore in the eukaryotic plasma membrane. Adapted from 
Pallen et al. (2005).  
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Table 1.1: LEE encoded Type III components in AE pathogens. Adapted from 
Deane et al. (2010). 
 
Early substrates: 
           Needle subunit 
           Inner rod subunit 
           Ruler protein 









           Needle filament 







Secretion apparatus components: 
           Outer membrane ring (OM)         
           Inner membrane ring (IM) 
           Export apparatus           
           ATPase 
           ATPase-associated protein  





EscR, EscS, EscT, EscU, EscV 
EscN 






CesT (Tir), EspA (CesA), EscG, EscE 
 
Late substrates (Effectors) 
 
 
LEE encoded Tir, Map, EspB, EspF, 








1.3.4 Signal transduction and intimate attachment  
Upon completion of the T3SS injectisome, one of the first effectors to be injected 
into host cells is the translocated intimin receptor (Tir) (Kenny et al, 1996). 
Following entry into host cells, Tir proteins insert themselves back into the apical 
membrane of host epithelial cells, where they act as receptors to interact with their 
own bacterial intimin (Fig.1.11). The N- and C-termini of the Tir protein are 
cytosolic, while the central portion, known as the intimin binding domain, forms a 
hairpin loop on the external surface of the host cell (Kenny et al, 1999; Luo et al, 
2000). This hairpin loop binds bacterial intimin with high affinity, enabling an 
intimate attachment between the bacteria and the mammalian host cell (Devinney et 
al, 1999; Ross and Miller, 2007).  
Intimin, encoded by the eae gene, is a 94-kDa protein that is found in all strains 
capable of inducing AE histopathology (Nataro & Kaper, 1998). Intimin binding 
causes Tir clustering inside the host cell, where host kinases phosphorylate Tir 
tyrosine (Y474) residues located within the C terminus (Kenny et al, 1997; Lai et al, 
2013). Tir phosphorylation recruits Nck host adapter proteins that activate actin 
nucleation promoting factors such as N-Wiskott-Aldrich syndrome protein (N-
WASP). This, in turn, activates the actin-related protein (Arp) 2/3 complex required 
for actin polymerization and pedestal formation (Gruenheid et al, 2001; Campellone 
et al, 2002; Miki & Takenawa, 2003).  
Unlike EPEC, EHEC Tir is not tyrosine phosphorylated by the host cell, and the 
pedestal formation is Nck-independent (Fig.1.11). This type of actin assembly is 
promoted by another translocated EHEC effector, EspFU, also known as Tir 
cytoskeleton-coupling protein (TccP) (Campellone et al, 2004; Garmendia et al, 
2004). EspFU is linked to Tir by host insulin receptor tyrosine kinase substrate 
(IRTKS) and interacts with N-WASP to activate the Arp2/3 complex for actin 
assembly (Weiss et al, 2009; Vingadassalom et al, 2009). Although Tir is essential 
for the formation of A/E lesions and bacterial colonisation of host gut surfaces in 
vivo (Deng et al, 2003; Vlisidou et al, 2006), the phosphorylation of Tir is 
dispensable for A/E lesion formation ex vivo, as a Tir phosphorylation mutant can 
still recruit N-WASP independently of Nck, activate the Arp 2/3 complex, form 




1.3.5 Pedestal formation 
The Arp 2/3 complex contains two ATP-binding subunits (Arp2 and Arp3) that 
closely resemble an actin monomer and serve as the nucleation site for new actin 
filaments (Fig.1.11). The Arp 2/3 complex binds to the sides of existing (“mother”) 
filaments and initiates growth of a new (“daughter”) filament at a distinctive 70-
degree angle from the mother filament through ATP hydrolysis. This generates the 
build-up of densely branched filamentous actin (F-actin) networks directly beneath 
where the bacteria is attached to the host cell (Campellone & Welch, 2010; Veltman 
& Insall, 2010; Smith et al, 2013). The growth of actin filaments pushes the cell 
membrane upward, and the bacterium becomes perched on a pedestal-like structure 
which may stand up to 10µm away from the epithelial cell surface (Kaper et al, 
1998; Wales et al, 2004). These actin pedestal structures, which can act as localised 
signalling centres to coordinate bacterial modulation of host cell functions, are 
important virulence factors required for efficient colonisation of the host (Munera et 
al, 2012; Lai et al, 2013).   
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Figure 1.9: Molecular mechanisms of pedestal formation. In EPEC infection, the 
intimin receptor (Tir) translocates into the host cell and inserts itself into the host-cell 
plasma membrane. Tir interacts with intimin on the bacterial surface, firmly 
anchoring the bacterium to the host cell. The carboxy terminus of EPEC Tir becomes 
phosphorylated on the tyrosine residue at position 474, resulting in host adaptor 
protein Nck being recruited and binding directly to Tir. In EHEC infection, the 
tyrosine-phosphorylation event is fulfilled by the EHEC effector EspFu, so Nck is not 
required. Subsequently, N-WASP and the Arp2/3 complex are recruited downstream 
of the Tir-interacting protein (Nck or EspFu), leading to the generation of actin 
filaments beneath the attached bacteria and the formation of the pedestal structure. It 
has been demonstrated that the tight junction-associated protein ZO1 localises to the 
distal portion of the actin filaments of the EPEC pedestal. In addition, the actin-
disassembly protein cofilin has been shown to localise to pedestals and, presumably, 
together with the actin-assembly protein profilin, regulates the actin-filament 
dynamics in pedestals. Taken from (Bhavsar et al. 2007). 
 
67 
1.3.6 Locus of Enterocyte Effacement (LEE) 
The genes responsible for AE lesion formation are encoded on a 35.4kb 
pathogenicity island known as a LEE (Fig. 1.12) (reviewed in Schmidt 2010). The 
LEE sequence is different from the rest of the chromosomal DNA because it has a 
lower GC content (38%) than that of chromosomal DNA (50.8%) and has been 
associated with the ability to induce diarrheal disease (McDaniel et al, 1995). It is 
present in all AE pathogens and absent from non-pathogenic E. coli, for which 
transfer of the LEE into an avirulent strain, such as E. coli k12 or commensal E.coli, 
is sufficient to confer the AE phenotype on the recipient (McDaniel & Kaper, 1997). 
EPEC LEE contains approximately 41 open reading frames (ORFs) organised into 5 
operons termed LEE 1-5 (Fig. 1.12). Together, LEE encodes the structural 
components of the T3SS apparatus, the effector proteins, chaperone proteins, and 
LEE regulator proteins (Sal-man et al, 2012b). The LEE genes encoding the 
structural proteins of the T3SS are highly conserved among all AE pathogens and is 
thought to have been acquired by horizontal gene transfer (Deng et al, 2001; Muller 
et al, 2009). The genes encoding the effector proteins, however, show substantial 
variability and may have been obtained by distinct genetic events (Castillo et al, 
2005). In addition, the LEE is inserted into different chromosomal loci amongst the 
different AE pathogens, which suggests that the LEE may have been acquired more 
than once during bacterial evolution (Schmidt 2010). The role of LEE-encoded 




Figure 1.10: Genetic organisation of LEE genes in AE pathogens. LEE 
pathogenicity island of pathogenic E. coli. Taken from Stevens and Frankel (2014). 
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Table 1.2: Common LEE encoded effectors in AE pathogens and their role in   










Tir Receptor for intimin. Nucleates and polymerises actin 
filaments. Involved in attaching effacing lesions. 
Regulates the functions of other effectors including Map, 
EspF and EspG. Inhibits NFκB activation. Initiates a 
strong host antibody response. Promotes T3 translocation 
and host cell binding. 
 
Kenny et al, 1997 
Garmendia et al, 2004 
Ruchaud-Sparagano et al, 
2011  
Gavilanes-Parra et al, 2013 
Battle et al, 2014 
 
Map Mediates tight junction disruption and microvilli 
effacement. Alters mitochondrial morphology and 
function. Interacts with Tir to activate processes that 
contribute to formation of membrane filopodia. Map 
expression contributes to the maintenance of EPEC 
colonisation. 
 
Kenny & Jepson, 2000 
Jepson et al, 2003 
Papatheodorou et al, 2006 
Molloy 2012 
Nguyen et al, 2014 
EspB 
(eaeB) 
Component of the pore-forming translocator, essential 
for effector translocation into host cell. Promotes actin 
bundling, involved in microvilli effacement and inhibits 
macrophage phagocytosis. Oral immunisation with EspB 
induces specific mucosal and systemic antibody 
responses, implicating its use as an oral vaccine. 
 
Donnenberg et al, 1993 
Hamada et al, 2010, 
Hamaguchi et al, 2013 
Ahmed et al, 2014 
 
EspF 
Mediates F-actin filament aggregation to form AE 
lesions and induce pedestal formation. Induces 
mitochondria-targeted apoptosis, inhibits macrophage 
phagocytosis, disrupts tight junctions and limits bacterial 
translocation through M cells. Stimulates the cleavage 
and loss of epidermal growth factor receptor in host 
epithelial cells resulting in host cell death later in 
infection. 
 
McNamara & Donnenberg, 
1998, 
Tahoun et al, 2011;  
Zhao et al, 2013 
Maddocks et al, 2013 
Roxas et al, 2014 
 
EspG Plays a minor role in epithelial barrier dysfunction. 
Interacts with tubulin to disrupt microtubule formation. 
Causes actin stress fibre formation. Localises to Golgi 
apparatus and disrupts protein secretion. Disrupts 
recycling endosome function and cell surface receptor 
levels during infection. 
Elliot et al 2001 
Selyunin et al, 2011 
Clements et al, 2011 
Clements et al, 2014 
Glotfelty et al, 2014 
 
EspH Necessary for actin pedestal formation and elongation. 
Promotes recruitment of N-WASP and the Arp2/3 
complex to the bacterial attachment site. Induces focal 
adhesion disassembly, triggers cell detachment, induces 
apoptosis and cytotoxicity. Inhibits macrophage 
phagocytosis. 
 
Tu et al 2003;  
Wong et al, 2012a 
Wong et al, 2012b 
EspZ Blocks protein translocation of effectors (Tir, Map, 
EspF) following a secondary infection. Inhibits host cell 
apoptosis by localising to host mitochondria. Inhibits  
epidermal growth factor receptor cleavage and loss, 
which contributes to the survival of host cells early in 
infection. 
 
Kanack et al 2005;  
Berger et al, 2012; 
Roxas et al, 2012 
Shames et al, 2011 




1.3.7 Non–LEE encoded (Nle) effectors 
The T3SS translocated proteins, which are not encoded by the LEE genes, are known 
as non-LEE encoded (Nle) effectors. First described in C. rodentium, Nle proteins 
are a topic of recent research (Deng et al, 2004; 2010). The Nle genes are carried on 
mobile genetic elements that are surrounded by phage-related and transposase-like 
genes. They are clustered in to six pathogenicity islands scattered throughout the 
genome (Fig. 1.13) (Dean et al, 2009). Like LEE, Nle pathogenicity islands have a 
low GC content and are thought to have been acquired through horizontal gene 
transfer. Unlike LEE encoded effectors, which are well conserved among AE 
pathogens, the Nle effectors vary. For instance, all AE pathogens contain over 40 
LEE genes, while rabbit EPEC contains an additional 40 Nle effectors in comparison 
to EPEC/69 which contains an additional 21 Nle genes (Iguchi et al, 2009). The role 














Figure 1.11: Genetic organisation of Non-LEE encoded genes in AE pathogens. 
Non-LEE pathogenicity islands of EPEC. Taken from Dean and Kenny (2009). 
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Disrupts tight junction and impairs cellular secretion. 
Mediates proteolytic cleavage and inactivation of host 
proteins during infection.  
 
Gruenheid et al, 2004;  
Mundy et al, 2004; 
Thanabalasuriar et al, 2011 
Weiss et al, 2014 
NleB Suppresses NFκB  activation and antagonises death 
receptor induced apoptosis of infected cells.  C.rodentium 
lacking NleB is unable to colonise mice. 
Deng et al, 2004;  
Kelly et al, 2006;  
Gao et al, 2013;  
Pearson et al, 2013 
NleC Targets and cleaves  NFκB  transcription factors to 
dampen the host inflammatory response. Antagonises 
repression of IL-8 secretion. No role identified in vivo.  
Deng et al, 2004;  
Marches et al, 2005;  
Sham et al,2011;  
Pearson et al, 2011 
Turco & Sousa, 2014 
Li et al, 2014 
NleD Inhibits NFκB activation. Contributes to bacterial 
inhibition of IL-8 in vitro. Displays pro-apoptotic activity. 
Plays a role in colonization of calves. Inhibits cytokines 
that regulate IEC tight junction proteins that are necessary 
to maintain barrier function and enhances TNFα 
production to promote barrier disruption.  
 
Marches et al, 2005,  
Baruch et al, 2011 
Long et al, 2014 
NleE Shuts off nuclear translocation of NFκB following 
translocation into intestinal DCs. This inhibits expression 
of proinflammatory cytokines. Can also bind to and 
interact with molecules involved in the DNA repair 
processes. 
Wickham et al, 2007; 
Vossenkaemper et al, 2010; 
Nadler et al, 2010;  
Newton et al, 2010.  
Yao et al, 2014 
NleF Binds to  and inhibits catalytic activity of host caspases, 
preventing apoptosis of cells in vitro. Slows down 
intracellular trafficking of proteins from the endoplasmic 
reticulum to the Golgi. Contributes to bacterial 
colonisation in vivo. Induces the NFκB mediated 
proinflammatory pathway and IL-8 expression early 
during EPEC infection. 
 Dean, 2011;  
Blasche et al, 2013;  
Olsen et al, 2013; 
Pallett et al, 2014  
NleG/ 
NleI 
NleG homologues make up the largest family of T3 
effectors delivered by pathogenic E. coli. Inhibits 
apoptosis. 
Deng et al, 2004;  
Tobe et al, 2006;  
Wu et al, 2010 
Li et al., 2006b 
NleH1 
NleH2 
Blocks apoptosis and has a role in post-translational 
regulation of effectors required for active secretion of 
effectors through the T3SS. NleH1 and NleH2 have high 
sequence similarity but are expressed differentially. NleH2 
resembles the structure of protein kinases and NleH1 
inhibits NFκB signalling. NleH deletion reduces C. 
rodentium colonisation and mice mortality, which can be 
reversed after complementation with NleH1. C. rodentium 
expressing EHEC NleH1 and NleH2 is hypervirulent in 
mice.  
Garcia-Angulo et al, 2008; 
Gao et al, 2009 
Hemarajani et al, 2010 
Pham et al, 2012 
Holmes et al, 2012 
Halavaty et al, 2014 
Feuerbacher & Hardwidge, 
2014 
Grishin et al, 2014 
EspJ Blocks phagocytosis of opsonised bacteria. Contributes to 
bacterial clearance in mice.  
Dahan et al, 2005; 
Marches et al, 2008; 
Kurushima et al, 2010 
EspL Enhances F-actin bundling activity and formation of 
micro-colonies.  
Dean & Kenny, 2009 
EspO Interacts with integrin linked kinase to reinforce host cell 
adherence to the basement membrane.  
Dean & kenny, 2009 
Deng et al, 2010 
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1.3.8 Effector targeting host defences 
Like many disease-causing bacteria, a key feature of the virulence of AE pathogens 
is their ability to deliver effector proteins into eukaryotic cells via the T3SS. These 
T3SS effectors are virulence proteins that mimic eukaryotic proteins in structure and 
function. An important feature of bacterial effectors is their modular architecture, 
which comprises domains that have subversive functions inside the eukaryotic cell 
(Dean et al, 2011). These subversive functions include, the regulation of actin 
dynamics (previously discussed), inhibition of phagocytosis, modulation of the 
apoptotic pathway, and subversion of host inflammatory responses (Fig. 1.14) 
(reviewed in Vossenkamper et al, 2011; Wong et al, 2011; Clements et al, 2012; 
Raymond et al, 2013). By manipulating host cellular processes and protective 
mechanisms, these pathogens are able to facilitate their own survival and 
subsequently colonise, infect, and disseminate to additional hosts.  
 
1.3.8.1 Apoptosis 
One of the protective mechanisms of the gut mucosa is the removal of damaged or 
infected cells through programmed cell death, or apoptosis. Apoptosis is triggered by 
cell stress that stimulates pro-apoptotic signalling pathways, which activates caspase 
proteases and causes mitochondrial dysfunction. Apoptotic cells undergo 
characteristic changes in cell morphology, including chromatin condensation, nuclear 
fragmentation, cell rounding, and plasma membrane blebbing to eventually form 
apoptotic bodies that are engulfed by phagocytes (reviewed in Galluzzi et al, 2014).  
The host apoptotic defence mechanisms can be averted by AE pathogens (Fig. 1.14), 
which, like other gram-negative bacteria, use T3S effectors to promote their own 
colonisation. The effector NleH, for example, is able to block apoptosis in infected 
epithelial cells by directly interacting with Bax inhibitor I, which is an anti-apoptotic 
protein (Hemrajani et al, 2010; 2008). The role of NleH to protect cells from the 
activation of the pro-death pathway is complemented by NleD, which suppresses the 
transcription factors required for activation of the pro-apoptotic proteins (Baruch et 
al, 2011). More recently, two additional effectors, NleF (Blasche et al, 2013) and 
NleB (Pearson et al, 2013), were shown to inhibit apoptosis by specifically binding 
to and inhibiting caspase activity and antagonising death receptor-induced apoptosis 
of infected cells, respectively.   
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Other anti-apoptotic effectors protect host cells from death by promoting cell 
survival mechanisms. This includes preventing epithelial cell detachment by 
stabilising intestinal cell adhesions to the extracellular matrix. For example, EspO 
binds to host integrin-linked kinase, while EspZ interacts with host protein CD98, 
both of which lead to increased cell adhesion and survival (Kim et al, 2009; Shames 
et al, 2010). Infection of cell monolayers with an EPEC mutant lacking EspZ 
resulted in strong cytotoxicity (Shames et al, 2010), while infection of mice with C. 
rodentium mutants lacking EspZ led to severe attenuation and reduced colonisation 
by C. rodentium (Deng et al, 2004). In summary, the combined activities of the anti-
apoptotic effectors may stabilise the epithelium during bacterial colonisation and 
reduce the cytotoxic effects of bacterial infection, which in turn may promote 
sustained colonisation by these pathogens (Shames et al, 2010).  
The anti-apoptotic activities of AE pathogens are antagonised by the translocation of 
pro-apoptotic effectors such as EspF and Cif (Fig. 1.14) (Raymond et al, 2013). EspF 
is targeted to the mitochondria, where it induces mitochondrial lysis and is involved 
in degradation of anti-apoptotic proteins that leads to an increase in caspase cleavage 
(Nougayrede & Donnenberg, 2004). In contrast, Cif acts mainly as a bacterial 
cyclomodulin and arrests cell cycle by stabilising cell cycle inhibitory proteins, 
thereby inducing a delayed form of apoptosis (Samba-Louaka et al, 2009). Other pro-
apoptotic effectors include Map and EspH, which trigger mitochondrial dysfunction 
and induce caspase cleavage, respectively (Wong et al, 2011; Raymond et al, 2013) 
 
1.3.8.2 Phagocytosis 
Phagocytosis is the process by which a cell engulfs solid particles, including 
microorganisms or dead cells from the extracellular space. Once internalised, the 
engulfed particles are contained within a phagosome, which then fuses with the 
lysosomes for degradation. This leads to the clearance of the microorganism and 
initiation of adaptive immune responses. Professional phagocytes include 
neutrophils, macrophages, and dendritic cells, which can recognise bacteria directly 
or indirectly through recognition of antibody-coated bacteria and bacteria coated 
with complement receptors (Underhill & Goodridge, 2012).  
Although there is no direct evidence that AE pathogens target professional 
phagocytes for effector translocation in vivo, recent data suggest that these pathogens 
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have the ability to paralyse the general phagocytic mechanism (Fig. 1.14). For 
example, the effector EspB targets myosin function, which is required for 
phagosome closure during phagocytosis of non-opsonised bacteria (Cox et al, 2002). 
An EPEC expressing EspB lacking the myosin-binding domain is unable to inhibit 
its own uptake by phagocytosis (Iizumi et al, 2007). EspF is another effector known 
for inhibiting the phagocytosis and translocation of bacteria through macrophages 
and an M-cell co-culture system, respectively (Quitard et al, 2006; Martinez-Argudo 
et al, 2007; Tahoun et al, 2011). EPEC lacking EspF and a functional T3SS are 
phagocytosed by macrophages and translocated through M cells (Quitard et al, 2006; 
Marches et al., 2008). Additionally, EspJ was recently shown to prevent 
phagocytosis of both IgG and complementary opsonized particles, although it could 
not prevent phagocytosis of non-opsonised bacteria (Marches et al., 2008). EspH is 
another newly characterised anti-phagocytic effector, without which EPEC loses its 
ability to inhibit both opsonized and non-opsonized phagocytosis (Dong et al, 2010; 
Marches et al, 2008).  
By targeting multiple pathways for bacterial uptake, anti-phagocytic effectors 
cooperate to exclude AE pathogens from the intracellular environment of the 
professional phagocytes (Wong et al, 2011). As a result, these pathogens not only 
escape phagocyte killing but also prevent the generation of MHC peptides for 
antigen presentation by antigen presenting cells, which is necessary for the activation 
of adaptive immune responses. Although AE pathogens are unlikely to encounter 
professional phagocytes during their colonisation of epithelial cell surface, 
neutrophils were shown to be necessary for bacterial clearance in a C. rodentium 
model of mice infection (Spehlmann et al, 2011). In addition AE pathogens are 
known to preferentially adhere to the FAE of the gut, which contains M cells 
surrounded by professional phagocytes and antigen presenting cells. Such findings 
suggest that bacteria may interact with phagocytes at some point during infection. 
 
1.3.8.3  Inflammation 
The inflammatory response is initiated when host PRRs recognize PAMPs on the 
surfaces of microorganisms. This initiates host inflammatory cascades, including 
NFκB and MAPK pathways, which lead to the production of cytokines involved in 
the host inflammatory response. Central to the initiation of inflammation is the 
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transcription factor NFκB, which exists as inactive dimers bound to an inhibitor of 
NFκB (IκB) in the host cell cytoplasm. With the phosphorylation and degradation of 
IκB by the cell proteosome, NFκB is released and allowed to translocate to the 
nucleus, where it initiates the transcription of many proinflammatory cytokines, 
including IL8 (reviewed in Newton & Dixit, 2012). 
Infection of host cells with AE pathogens results in the induction of an inflammatory 
cell response, mainly through the host recognition of bacterial flagella (Schuller et al, 
2009). In addition, the translocation of EspT effector was shown to trigger the 
expression of proinflammatory genes (Raymond et al, 2011). However, in the 
presence of increasing bacterial burden, the production of proinflammatory cytokines 
such as IL8 is reduced, indicating that these pathogens have the ability to dampen 
host inflammatory responses in a type 3-dependent manner (Fig. 1.14) (Wong et al, 
2011).  
NleB, for example, was shown to inhibit the activation of NFκB in epithelial cell 
lines in vitro (Newton et al, 2010) and play an important role in the bacterial 
colonisation of mice (Kelly et al, 2006). Mice infected with C. rodentium containing 
a deletion in the nleB gene displayed reduced crypt hyperplasia and reduced 
colonisation of the gastrointestinal tract (Kelly et al, 2006). Similarly, NleE was also 
shown to inhibit NFκB subunits and cause a decrease in the expression and 
production of IL8 (Nadler et al, 2010; Newton et al, 2010; Vossenkamper et al, 
2010). Although this was reported in epithelial cells by a number of studies, 
Vossenkamper et al (2010) was the first to show this in immune cells (dendritic 
cells).  Both NleB and NleE were able to suppress the inflammatory pathway by 
inhibiting Ikb degradation and hence the nuclear translocation of NFκB subunits 
(Newton et al, 2010). Additionally, NleC and NleD were reported to downregulate 
the inflammatory responses by targeting NFκB subunits and MAPK proteins. NleC 
can cleave more than one NFκB subunit and block the subsequent production of IL8 
following infection (Marches et al, 2005; Baruch et al, 2011; Pearson et al, 2011), 
while NleD specifically degrades MAPK proteins and contributes to the overall 
inhibition of IL8 secretion by infected cells.  
The absence of genes encoding NleC, NleE, or NleD in a single EPEC mutant does 
not affect colonization of EPEC in calf, lamb, or mouse animal models (Marches et 
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al, 2005; Kelly et al, 2006), nor does it result in increased production of IL8 in the 
host (Baruch et al, 2011; Pearson 2011). However, infection with an EPEC NleEC 
double mutant (in comparison to a single mutant), nleBEC triple mutant (in 
comparison to a double mutant) or nleBECD quadruple mutant (in comparison to a 
triple mutant) results in significantly higher IL8 production (Baruch et al, 2011; 
Pearson et al, 2011). This demonstrates the functional redundancy of these effectors, 
which seem to work together simultaneously and contribute to the overall anti-
inflammatory activities of the AE pathogens.  
NleH effectors seem to have an uncertain role in the inflammatory responses, as 
NleH1 was shown to block the nuclear translocation of NFκB subunits, while NleH2 
induced the expression of proteins required for the nuclear translocation of NFκB 
(Gao et al, 2009; Wan et al, 2011). However, the role of NleH in promoting 
colonization and modulating the host inflammatory response was clearly 
demonstrated in mice during subsequent studies. Mice infection with EPEC mutants 
lacking NleH1 and NleH2 led to a decrease in bacterial colonisation and an increase 
in the infiltration of neutrophils and keratinocyte cell levels (a mice homologue of 
IL8), in comparison to mice infection using wildtype EPEC (Royan et al, 2010). 
Lastly, Tir, most well-known for its role in pedestal formation, was also shown to 
inhibit host inflammatory responses and cytokine production in infected cells, since 
deletion of Tir enhanced the activation of MAPK proteins during EPEC infection 
(Yan et al, 2012).  
By inhibiting proinflammatory responses, these AE pathogens effectively reduce the 
secretion of cytokines and chemokines that facilitate leukocyte extravasation from 
the circulation to the affected site. Leukocytes, mainly neutrophils and macrophages, 
are able to kill bacteria directly or secrete antimicrobial factors (Newton & Dixit, 
2012). Therefore, by preventing the recruitment of these cells during infection, AE 
pathogens are able to subvert innate immune responses that may allow prolonged 





Figure 1.12: Common T3SS effectors of AE pathogens and their targets within 
host cells. Effectors from AE pathogens target sub- cellular structures and organelles 
in the host cell including TJ (tight junction), AJ (adherens junction), ER 
(endoplasmic reticulum), MT (microtubules), FAK (focal adhesion kinase), BI-I 
(BAX inhibitor-1), TNFR (tumour necrosis factor receptor), TRAF2 (TNF-
associated factor 2). The figure depicts the multifunctional nature of the effectors and 
their overlapping functions, adapted from Law et al. (2013).  
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Table 1.4: Host cells targeted for effector injection and subsequent cellular 
modulation by AE pathogens (summarized). 
 
 Effector Target cell Host modulation 
 
Tir Epithelial cells Modulates actin cytoskeleton, blocks MAPK 
signaling, inhibits NFκB  activation 
Map Epithelial cells Modulates actin cytoskeleton 
Cif Epithelial cells Blocks cell cycle 
EspZ Epithelial cells Prevents cell detachment 
NleB Epithelial cells Inhibits   NFκB activation, blocks apoptosis of 
infected cells 
NleC Epithelial cells Inhibits NFκB activation, induces IL8 secretion 
NleD Epithelial cells Delays apoptosis, inhibits MAPK pathway, inhibits 
IL8 production 
NleF Epithelial cells Delays or inhibits apoptosis and disrupts 
intracellular trafficking 
NleH Epithelial cells Blocks apoptosis, inhibits  NFκB  activation 
NleE Epithelial cells, 
Dendritic cells 
Inhibits activation of  NFκB  and production of 
inflammatory cytokines 
EspT Epithelial cells, 
macrophages 
Modulates actin cytoskeleton, induces production 
of IL8 and IL1b 
EspF M cells, 
macrophages 
Inhibits M cell uptake of bacteria and prevents 
phagocytosis in macrophages 
EspB Macrophages  Prevents phagocytosis of bacteria 
EspJ Macrophages Blocks FcyR and CR3 opsonophagocytosis 




1.4 Concluding remarks 
By injecting effectors into host cells, AE pathogens not only (1) alter the host 
cytoskeleton for secure attachment to epithelial cells, but also dampen the host 
immune responses by (2) preventing their uptake by phagocytes, (3) inhibiting 
apoptosis, and (4) suppressing proinflammatory signalling pathways. The ability to 
antagonise and subvert host immune responses is a central feature of many 
enteropathogens. Despite the variation in bacterial morphology and infection 
strategies, T3SS-containing pathogens including EPEC, EHEC, Citrobacter, 
Salmonella, Shigella, and Yersinia show a high degree of homology between the 
effectors they translocate 
Although these translocated effectors often act in concert with each other, their 
functions can sometimes seem contradictory. The apparent contradiction can be 
resolved if effector injection occurs at different time points during bacterial 
pathogenesis according to the specific survival needs of and/or virulence strategy 
required by the pathogen at that time. Attaching effacing bacteria, for example, 
initially inject effectors such as EspT into host cells, which trigger host innate 
inflammatory responses including the release of proinflammatory cytokines IL-8 and 
IL-1β following the activation of the NFκB pathway. However, the resulting 
proinflammatory responses are unlikely to kill the AE pathogens, and instead may 
disrupt and remove the competing commensal microbiota (Lupp et al, 2007). This 
may give the AE pathogens a survival advantage over the commensal bacteria, 
enabling them to colonise the host gastrointestinal tract. Subsequently, the AE 
pathogens inject anti-inflammatory effectors that suppress different components of 
the NFκB and MAPK pathway, inhibiting host inflammatory responses against 
themselves. Bacterial anti-inflammatory effectors therefore limit the effectiveness of 
the host resistance mechanisms directed against the AE pathogens to facilitate their 
own survival.  
A similar phenomenon is seen in invasive Salmonella, where the injection of proteins 
occurs in two stages. During the initial stage of infection, S. enterica injects effectors 
using the Salmonella pathogenicity island 1 (SPI-1) to facilitate its invasion of the 
intestinal epithelial cells (Coburn et al, 2007). This results in host macrophages 
migrating to the site of infection and engulfing bacteria in an attempt to destroy it 
through the production of reactive oxygen species such as nitrogen oxides (Swindle 
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& Metclife, 2007). However, the intracellular environment of the macrophage 
induces the expression of a second wave of effector injection from Salmonella 
pathogenicity island 2 (SPI-2) that enables the bacteria to create protected vacuoles 
termed Salmonella containing vacuoles (SCVs) within which Salmonella can grow 
and multiply (McGourty et al, 2012). Similarly, the inhibition of apoptosis in 
epithelial cells (AvrA from SPI-1) may be beneficial for promoting sustained 
colonisation of Salmonella initially, while the subsequent induction of pyroptosis in 
macrophages (SipB from SPI-2) may facilitate dissemination of Salmonella 
(Stavrinides et al, 2008; Raymond et al 2013). Thus, although the immune responses 
initiated by SPI-1 effectors are very different from those initiated by SPI-2, both are 
employed by Salmonella to facilitate its survival and spread in the host epithelium. 
Due to this, it is believed that the interactions between the T3S effectors and their 
host cells may have resulted in the co-evolution of survival strategies by both the 
pathogen and the host.  
In summary, the manipulation of host immune responses by AE pathogens has not 
been reported until recently. Perhaps this is due to the non-invasive nature of these 
pathogens, which, unlike their invasive counterparts, colonise the surface of the 
epithelial cells and are thought not to encounter immune cells. However, recent 
reports of the ability of AE pathogens to inhibit apoptosis, prevent phagocytosis, and 
suppress host inflammatory pathways in a type three-dependent manner has shed 
new light on the possibility that immune cells may be targeted for effector 
translocation by these pathogens.  
Since AE pathogens colonise the surface of lymphoid structures (described in detail 
in chapter 5), such as the PP and the caecal patches, there is a possibility that these 
pathogens may exploit the M cell gateway to enter the subepithelial dome, where 
they may encounter professional APCs and other immune cells. In addition, 
subepithelial DCs send processes through the epithelium and into the gut lumen, 
during which the DCs may have some contact with luminal pathogens. Furthermore, 
intraepithelial T lymphocytes residing between the epithelial cells are another 
population of immune cells that may be encountered by these AE pathogens. Innate 
cells such as neutrophils, monocytes, and macrophages may be exposed to these gut 
pathogens during the leukocyte extravasation process as a result of inflammation 
occurring in response to bacterial infection. Additionally, the disruption of tight 
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junctions and the loss of barrier properties in the gut epithelium during AE infection 
may result in a “leaky gut”, enabling increased translocation of bacteria through the 
epithelial barrier and resulting in increased interaction between bacteria and immune 
cells. Following interaction with bacteria, these immune cells may be targeted for 
effector injection. The injected immune cells may subsequently drain to the MLN 
and spleen, where they may be impaired from generating protective immune 
responses. 
To gain more insight into the consequences of bacterial effector injection on host 
immune cells, it would be interesting to visualise which host cells are being targeted 
for effector delivery and at which stage of the infection these cells are being targeted. 
Several different reporter systems have been previously utilised to detect the 
translocation of effector proteins inside eukaryotic cells. One of the first reporter 
systems developed was adenylate cyclase (CyaA) toxin of Bordetella pertussis 
(reviewed in Dautin et al, 2004). Sory and Cornelis (1994) created translational 
fusions of Yops (Yersinia outer membrane proteins) with the calmodulin-dependent 
catalytic domain of CyaA to study the Yersinia enterocolitica T3S pathway. CyaA is 
able to convert cellular ATP to cyclic AMP (cAMP) in the presence of the eukaryotic 
protein calmodulin, which is not produced in bacteria. So by monitoring cyclic AMP 
(cAMP) accumulation in eukaryotic cells, they were able to detect the translocation 
of Yops into host cells.  Although extensively used, this reporter system has some 
drawbacks. The CyaA assay is time consuming and some pathogenic bacteria 
produce toxins that can synthesize cAMP, such as ExoY toxin from Pseudomonas 
aeruginosa, leading to an increase in cellular cAMP that could mask the increase of 
cAMP converted by the CyaA fusion.  
Another method to detect the translocation of effector proteins inside eukaryotic cells 
involves the use of a phosphorylatable Elk tag (Day et al, 2003). The translocation of 
an ELK-tagged effector protein into a eukaryotic cell results in host cell protein 
kinase-dependant phosphorylation of the ELK tag, which can be subsequently 
detected by Western blotting with phosphospecific Elk antibodies. The ELK tag has 
been utilized to study the injection of T3S effector proteins by Yersinia pestis (Day et 
al, 2003), Yersinia pseudotuberculosis (Rosenzweig et al, 2005), and Salmonella 
enterica (Day et al, 2003). This system is specific since it relies on cellular processes 
to detect proteins that are specifically injected into the host cells. However, the Elk 
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tag needs to be artificially directed to the host nucleus for phosphorylation through 
fusion with a nuclear localization signal from a simian virus 40 antigen, and this is a 
major limitation for the study of many effectors which are naturally targeted to other 
compartments of the host cell, such as the mitochondria (Map), the plasma 
membrane (Tir), or the Golgi apparatus (NleA). 
Lee et al. (1998) developed an alternative strategy based on cell fractionation that 
selectively solubilised the eukaryotic plasma membrane with digitonin to measure 
Yop targeting during Yersinia infections of HeLa cells by immunoblotting. 
Neomycin phosphotransferase (NPT) fusions to Yops using the fractionation assay 
further enabled the presence of Yop-NPT fusions in the cytosol of HeLa cells to be 
visualised with anti-NPT staining and immunofluorescence confocal laser 
microscopy. However, the requirement for disruption of the eukaryotic cell is a 
major limitation of this strategy.  
In contrast, recent studies have demonstrated the use of a novel fluorescence-based 
reporter system involving the TEM-1 β-lactamase enzyme (Described in detail in 
chapter 4) (Charpentier & Oswald, 2004). TEM-1 β-lactamase lacks a leader peptide 
sequence for export, which means it can only enter host cells if fused to a secreted 
protein such as a translocated effector protein. Studies have shown that fusing this 
enzyme to the ends of T3 effectors did not affect their activity (Charpentier & 
Oswald, 2004). Following translocation of the fusion proteins into host cells, TEM-1 
β-lactamase activity can be measured directly by the addition of the fluorescent 
substrate CCF2-AM. In the presence of TEM-1 β-lactamase enzyme, the CCF2-AM 
substrate molecule is cleaved, causing the host cell to appear blue under UV 
illumination, whereas in the absence of the enzyme the CCF2-AM substrate remains 
intact, causing the host cell to appear green. The major advantage of this reporter 
system is its use of the CCF2-AM fluorescent substrates, which enables the analysis 
of effector translocation in live cells without disruption of the host cell. Therefore, 
the TEM-1 β-lactamase reporter system was chosen to be used in this study to enable 




In this study, the TEM-1 β-lactamase reporter system will be utilised to visualise 
host intestinal cells targeted for protein translocation by C. rodentium.  
The aims of this study are to: 
• generate a reporter C. rodentium strain that encodes a fusion protein between 
an effector and TEM-1 β-lactamase (Chapter 3);  
• visualise effector translocation into murine cell lines and primary immune 
cells in vitro using TEM-1 β-lactamase translocation assay (Chapter 4); and 
• visualise effector translocation into murine cells in vivo using TEM-1 β-
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2. Materials and Methods 
2.1 Bacteria 
2.1.1 Bacterial strains  
Formerly known as Citrobacter freundii biotype 4280 (ATCC 51459) (Barthold et al, 
1976), ICC169 Citrobacter rodentium is a nalidixic acid resistant derivative of strain 
ICC168 and was kindly provided by Dr. S. Wiles for this study (Division of Cell and 
Molecular Biology, Imperial College, London). The strain Citro pKD46, containing 
a λ Red expression system, was used for the homologous recombination of linear 
DNA into C. rodentium chromosome. TOP10 chemically competent E. coli cells 
(Invitrogen, UK) was used for the routine propagation of cloning plasmids.  
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Table 2.1: Strains and plasmids used in this study 
Strain name Strain description Reference 
Citrobacter rodentium 
(ICC169) 
Wild type C. rodentium, Nalr Wiles et al., 2004 
Citro pKD46 
ICC169 encoding the λ-red expression system, Nalr, 
Ampr 
This study 
Citro pCXnleD ICC169 containing pCXnleD plasmid, Nalr,Tetr This study 
Citro ΔescN ICC169 containing escN deletion, Nalr, kanr This study 
Citro ΔescNpCXnleD 
ICC169 containing escN deletion and pCXnleD 
plasmid, Nalr,Tetr, kanr 
This study 
Citro pACYCnleD ICC169 containing  pACYCnleD plasmid, Nalr, Cmr This study 
Citro ΔescNpACYCnleD 
ICC169 containing escN deletion and pACYCnleD 
plasmid, Nalr, Cmr, Kanr 
This study 
Top 10 E. coli cells 
Chemically competent E. coli cells for plasmid 
propagation, Ampr 
Invitrogen 
Plasmid name Plasmid description Reference 
pKD46 Plasmid encoding the λ-red expression system, Ampr Dr. Marches 
pCX340 Expression vector encodingTEM-1, Tetr 
Charpentier & 
Oswald, 2004 
pSB315 Expression vector encoding Kanr  Dr. Marches 
pCR2.1 TOPO Expression vector for TA cloning, Ampr , Kanr Invitrogen 
pCX315 pCX340 plasmid encoding Kanr, Tetr This study 
pCX315nleD pCX315 plasmid encoding NleD. Tetr , Kanr This study 
pCXnleD pCX340 plasmid encoding NleD. Tetr This study 
pACYC184 Expression vector, Cmr , Tetr Dr. Marches 
pICC440 
pACYC184 containing 5’ and 3’ regions of xylE. Cmr 
Tetr 
Girard et al., 2009 
pICC442 
pICC440 encoding nleDTEM-1 fusion constructs,  
Cmr , Tetr 
This study 
pACYCnleD 
pACYC184 encoding  nleDTEM-1 fusion constructs,  






2.1.2 Bacterial media & growth conditions  
All bacteria were grown aerobically in solid agar or liquid broth in Luria-Bertani 
(LB) medium. The solid agar was prepared by dissolving 35g of Lennox LB agar 
powder (15g/L Agar, 10g/LTryptone, 5g/L Yeast extract, 5g/L NaCl from Sigma-
Alderich, uk) in 1 litre of distilled water and autoclaved. Antibiotics were added to 
the liquid agar as required (Listed in table 2.2) and poured into standard 90mm x 
15mm triple vent petri dishes (Sterillin). The liquid broth was prepared by 
autoclaving 25g of Miller LB broth powder (tryptone, yeast extract and sodium 
chloride from Sigma-Alderich, uk) dissolved in 1 litre of distilled water. For growth 
on solid medium, agar plates containing the appropriate antibiotics were streaked 
with freshly isolated colonies, frozen beads (-80C) or overnight broth cultures and 
incubated in a static incubator at 37˚C overnight. For liquid cultures, 3ml LB broth 
containing 3µl of the corresponding antibiotic was inoculated with a freshly isolated 
colony or a frozen bead and grown in a 37°C orbital shaker at 200 rpm overnight. 
For long-term storage of bacterial cells in -80°C, 750 µl of an overnight liquid 
culture was added to a cryovial containing cryobeads and vigorously mixed. The 
liquid was then decanted and the cryovial containing bacteria-coated-cryobeads 
stored in -80°C.  
 
Table 2.2: Antibiotics used for the selective growth of bacteria 
Antibiotic Final concentration 
(µg/ml) 
Source 
Nalidixic Acid (NA) 30 
Ampicillin (Amp) 100 
Tetracycline (Tet) 12.5 
Kanamycin (Kan) 50 




































2.2.1 Polymerase chain reaction (PCR) 
To amplify the gene of interest, PCR was carried out using the correct primer pairs 
(listed in Table 2.4). Primers were designed using the DNAssist software, 
synthesised by Eurofins Genomics and supplied at a concentration of 100µm.  A 
typical PCR reaction mix (Table 2.3) contained 0.75µl of the DNA template 
(genomic or plasmid DNA), 5µl of 10X Taq buffer (NEB), 5 µl of dNTP mix 
(5mM/µl per dNTP, NEB), 5 µl of each primer (10Þm/µl), 0.3µl of Taq polymerase 
(NEB) in 50µl total volume (made up by 28.95µl dH2O). A typical PCR programme 
comprised of an initial denaturation at 97oC for 3 min, 30 cycles of 45seconds at 
94oC, 45 seconds at 58-75 oC, 2 minutes at 72 oC in each cycle and a final extension 
at 72oC for 10 minutes. Annealing temperatures varied according to the primer sets 
(typically between 58-75oC). Colony PCR was carried out using the same PCR 
programme but with a smaller reaction volume (25µl) and a single bacterial colony. 
A typical thermocycling programme used in this study is shown below. 
 
Initial denaturation    97oC           3 minutes 
 
Denaturation    94 oC          45 seconds  
Annealing temperature (Tm)        58 -75 oC          45 seconds 
Extension     72 oC           2 minutes 
 
Final extension    72 oC           10 minutes  
Hold        4 oC            until use 
 
 
Table 2.3: Reaction components for PCR  
Volume (µl) to add in a single 




Total 50 25  
dH2O 28.95 14.35  
dNTP (5mM/µl) 5 2.5 0.5mM 
ThermoPol  Buffer 
(10x) 5 2.5 1x 
Primer (fw) 
10pM/µl 5 2.5 1pM/µl 
Primer (rv) 
10pM/µl 5 2.5 1pM/µl 
Template DNA 0.75 colony  




Table 2.4: Primers used in this study 
Gene or DNA 
region amplified 






























Nde1-NleD(fw) GAATAACATATGCGCCCTACATCCCTT nleD in C. 














escN in C. 
rodentium 
B171DescN(fw) CGTCATTCTGACCGCTTTAG 
K1 (fw) AGGCTATTCGGCTATGACTG KanamycineR in 




xylE in pICC440 
and pICC442 
AseI-N-XylE (rv) CCCATTAATACGCAGTACACCAGCAGCTG 
M13 (fw) GTAAAACGACGGCCAGT 
M13 (rv) CAGGAAACAGCTATGAC. 
Insert region in 
pCR2.1TOPO  
T7 TAATACGACTCACTATAGGG 
pJET1.2 (fw)  CGACTCACTATAGGGAGAGCGGC Insert region in 
pJET1.2  pJET1.2 (rv) AAGAACATCGATTTTCCATGGCAG 
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2.2.2 DpnI digestion 
Following the completion of PCR cycle, any remaining template plasmid was 
removed by DpnI digestion. Dpn1 cleaves off and removes methylated sites which 
are only present in the template plasmid and not in the PCR product. For Dpn1 
digestion, 2µl of Dpn1 (NEB) was added to a 50µl reaction and incubated at 37°C for 
1 hour (Table 2.5). The PCR products were then separated on an agarose gel, gel 
purified and stored at -20°C until use.  
 
Table 2.5: Reaction components for Dpn1 digestion 
Component Volume (µl) 
PCR product 200 




Incubate for 1 hour at 
37°C 
 
2.2.3 PCR purification 
Purification of the PCR products was carried out using a commercially available 
QIAquick PCR purification kit (Qiagen) according to the manufacturers instructions. 
To bind the DNA, Buffer PB was added to the PCR reaction and passed through a 
QIAquick column by centrifugation at 16000 x g for 1 minute using a bench top 
centrifuge (Heraeus Fresco 17, Thermoscientific). To wash the DNA, 0.75ml buffer 
PE, which contains ethanol, was added to the QIAquick column and centrifuged at 
16000 x g for 1 minute. The residual wash buffer was subsequently removed by 
quick centrifugation, before eluting the DNA using 50 µl of dH2O.  The resulting 
purified PCR product was kept on ice until further use, including the electroporation 
of PCR products into bacterial cells. 
 
2.2.4 Gel electrophoresis: 
DNA was analysed by electrophoresis in 0.7% agarose gels. This was made by 
dissolving 700mg molecular biology grade agarose powder (Melford labs) into 
100ml of 1x Tris-acetate-EDTA (TAE) and melting it. The TAE buffer was made 
using 242g Tris base, 57.1 ml glacial acetic acid and 100 ml 0.5 M EDTA (pH 8.0) 
per litre of distilled water and diluted 1 in 50 for working concentration. Once the 
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agar had cooled but not set, 5µl of ethidium bromide (100ng/ml from VWR) was 
added.  The agar was then poured into pre-made moulds containing combs of the 
required size (Biorad) and once set, submerged in to TAE buffer in a Biorad 
electrophoresis tank. DNA samples were mixed with DNA loading buffer (6x blue 
loading dye: 0.25% bromophenol blue, 0.25%  xylene cyanol FF, 30% glycerol in 
dH2O, from NEB) of which, 5µl was added to each well. To determine the size and 
quantity of the DNA bands, -2 log kb DNA ladder (NEB) was added to the left most 
lane. Gels were typically run at 100 volts for 45 minutes. DNA bands were visualised 
using a UV-transluminator and analysed using the GeneSnap software.  
 
2.2.5 DNA Gel extraction 
DNA extraction was carried out using a gel extraction kit (Qiagen) according to the 
manufacturer’s instruction. In summary, a slice of the agarose gel containing the 
DNA band was cut out using a sterilised scalpel under UV light. The gel pieces were 
dissolved in buffer QG and incubated in a 50°C water bath for approximately 10 
minutes. Once the gel dissolved, it was pipetted into the spin columns and 
centrifuged at 16000 x g for 1 minute.  The spin column containing the bound DNA 
was then washed with 1ml buffer QG to remove any residual agarose. The DNA was 
further washed with buffer PE, which contained ethanol to remove the salt. With 
20µl of distilled water, the DNA was eluted out from the column and stored at 4°C or 
-20°C depending on its subsequent use.  
 
2.2.6 Plasmid preparation 
Plasmid DNA was obtained from bacterial cells using the commercially available 
miniprep kits following the manufacturer’s instructions (Qiagen). Three ml of 
overnight cultures were centrifuged at 3000 x g for 10 minutes at 4°C. The resulting 
palette was resuspended in 250µl of buffer P1. A further 250µl of buffer P2 was 
added to the sample and thoroughly mixed before incubating at room temperature for 
5 minutes.  For neutralisation, 350µl of buffer N3 was added and thoroughly mixed. 
The resulting solution was centrifuged at 16000 x g for 10mins after which the 
supernatant was put into the spin column for a further 1 minute spin in the centrifuge. 
The plasmid DNA was washed with 70 µl of buffer PE and eluted with 50µl of 
distilled water.  
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2.2.7 DNA restriction digestion 
Restriction digestion of plasmid DNA was completed using 10µl of DNA (approx. 
0.5-1 µg), 5µl of 10X buffer and 1µl of each restriction enzyme in a final reaction 
volume of 50µl (made up by dH2O). Samples were incubated in a 37 oC water bath 
for 2 hours and the resulting degests were confirmed by gel eletrophoresis. 
Restriction enzymes are listed in Table 2.7. 
 
Table 2.6: Reaction components for Restriction digestion  
Component Volume (µl) 
DNA 10 (0.5 – 1 µg) 3 
10X buffer 5  2 
Restriction enzyme I 1  0.5 
Restriction enzyme II 1 0.5 
dH2O 33 14 
Total  50  20 
 





Table 2.7: Enzymes used for restriction digestion 
Enzyme Buffer used Source 
Xba1 Buffer 4 
Sal1 Buffer 3 
Nde1 Buffer 4 
EcoRI EcoRI buffer 






2.2.8 Dephosphorylation  
Following restriction digestion, the open plasmids were dephosphorylated by 
alkaline phosphatase to remove any phosphate groups from the 5’end of the cut DNA 
to prevent self-ligation. Dephosphorylation was only necessary in the case where 
plasmids were digested by a single enzyme or by two enzymes with compatible ends. 
For dephosphorylation, 50µl of digested plasmid was mixed with 1µl of alkaline 
phosphatase in 5µl of phosphate buffer and incubated at 37˚C for 1 hour. Enzyme 





Table 2.8: Reaction components for dephosphorylation 
Component Volume 
Digested plasmid 50µl 
Antarctic phosphate buffer  5 µl 
Antarctic alkaline phosphatase 1µl 
Total  56 µl 
 
Incubated for 1 hour at 37˚C 
and heat inactivated for 5 




In a 20µl reaction volume, insert and vector were added at a quantitative ratio of 3:1, 
1µl of T4 DNA ligase, 2µl of buffer (10x) and the required volume of distilled water 
(Table 2.9). The ligation mixture was left at 16°C overnight and heat inactivated at 
65°C for 5 minutes to remove any remaining enzyme activity before transformation.  
 
Table 2.9: Reaction components for Ligation 
Component Volume (µl) 
Insert 9 (3:1) 
Vector 3 (1:3) 
T4 DNA ligase 1 




Leave O/N at 16°C and heat 
inactivated  at 65°C for 5 




2.2.10 Heat shock transformation  
A vial of chemically competent TOP 10 cells was transformed with 5µl of ligated 
plasmids before leaving on ice for 30 minutes.  The cells were subsequently heat 
shocked in a water bath at 42°C for 45 seconds and transferred back onto ice for 5 
minutes. The cells were mixed with 600µl of super optimal broth with catabolite 
repression (SOC: 20g/L tryptone, 5g/L yeast extract, 4.8g/L MgSO4, 3.6g/L dextrose, 
0.5g/L NaCl, 0.186g/L KCl, Invitrogen), transferred to a 15ml falcon tube and grown 
in agitation at 37°C for 1 hour. The transformed cells were plated onto LB agar 






2.2.11 DNA sequencing  
Plasmid DNA was extracted using the miniprep kits (Qiagen) as described above. 
The sequence of the insert DNA within the plasmid constructs were confirmed by 
automated DNA sequencing by MWG Eurofins (www.ecom.mwgdna.com). 
Sequencing reactions contained 2µl of primers (15 pmol/µl) and 8µl of purified 
plasmid template DNA (50-100ng/µl) in a final volume of 17 µl (made up with 
dH2O). All sequencing reactions were pre-mixed in a 1.5ml eppendorf tube, labelled 
with a MWG Eurofins barcode label and sent to MWG Eurofins for the value read 
services. Sequencing results were sent back by email and viewed using the DNAssist 
software. Sequence data were analysed by performing sequence alignments with 
theoretical sequences. The complete sequence of the C. rodentium genome is 
available online at the Sanger Institute: 
www.sanger.ac.uk/resources/downloads/bacteria/citrobacter-rodentium.html.  
 
2.3 TOPO TA Cloning  
TOPO TA cloning® is a commercially available kit that enable the subcloning of 
PCR products containing the gene of interest, directly in to a plasmid vector without 
the need for restriction enzymes or DNA ligase. The TOPO TA cloning process is 
based on the Topoisomerase I mediated ligation of the PCR product containing 
adenine (A) overhangs with the TOPO vector containing thymin (T) overhangs. The 
adenine overhangs are created by amplifying the PCR product with Taq DNA 
polymerase, which lacks 3’ to 5’ proofreading activity and attaches on adenine at the 
3’ end of the PCR product. The supplied vector pCR2.1-TOPO is found linerized 
containing a single 3’ thymin overhang and a covalently bound topoisomerase at 
each linear end. When the 5’ end of the PCR product attach to the 3’ end of the 
vector, the complementary base pairs adenine and thymine hybridize, and ligate in 
the presence of topoisomersae enzyme. The hydroxyl group of the PCR product then 
attacks the phosphotyrosyl bond between the vector DNA and the topoisomerase 









Figure 2.1: Topoisomerase I enzyme. The insertion of a PCR product into a TOPO 
vector containing topoisomerase I enzyme 
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Table 2.10: Reaction components for TA PCR 
Component Volume (µl) 
Total 50 
dH2O 28.95 
5mM/µl dNTP 5 
10x ThermoPol  Buffer 5 
10pM/µl Primer (fw) 5 
10pM/µl Primer (rv) 5 
Template DNA 10-100ng 
Taq polymerase 1 
The TOPO cloning reaction was performed using 4µl of the PCR products, 1µl of 
salt solution (200mM NaCl and 10mM MgCl2) and 1µl of TOPO vector, and 
incubated for 5mins at room temperature. The resulting pCR2.1-TOPO plasmid 
containing the insert was then transformed into chemically competent E.coli cells 
and plated onto ampicillin and x-gal containing plates at 37⁰C overnight. Positive 
transformants (white) were confirmed by colony PCR, restriction analysis and 
sequencing. 
Table 2.11: Reaction components for TOPO cloning 
Component Volume (µl)  
PCR product 4  
Salt solution 1 (200mM NaCl and 10mM MgCl2) 
TOPO vector 1 
Total 6 
Incubate for 5 
minutes at room 
temperature 
For selection of positive transformants, the pCR2.1-TOPO vector contains ampicillin 
and kanamycin resistant markers. Additionally, the vector contains lacZα gene for 
blue / white screening. In the presence of pCR2.1-TOPO without the insert, E.coli 
cells carrying the lacZ deletion mutant (lacZΔM15) express an intact lacZα gene, 
which produces a functional ß-galactosidase enzyme. This enzyme can cleave x-gal, 
which is a chromogenic analogue of lactose, to form a blue colour. However, in cells 
where the plasmid contains an insert, the lacZα gene is disrupted, resulting in a non-
functional ß-galactosidase enzyme that is incapable of cleaving x-gal, thereby 
producing white colonies. Therefore, the presence of white colonies on x-gal plates 




2.4 CloneJET PCR Cloning 
An alternative method of sub-cloning required the use of a pJET1.2/Blunt cloning 
vector (Thermoscientific). This cloning strategy is based on the expression of a lethal 
restriction enzyme by the pJET1.2/Blunt cloning vector. The ligation of a DNA 
insert  into the cloning site of the pJET1.2/Blunt vector, disrupts the expression of 
this lethal gene, enabling the cells containing only the insert to grow and replicate. In 
contrast, the PJET1.2/Blunt cloning vector that does not contain a DNA insert, 
circularizes to express the lethal restriction enzyme, eco47IR, which kills its host (E. 
coli) after protein synthesis. This results in the positive selection of the transformant 
cells while reducing the time required for colony screening and additional cost 




2.5 Lambda (λ) Red mediated recombination  
In order to generate a chromosomally encoded gene disruption or gene fusion in the 
C. rodentium genome, linear DNA was generated by PCR amplification.  In the case 
of a chromosomally encoded gene fusion between an effector and the TEM-1 
reporter, the PCR product was generated through the PCR amplification of the 
plasmid region containing TEM-1 and the kanamycine resistance gene using primers 
that have homology sequences to the C. rodentium effector gene. In the case of an 
escN deletion mutant, the PCR product was generated by PCR amplifying a 
kanamycine resistance gene using primers that contained homology extensions to the 
escN gene sequence. The primers used are listed in Table 2.4. The resulting PCR 




Figure 2.4: Overveiw of the λ  Red recombination system. The use of λ Red 
recombinase mediated homologous recombination for the disruption or fusion of 
chromosomal genes in C. rodentium.  
1. PCR amplify the 
antibiotic resistance gene 
with primers that have 
homology to target site of 
insertion. 
2. Electroporate PCR 
product into strain 
expressing  λ recombinase 
for homologous 
recombination 
3. Select antibiotic resistant 
transformants containing the 








Gene of interest Gene A Gene B 
Primer size is 70bp 
Final strain 
containing fused 
construct  Antibiotic  resistance 
P1#H1#
P2# H2#
Gene of interest Gene A  B 








2.5.1 Electrocompetent cells 
Electrocompetent cells were prepared by growing an overnight culture of Citro 
pKD46 at 30˚C with antibiotics and agitation. In the following morning, 500µl of 
overnight culture was diluted in fresh 50ml LB broth containing 50µl of ampicillin 
and grown in 200 rpm agitation at 30 ˚C until bacterial cells had reached OD600 0.3-
0.4. At this point, 50µl of L-Arabinose (1mM) was added to the Citro pKD46 cells 
before putting back in the shaker for the bacterial cells to reach mid-log phase (OD600  
0.6- 0.7) for approximately 2-2 ½ hours in total.  
The culture was then chilled on ice for 15 mins before being divided into 50ml 
falcon tubes. The cells were then spun at 3000 x g for 15 minutes in a pre-cooled 
centrifuge. The supernatant was discarded and the pellet was washed by gently 
resuspending with 50ml sterile, ice-cold 15% (v/v) glycerol water. The pellets were 
washed twice more and after the final wash, bacterial cells were resuspended with 
200µl sterile cold glycerol water and transferred to a 1ml eppendorf tube. The cells 
were centrifuged again for 5 mins, resuspended into 80µl of cold glycerol water and 
kept on ice until electroporation.  
 
2.5.2 Electroporation  
For electroporation, 80 µl of electrocompetent cells were pipetted into pre-cooled 
2mm gap cuvettes. 8-10µg of purified PCR product was added to the cuvette and 
mixed with the electrocompetent cells.  The cuvettes were dried and the cells 
shocked in the electroporator with a pre-set programme (OHMS: 200, Voltage: 2.50 
kV, capacitance: 25). Immediately after electroporation, 700µl of SOC medium was 
added to the cuvette and the electroporated cells were transferred to a 15ml falcon 
tube and incubated with agitation (225rpm) at 37˚C for 1 ½ -2 hours. The cells were 
then spread across agar plates containing the appropriate antibiotic and incubated 




2.6 Mammalian cell culture 
2.6.1 Mammalian cell lines  
In this study, the following murine cell lines were used:  Swiss 3T3 fibroblasts, 
CMT93 Colonic epithelial cells, J774 macrophages and BW5157 T cells 
(summarised in Table 2.12) 
Table 2.12: Cell lines used in this study 





Complete DMEM Dr O. Marches 




25 mM Hepes) 
Dr V. 
MacDonald 
J774 Mice macrophages / monocyte 
(adherent) 
Complete DMEM Dr O. Marches 









2.6.2 Growing & harvesting cells 
All cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) high 
glucose, GlutaMAXTM supplemented with 10% Foetal calf serum (FCS) and 1% 
penicillin-streptomycin (100 U/ml penicillin and 100 µg/ml streptomycin) (all from 
GIBCO/Invitrogen, UK). The complete media was further supplemented with either 
25mM Hepes for culturing CMT93 Colonic epithelial cells or 0.05mM 2-
Mercaptoethanol for culturing T cells (all from GIBCO/ Invitrogen, UK). The 
complete medium was filter sterilised using 500ml vacuum filter system and a 
cellulose nitrate filter membrane with a pore size of 0.22um (Corning), prior to use. 
All cell lines were grown in 75cm2 flasks placed in 5% CO2 incubators at 37°C.  
When a cell density of greater than 70% to 80% confluency was reached, cells were 
subcultured. Briefly, the media was aspirated and the adherent cells were washed 
twice with Dulbeccos phosphate buffered saline (DPBS). To detach cells from the 
flasks, Swiss 3T3 cells were incubated with Trypsin-EDTA at 37°C for 5 minutes, 
CMT93 cells were incubated in DPBS at 37°C for 15 minutes and macrophages were 
detached using a cell scraper in DPBS, followed by strong shaking or tapping of the 
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flask. Pre-warmed media was then added (to inactivate the trypsin) and cell clumps 
were disrupted with gentle pipetting. Cells were spun at approximately 300 x g using 
a swing out rotor centrifuge (Jouan CR412) for 5 minutes and subsequently 
resuspended in fresh, pre-warmed media. The cells were then distributed into fresh 
75 cm2 flasks (with a dilution of 1 in 9) for subculturing. For cells in suspension, an 
aliquote of confluent cells were pippeted into fresh flasks containing pre-warmed 
media at an approximate dilution of 1 in 20 for subculturing. 
For frozen storage, cells were harvested at 300 x g following cell detachment. Cell 
palletes were resuspended at a density of 3 x 106 cells per ml in 5% DMSO in foetal 
bovine serum in polypropylene vials. Vials were frozen for 12-24 hours inside 
styrofoam racks before permanent storage in the -80°C freezer. Cells were recovered 
by rapid thawing at 37°C and mixing with 10 to 15 ml of fresh pre-warmed complete 
medium.  
 
2.6.3 Isolation of intestinal cells 
All lymphoid organs were harvested from female Balb/c mice and placed in 10ml 
ice-cold complete medium (RPMI 1640 GlutaMAXTM supplemented with 10% heat 
inactivated filter sterilised fetal calf serum (FCS), 1% penicillin-streptomycin 
(100U/ml penicillin and 100µg/ml streptomycin) and 25µg/ml gentamycin (all from 
GIBCO/Invitrogen, UK).  
 
2.6.3.1 Spleen and mesenteric lymph node (MLN) cells 
Single cell suspensions were prepared from the spleen or MLN by gentle 
compression between the frosted ends of two glass slides in ice cold RPMI media 
and the resulting cell suspension homogenised by repeatedly passing through a 10ml 
pipette. After allowing the debris to settle by leaving the cell suspension on ice for 5 
mins, the supernatant was passed through a sterile 100µm cell strainer (VWR, UK). 
Cells were subsequently washed by centrifugation at 300 x g for 5 minutes at 4°C in 
calcium and magnesium free (CMF) HBSS (GIBCO/Invitrogen). After the final 
wash, cells were re-suspended in 1-2 ml of complete medium and viable cell counts 
were performed using trypan blue in the haemocytometer. The cells were then 
diluted to 2x105 - 6x105 cells/ml or 1x106 cells/ml depending on subsequent 
experiment and kept on ice until use.   
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2.6.3.2 Peyer’s patch (PP) cells 
The small intestine was placed in a petri dish containing ice-cold complete medium. 
The PP were removed from the small intestine, transferred into calcium and 
magnesium free (CMF) HBSS solution containing 2mM EDTA (GIBCO/Invitrogen) 
and incubated on a magnetic stirrer for 30 minutes in 37°C. The resulting 
supernatant, containing the epithelial cells were discarded. The PP were then teased 
apart with tweezers and digested in collagenase (2mg/ml) for 30 minutes in a 37°C 
cell shaker. The resulting cell suspension was poured through a sterile 100µm cell 
strainer, washed using CMF HBSS and resuspended in 1ml of complete medium for 
performing viable cell counts (described below). 
 
2.6.3.3 Colonic epithelial cells 
The colons of infected mice were collected in 50ml tubes containing RPMI on ice. 
The whole colon was washed by flushing with ice cold PBS using an oral gavage 
needle. The colons were placed onto pre wet (ice cold PBS) paper towels and the 
debris from fat, blood vessels and the mesentery removed using fine tweezers. The 
colon was cut into smaller pieces, put individually on to parafilm, and cut 
longitudinally. Once each piece was opened and the lumen exposed, the epithelium 
was gently scrapped off the intestine using a scalpel. The epithelium was rinsed off 
the scalpel into a100ml beaker containing RPMI supplemented with 10% Newborn 
calf serum (NCS) at 37°C. The beaker was topped up to 50ml and 8mg of 
Dithioerythritol (DTE) added to a final concentration of 1mM (Sigma). Each beaker 
was covered with foil and placed on a magnetic stirrer for 40 minutes at room 
temperature.  The contents of the beaker were then collected into a 50ml falcon tubes 
and spun at 300 x g for 5 minutes at room temperature. The supernatant was 
discarded and the pellets were resuspended in 10ml RPMI 10% NCS. After 
vortexing the tubes at maximum speed for 3 minutes, 40ml of RPMI 10% NCS was 
added and poured through nylon wool columns to remove mucus and large debris. 
The nylon wool columns were prepared using 0.7g of nylon wool, separated into fine 
strands and pushed into a 50ml syringe barrel, wrapped in foil and autoclaved. The 
columns were set up using clamps to hold the syringe, an infusion tube with fitted 
clamp to modulate the column flow and sterile 50 ml falcon tubes to collect the 
eluate. The columns were equilibrated with RPMI containing added Hepes 
(0.5mg/50ml at a final concentration of 38mM). The epithelial cell suspension was 
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run through the columns by gravity flow and the columns washed with a further 
50ml RPMI 10% NCS. The column eluate was spun at 300 x g for 5 minutes and 
resuspended in CMF HBSS for CCF4 staining.   
 
2.6.4 Cell count  
All viable cell counts were performed using 1 in 20 dilution of cells in 0.4% tryphan 
blue (Sigma-Alderich), a haemocytometer cell counting chamber (Hausser Bright-
line 3100) and a phase contrast microscope. 
 
 2.6.5 Microscopy 
Live cells were viewed using Leica DM5000B Epi-fluorescence microscope with the 
DAPI filter set (340-380 nm excitation and 425 nm long pass emission). Images were 
taken using DFC490 digital colour camera using the Leica Application Suite V3 
(LAS) software. All microscopy work was carried out in the Blizzard Advanced 
Light Microscopy core facility (BALM).  
 
2.6.6 Flow cytometry 
Cells were analysed using the BD FACS Canto II machine with BD FACSDiva 
v6.1.3 software located in the Flow cytometry core facility at the Blizzard Institute of  
Cell and Molecular Sciences (BICMS).  
 
2.6.7 Cell characterization 
Cell characterization by flow cytometry was performed to identify various immune 
cell populations present in the spleen. Single cell suspensions of splenocytes were 
washed and resuspended into 100µl of FACS buffer (0.5% BSA, 0.05% NaN3 and 
sterile PBS) containing up to 5x107 cells in round bottom FACS tubes. The cells 
were stained with various anti-mouse antibodies (all from BD eBioscience) 
conjugated to different flurochrome, including anti-mouse CD3e PE Cy7 (1µg/test), 
CD19 PerCP-Cy5.5  (0.25/test) or CD11c APC (0.25µg/test) and incubated on ice for 
15 minutes in the dark. After staining, cells were washed and resuspended into 300µl 
of ice-cold FACS buffer for analysis in the flow cytometer. Fluorochrome 




2.6.8 Cell stimulation assay 
Single cell suspensions were prepared from the spleen, MLN and PP as outlined 
above. Aliquots of 2x105 to 7x105 viable cells were cultured in 1 ml of complete 
medium in a 12 well plate. Cells in duplicate plates were stimulated by the addition 
of 5µg/ml of concanavalin A (ConA) and cultured at 37°C for 72 hours in the C02 
incubator. Stimulation was confirmed using visual inspection, such as the increase in 
cell size and presence of cell clumps. After 72 hours, cells were harvested, infected 
with C. rodentium and stained with CCF4-AM substrate.  
 
2.7 β-lactamase translocation assay  
The β-lactamase translocation assay, which utilizes translational fusions to TEM-1 
was recently developed to study effector translocation into host cells (Charpentier & 
Oswald, 2004). Fusing a T3SS effector gene with the TEM-1 β-lactamase reporter 
gene generates a translational fusion protein that can be detected by the addition of 
the fluorescent substrate CCF4-AM. Eukaryotic cells containing TEM-1 are able to 
cleave CCF4-AM and appear blue under UV light, while cells lacking TEM-1 are not 
able to cleave CCF4-AM and appear green. To detect the translocation of NleD-
TEM-1 fusion protiens in this study, mice cells were infected with Citro 
pACYCnleD expressing a gene fusion between the NleD effector and the TEM-1 β-
lactamase enzyme, and incubated with CCF4-AM substrate. The β-lactamase 
substrate CCF4 is more soluble than CCF2 in aqueous solutions and has therefore 
been preferred over CCF2.  β-lactamase enzyme activity in mouse cells was detected 
using fluorescence microscopy or flow cytometry. The translocaion assays, 
originally described in EPEC (Charpentier & Oswald, 2004), were adapted for use in 
C. rodentium according to the advice of Dr. O. Marches. 
 
2.7.1. Day before the assay 
To prepare the bacterial inoculum, 3 ml LB broth (supplemented with 1mg/ml 
chloroamphenicol) was inoculated with a single colony of Citro pACYCnleD and 
grown in a 37°C shaker at 200 rpm. After 8 hours, the resulting bacterial culture was 
diluted 1:100 in the interaction media (25mM Hepes modified DMEM with 
glutamax and 10% FCS) and transferred into a 6 well plate (Corning). The plates 
were incubated static at 37°C in a 5% CO2 incubator overnight (for activation).  
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To prepare the mouse cell lines, adherent cells were seeded at an approximate 
density of 4x104 cells into each well of an 8-well LabTek chamber slide (Sigma-
Alderich) containing 500µl DMEM, while non-adherent cells were seeded at an 
approximate density of 8x104 cells / ml. All cells were incubated at 37°C in 5% CO2 
overnight.  
 
2.7.2 Day of the assay  
Adherent cells in the LabTek were washed twice with pre warmed DPBS and 
replaced with 500µl of the bacterial suspension. The bacterial suspension was 
prepared from overnight cultures by washing with DPBS (centrifuging at 3000 x g 
for 5 minutes) and resuspending in the interaction media. 1 in 10 dilution was made 
by diluting 50µl of overnight bacterial culture into 450µl of pre-warm interaction 
media to prepare a 500 µl bacterial inoculum.  The infected cells were incubated in a 
static incubator with 5%CO2 and 37°C for 6 hours. After infection, bacteria were 
removed by washing cells three times in calcium and magnesium free (CMF) HBSS. 
After the final wash, cells were resuspended in 200µl of HBSS to which 40µl of 
freshly prepared CCF4-AM solution was added at a concentration of 1mM per well 
according to the CCF4-AM substrate loading kit (Invitrogen). The cells were 
incubated in the dark, at room temperature for 60 minutes and then washed three 
times in HBSS. After the final wash, the plastic chamber partitions were removed 
from the LabTek slide and excess HBSS removed using Whatman 3 mm filter paper. 
The wells were covered with 2cm2 glass coverslips and ready for observation by 
fluorescence microscopy. 
Non-adherent cells were washed in HBSS by centrifugation at 300 x g for 5 minutes, 
resuspended in the interaction media and distributed into a 12 well plate at an 
approximate density of 5x105 cells per well. The bacterial inoculum was made by 
diluting the overnight cultures in 1:10, 1:100 or 1:1000 in the interaction media. 
100µl of the diluted bacterial culture was added to the 900µl cell suspension and 
mixed by gentle pipetting. The infected cell suspensions were incubated in a static 
incubator with 5%CO2 and 37°C for 6 hours. After infection, bacteria were removed 
and the cells were washed in HBSS. After the final wash, cells were resuspended in 
400µl of HBSS in a 24 well plate to which 80µl of freshly prepared CCF4-AM 
solution was added at a concentration of 1mM per well according to the CCF4-AM 
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substrate loading kit (Invitrogen). After an hour long incubation in the dark at room 
temperature, cells were washed three times in HBSS, resuspended into 1ml of DPBS 
and transferred to FACS tubes for immediate FACS analysis.           
For the time course assay, approximately 105 T cells were infected with 
approximately 108 Citro pACYCnleD (MOI=1000 or 103) for 6, 4, 2 and 1 hour. The 
cells were subsequently stained and analysed by flow cytometry.  
To investigate the multiplicity of infection (MOI), overnight cultures of bacteria 
were washed and resuspended in the interaction media at various dilutions including 
1:10, 1:100, 1:1000, 1:10000 and 1:100000. Bacteria from the various dilutions were 
pipetted in to each well containing ~105 cells/ml. Retrospective plating confirmed the 
number of bacteria per cell.  
 
Table 2.13: The multiplicity of infection (MOI). All values are approximate.  
Bacterial dilution of 
overnight  culture 
Bacterial count 
per well 
T cell count 
per well 
MOI 
1:10 1010 105 105 
1:100 109 105 104 
1:1000 108 105 103 
1:10 000 107 105 102 
1:100 000 108 105 101 
 
 
2.7.3 β-lactamase translocation assay in vivo 
Single cell suspensions were prepared from the spleen, MLN and PP of infected 
mice, washed and resuspended in HBSS. 400µl of each cell suspension was 
distributed in a 24 well plate with an approximate density of ~ 106 cells per well. For 
substrate staining, 80µl of freshly prepared CCF4-AM solution (1mM) was added to 
each well according to the manufacturers instructions from the CCF4-AM substrate 
loading kit (Invitrogen). Following an hour long incubation in the dark at room 
temperature, cells were washed three times in HBSS, resuspended into 1ml of DPBS 






2.8 Mouse infection studies 
2.8.1 Mice 
Five to seven week old, female, specific pathogen free (SPF) Balb/c mice were 
purchased from Charles River Laboratories (Scotland, UK). They were housed in 
groups of 5-6 mice in closed, ventilated cages with sterile bedding and free access to 
commercial food and water in the biological sciences unit (BSU). Following 
transportation to the BSU, the mice were left to acclimatize for a period of 10 days 
before the commencement of any mice experiments. Independent infection 
experiments were performed at least twice using a minimum of five mice per group. 
All procedures were performed in accordance with the Animals in Scientific 
Procedures Act and United Kingdom home office regulations.  
 
2.8.2 Bacterial inoculum for mice infection       
The day before infection, 50ml of LB broth containing nalidixic acid (100µg/ml) 
and/or chloramphenicol (50µg/ml) were inoculated with freshly isolated C. 
rodentium and grown overnight in a 37°C shaker (200 rpm). On the day of infection, 
bacterial cultures were harvested by centrifugation at 3000 x g for 10 minutes 
followed by washing to remove any antibiotics in the media and resuspension in 5ml 
of sterile PBS (Sigma-Alderich) to prepare a 10x concentrated bacterial inoculum, 
which was kept on ice until use.  
 
2.8.3 Oral inoculation of mice 
Individual mice were orally gavaged with 200µl of 10x concentrated C.rodentium by 
a gavage needle. Retrospective plating confirmed that ~2x109 to ~6x109 colony 
forming units (cfu) of C. rodentium were received by each mice. The tails of each 
mouse was colour coded to enable the infection to be followed in each individual 
animal. Mice were regularly monitored over a period of 8-12 days post inoculation 
by measuring body weight and bacterial burden (recovering viable CFU counts from 
mice stool samples). At the end of the infection experiment, mice were killed by 
terminal anaesthesia (CO2 gas) or by cervical dislocation. The distal colon was 
removed and snap frozen in liquid nitrogen for subsequent Haematoxylin and Eosin 
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staining. The spleen, MLN and PP were collected for preparing single cell 
suspensions, which were analysed for β-lactamase activity.  
 
2.8.4 Retrospective plating 
Infection in individual mice was monitored by retrospective plating of viable bacteria 
from stool samples. Faecal pellets were collected in eppendorf tubes, weighed and 
added to sterile PBS at a concentration of 100mg/ml. The pellets were mashed using 
a 1ml pipette tip and vortexed before separating the debris by a quick centrifugation 
at 200 x g. The resulting supernatant containing the bacterial suspension was serially 
diluted in PBS and plated onto LB agar containing nalidixic acid. The plates were air 
dried and incubated at 37°C overnight. The number of bacteria shed per gram of 
stool was determined by viable count of CFU present on the plates, using the 
following formula: CFU/g of stool = CFU on plate / dilution factor. 
 
2.8.5 Hematoxylin and Eosine (H&E)  
Frozen colonic tissues were mounted in OCT (Agar Scientific Ltd, UK) on dry ice 
using plastic moulds and fast freeze spray. Five micrometer (µm) sections of tissue 
were cut on a cryostat (OTF5000, Bright Instruments Ltd, UK) and mounted on 
polysine slides (VWR, UK). The slides were air dried for 30mins at room 
temperature and fixed in 100% acetone for 20 minutes before drying again for 
another hour. The slides were then dipped in Meyer’s haematoxylin (Sigma-Alderich 
Ltd, UK) for 30 seconds, quickly rinsed in tap water before dipping into acid alcohol 
and washing again in tap water for 5 minutes to develop the blue stain. The slides 
were subsequently placed in 1% eosin yellow solution (VWR, UK) for 5 minutes, 
quickly rinsed in tap water, dipped into acid alcohol and washed again in tap water 
for 1minute. The sections were then dehydrated using an ethanol gradient (70%, 
90%, 95% and 2x 100%) with 2 minutes in each concentration. Finally, the sections 
were cleared in Histo-clear (VWR) for 5 minutes in the fume hood and mounted on 
cover glass using DPX mountant before drying them overnight at room temperature. 
The hematoxylin and the eosine stained tissue sections were viewed under an 
inverted, phase contrast microscope where the length of the colonic crypts were 
measured using a calliberated graticule placed on the eye piece of the microscope. 
An average of 10 to 25 measurments were recorded for each tissue section and the 
data expressed as colonic crypt length in µm.  
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2.8.6 Data analysis 
Data shown in a scatterplot or barchart were expressed as the mean+SEM values of 
several independent experiments / individual mice (indicated by error bars). All data 
analyses were performed using Graphpad prism version 4 software for Windows 
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3: Construction of a reporter C. rodentium strain encoding a 
fusion between the effector and the β-lactamase gene 
 
3.1 Introduction 
The purpose of this study was to create a reporter C. rodentium expressing a 
chromosomally encoded fusion protein between a T3SS effector and the ß-lactamase 
reporter enzyme (TEM-1). To do so, the Datsenko and Wanner (2000) strategy of λ 
Red recombination-mediated gene replacement was used. Previous gene replacement 
methods for disrupting or inserting a chromosomal gene in bacteria required the 
construction of various plasmids and suicide vectors in multiple cloning steps prior 
to the recombination of plasmid DNA into the bacterial chromosome (Metcalf et al, 
1996; Kato et al, 1998). Datsenko and Wanner (2001), however, developed a λ Red 
recombination system that directly creates a chromosomal gene replacement in E.coli 
using linear DNA in a single step. The use of linear DNA to disrupt chromosomal 
genes and insert foreign DNA was first demonstrated in Saccharomyces cerevisiae 
and Candida albicans (Rothstein, 1991). The linear DNA was generated through 
polymerase chain reaction (PCR) amplification of a selectable gene marker with 
flanking DNA regions homologous to the chromosomal target site. Mitotic 
recombination, a highly efficient homologous recombination process in yeast, then 
created a chromosomal gene disruption through the insertion of the marker gene at 
the flanking site (Rothestein, 1991).  
In bacteria, however, homologous recombination using PCR fragments is ineffective 
due to the presence of intracellular exonucleases. Exonuclease V (Exo V), for 
example, belonging to the bacterial RecBCD recombination complex, degrades linear 
DNA, including PCR products transformed into bacterial cells (Lorenz & 
Wackernagel, 1994). To overcome this problem, many studies used mutants of the 
RecBCD recombination complex and conditions that inhibit ExoV nuclease activity, 
but these resulted in inefficient homologous recombination between the chromosome 
and the PCR fragments (Dabert & Smith, 1997; Toro et al., 1998).  
The discrepancy was finally solved when extensive studies led to the exploitation of 
the homologous recombinase genes from bacteriophage λ. Bacteriophage λ possesses 




with chromosomal DNA in bacteria (Murphy et al, 1998). The Red system consists 
of three proteins, Gam, Bet and Exo, which are synthesised from the genes γ, ß, and 
exo clustered in a single operon. The Gam protein binds to the bacterial RecBCD 
recombination complex, inhibits its exonuclease activity, and prevents host 
degradation of linear DNA. This enables Exo and Bet proteins to have access to the 
ends of the linear DNA, where Exo digests the 5'-end of the double-stranded DNA to 
single-stranded DNA and Bet binds to the single-stranded DNA to promote strand 
annealing to complimentary DNA. By doing so, the Red enzymes induce a ‘hyper-
rec’ state in E. coli, wherein recombination events between the chromosome and 
linear DNA with shared sequences occur at high frequencies (reviewed in Poteete 
2001 & 2006 and in Madyagol et al, 2011).  
Use of the λ Red system for in vivo genetic engineering was revolutionised in 2000 
by three independent studies, which demonstrated DNA recombination of PCR 
products flanked by short (35-50bp) homologous sequences (Datsenko & Wanner, 
2000) or by long (1000bp) homologous sequences, in the presence of the Red system 
expressed either from the lac promoter (Murphy et al, 2000) or a defective λ 
prophage with a thermosensitive repressor (Yu et al, 2000) in E. coli. 
The strategy developed by Datsenko and Wanner (2000) for chromosomal gene 
replacement is rapid and highly efficient (outlined in Figure 3.1.1). It involves the 
expression of the λ Red enzymes on a low copy plasmid where γ, ß, and exo are 
placed under the control of the ParaB promoter and induced with arabinose (Fig. 
3.1.2). The linear DNA is generated through the PCR amplification of an antibiotic 
resistance marker using primers that contain 36 base pairs flanking regions 
homologous to the sequence of the desired insertion site. Electroporation of the 
resulting PCR products into E. coli cells, following arabinose induction, enables 
Red-mediated homologous recombination to occur between the PCR products and 
the E. coli chromosome at the flanking regions. Following selection, the resistance 
marker, flanked by FLP recognition target (FRT) sites, can be eliminated by the 
expression of FLP recombinase from a helper plasmid directly acting on the FRT 
sites. The λ Red expression plasmid and FLP helper plasmid, containing the 
temperature sensitive replicon maintained at 30°C, are eliminated by growth at 37˚C. 
Using this method, mutants can be created within a week, which is a short timeframe 




using traditional plasmid-based methods. In addition, the use of primers with short 
flanking regions homologous to the chromosomal insertion site allows flexibility in 
designing and choosing the specific chromosomal location (Datsenko & Wanner, 
2000; Madyagol et al, 2011). 
Since its inception, the λ Red-mediated gene replacement method has been used 
extensively for the mutational analysis of genes belonging to several different E. coli 
pathotypes, including enteropathogenic E. coli (EPEC), enteropathogenic E. coli 
(EHEC), enteroaggregative E. coli (EAEC), uropathogenic E. coli (UPEC), and 
enterotoxigenic E. coli (ETEC) (Murphy & Campellone 2003; Savage et al, 2006; 
Lee et al, 2009). In addition, it has been an indispensable tool in the creation of the 
Keio collection, which is a set of E. coli K-12 mutants containing precisely defined 
single gene deletions in all non-essential genes (Baba et al, 2006). Moreover, the λ 
Red-mediated gene replacement method has been widely used to study other gram-
negative bacteria including Salmonella (Uzzau et al, 2001; Hussaaeiny & Hensel 
2005; Yu et al, 2011), Shigella (Ranallo et al, 2006; Bhagwat et al, 2012), and 
Yersinia (Derbise 2003; Sun et al, 2008).  
Therefore, we used the Datsenko and Wanner (2000) strategy of λ Red 
recombination-mediated gene replacement to create a gene fusion between the T3SS 
effector and a ß-lactamase reporter gene (TEM-1) in C. rodentium (Fig 3.1.3).  
However, since the aim of this study was to create a reporter C. rodentium encoding 
a gene fusion rather than a gene replacement, the use of FRT sites and the expression 











Figure 3.1.1: The Datsenko and Wanner (2000) strategy of gene replacement. 
The antibiotic resistance gene is amplified using primers that contain primer binding 
sites (P1 and P2) and homology extensions (H1 and H2). P1 and P2 bind to the 
antibiotic resistance gene, while H1 and H2 are homologous to the chromosomal 
insertion site. Homologous recombination occurs at the H1 and H2 regions, resulting 
in the replacement of gene B with the antibiotic resistance marker in the bacterial 
chromosome. FLP recombinase acting on the FRT sites can subsequently eliminate 







                        
 
 
Figure 3.1.2 Plasmid map of pKD46. Described by Datsenko and Wanner (2004), 
pKD46 plasmid encodes the λ Red genes (γ, β, and exo) from the araBAD promoter. 
The temperature-sensitive replicon is maintained at 30°C and cured at 37°C. Image 



















Figure 3.1.3: Chromosomal gene fusion strategy. The plasmid region containing 
TEM-1 and the kanamycin resistance gene is amplified by primers that have primer 
binding sites (P1 and P2) and homology extensions (H1 and H2). Homologous 
recombination occurs at the H1 and H2 regions, resulting in the chromosomal 
insertion of TEM-1 and the kanamycin resistance gene into the C. rodentium 
chromosome. The insertion of TEM-1 next to a bacterial effector results in effector-


























The aim of this chapter was to generate a reporter strain of C. rodentium expressing a 
chromosomally encoded gene fusion between a T3SS effector and the ß-lactamase 
reporter (TEM-1) using the Datsenko and Wanner (2000) strategy for gene 
replacement. As a negative control, the Citro ΔescN mutant strain containing a 
chromosomal gene disruption in the escN locus was also generated. Although the ß-
lactamase (blaM) gene encodes the TEM-1 protein, for simplicity, the terms TEM-1 
or TEM will be used to refer to both the gene and the protein throughout the rest of 
this thesis. In addition, the figures in this chapter will be incorporated within the 
results section for the reader's convenience.  
 
3.2.1 Construction of a Citro ΔescN mutant 
Previous research has shown that Escherichia secretion component N (EscN) in E. 
coli is homologous to the extensively studied Yersinia secretion component N 
(YscN) in Yersinia and Invasion C (InvC) in Salmonella. These cytoplasmic proteins 
show high similarity to proton-translocating ATPases in bacterial cells (Hueck 1998), 
which interact with membrane-bound components of the T3SS to provide energy for 
the assembly of the T3 apparatus and secretion of its effectors (Fan et al, 1996). 
Mutations in these genes result in the inability of bacteria to catalyse ATP hydrolysis 
(Eichelberg et al, 1994) and energise the type 3-mediated translocation of proteins 
(Woestyn et al, 1994). Consequently, the use of YscN and EscN deletion mutants as 
negative controls enabled the study of T3SS-mediated translocation of effectors in 
Yersinia (Marketon et al, 2005; Koberle et al, 2009) and EPEC  (Ritchie & Waldor 
2005, Vossenkaemper et al, 2010), respectively. Therefore, a ΔescN deletion mutant 
of C. rodentium was used as a negative control in this study.  
The ΔescN deletion mutant was constructed by desrupting the C. rodentium escN 
gene with a kanamycin resistance cassette (kn315). To do so, the kn315 gene was 
amplified by PCR from pKD4 plasmid using primers escNFRT (fw) and escNFRT 
(rv) containing flanking DNA homologous to the escN gene (Fig. 3.2.1 A). The PCR 
product was then purified and electroporated into electrocompetent Citro pKD46 
cells expressing the λ Red recombinase genes. The resulting mutants were selected 





















Figure 3.2.1: Construction of the Citro ΔescN deletion mutant. (A) Gel 
electrophoresis showing PCR amplification of the kanamycin resistant gene 
(0.792kb) from the pKD4 plasmid using primers escN-FRT (fw) and escN-FRT (rv). 
The primers contain extension homologies to the escN gene in C. rodentium, thus 
resulting in a PCR product with a band size of  ~1.5kb in total. (B) Colony PCR of 
transformants using primers K1 (fw) and B171DescN(rv) that amplifies a ~1kb 
region comprising partly of the kanamycin resistance gene and partly of the escN 
gene, thus confirming the construction of the ΔescN deletion mutant . (C) Colony 
PCR of transformants using primers B171 (fw) and B171DescN (rv) resulting in a 
band size of 1.3kb (intact escN gene) or 2.1kb (disrupted escN gene with kanamycin 
insert) for verification of the ΔescN deletion mutant. Marker sizes are indicated next 





3.2.2 Construction of a chromosomally encoded gene fusion 
The translocated intimin receptor (Tir) is one of the first effectors to be delivered into 
host cells by the bacterial T3SS. It is essential for the attachment of bacteria to 
intestinal epithelial cells (Marches et al, 2000) and for bacterial colonisation of the 
host gut in vivo (Deng et al, 2003). Tir is encoded in the locus of enterocyte 
effacement (LEE) and expressed when AE pathogens come into close contact with a 
host cell (Knutton et al, 1997). Upon translocation into the host cell cytoplasm, Tir is 
inserted into the plasma membrane in a hairpin loop topology, exposing an 
extracellular loop that interacts with the bacterial surface protein Intimin and an 
intracellular domain that interacts with host cytoskeletal proteins. Intimin binding to 
Tir facilitates tight attachment to host epithelial cells, which leads to the formation of 
actin-rich pedestals and the characteristic attaching and effacing (AE) lesions (Kenny 
et al, 1997; Frankel et al, 2001; Goosney et al, 2000; Pelegrin et al, 2014). Since Tir 
is essential for AE pathogenesis, we aimed to create translational fusions to TEM-1 
in order to investigate the host cells targeted for Tir translocation by C. rodentium.  
 
3.2.2.1 Construction of plasmid pCX315 encoding TEM-1 and an antibiotic 
resistant marker 
To generate translational fusions of Tir with TEM-1, the plasmid pCX315 was first 
created using the plasmid pCX340. Plasmid pCX340, a β-lactamase TEM-1 fusion 
cloning plasmid, was previously constructed by Charpentier and Oswald (2004) to 
create translational fusions with EPEC effectors. It was designed to carry the ß-
lactamase (blaM) gene encoding TEM-1, Ptrc promoter upstream of blaM, 
tetracycline resistance gene and a multiple cloning site (containing unique restriction 
sites NdeI, KpnI, and EcoRI) upstream of blaM (Fig. 3.2.2). Consequently, the 
plasmid pCX340 encodes the β-lactamase TEM-1 enzyme under an isopropyl-ß-D-
thiogalactopyranoside (IPTG) inducible promoter. In addition, the presence of a 
multiple cloning site enables the cloning of effector genes with blaM to generate 
Effector-TEM fusion proteins (Charpentier & Oswald, 2004). 
To construct the pCX315 plasmid, a kanamycin resistance cassette (kn315) was 
inserted downstream of TEM-1 in the pCX340 plasmid (Fig. 3.2.3). The kn315 gene 
(968bp) was amplified by PCR from plasmid pSB315 (provided by Dr O. Marches) 




to contain the restriction sites Xba1 and Sal1 to enable the insertion of kn315 into the 
Xba1/Sal1 site located downstream of TEM-1 in the pCX340 plasmid. The resulting 
PCR product was cut using the Xba1 and Sal1 restriction enzymes and ligated into 
the cut pCX340 plasmid vector (Fig. 3.2.4). The transformed bacterial strains were 
grown on plates containing kanamycin. Despite several attempts, however, we did 
not manage to isolate any kanamycin-resistant transformants containing the pCX315 
plasmid.  
Since we were unable to clone the kn315 gene directly into pCX340 through the 
restriction digestion of linear DNA (PCR product containing kn315), we decided to 
subclone the kn315 gene into a plasmid because restriction digestion works better in 
circular DNA. Consequently, kn315 was subcloned into the TOPO TA cloning 
vector (3.9kb) to generate the plasmid pCR2.1TOPOkn315 (~4.9kb). TOPO TA 
cloning uses Toposiomerase I enzyme to directly insert PCR products (containing A 
overhangs) into the TOPO vector (containing T overhangs), without the need for 
restriction enzymes or DNA ligase (described in Chapter 2). In addition, the TOPO 
cloning reaction occurs in 5 minutes with up to 95% of transformants containing the 
cloned insert, which can be analysed through blue/white screening (on x-gal 
containing plates), restriction digestion, PCR analysis and sequencing (using the 
M13 forward and reverse primers). For these reasons, we hoped that TA sub-cloning 
would improve the efficiency of kn315 cloning into pCX340. Following verification 
(by PCR analysis, EcoR1 restriction digestion, and sequencing), the plasmid 
pCR2.1TOPOkn315 was digested with XbaI and Sal1 restrciton enzymes and ligated 
into the digested pCX340 vector (Fig 3.2.4). This generated the pCX315 plasmid 
containing a kn315 insertion downstream of TEM-1. The plasmid construct was then 










Figure 3.2.2: Map of the pCX340 cloning vector. The pCX340 plasmid carries the 
blaM gene encoding the ß-lactamase TEM-1 enzyme. The presence of the multiple 
cloning sites upstream of TEM-1 enables the creation of translation fusion proteins 





















Figure 3.2.3 Overview of pCX315 plasmid construction. The kn315 antibiotic 
resistance cassette was PCR-amplified from pSB315 using primers that contain the 
restriction sites Xba1 and Sal1. The PCR product was TA-cloned, cut using Xba1 








Figure 3.2.4: Cloning of pCX315 plasmid. Sal1 and XbaI restriction digestion of 
pCR2.1TOPOkn315 (produce DNA fragments 3.9 kb and 9.68 kb) in lane 1 and 
pCX340 (produce DNA fragments 4.914 kb and 0.755 kb) in lane 2. The 0.968 kb 









Figure 3.2.5: Verification of pCX315 plasmid. HindIII restriction digestion of 
pCX315 (lane 1-2) and pCX340 (lane 4). Two HindIII restriction sites are located at 
4.402 kb and 1.267 kb sites in the pCX340 plasmid, and at 4.402 kb and 1.480 kb in 
the pCX315 plasmid just outside the insert (kn315) fragment. Undigested plasmid 




3.2.2.2 Homologous recombination with tir  
To generate the PCR product required for λ-Red mediated homologous 
recombination, the plasmid construct containing the TEMkn315 region was 
amplified by PCR using pCX315 and primers with flanking regions homologous to 
the chromosomal insertion site adjacent to tir. The 5’ end of the Citro tirTEMkn315 
(fw) primer contained 50bp sequences homologous to 3’ end of tir, while the 5’ end 
of the Citro tirTEMkn315 (rv) primer contained 50bp sequences homologous to the 
non-coding sequences directly after the end of tir. The primers were designed to 
ensure that the effector-TEM gene fusion, through homologous recombination at the 
flanking sites, occurred with minimum disruption to the C. rodentium LEE genes 
(Fig. 3.2.6). 
The resulting PCR product (Fig. 3.2.7) was purified and electroporated into the C. 
rodentium strain expressing the λ-Red recombinase system (Citro pKD46). In theory, 
this process of homologous recombination should create a chromosomally encoded 
fusion between tir and TEMkn315, resulting in the expression of tir from its native 
promoter in the C. rodentium chromosome. However, despite many attempts to 
electroporate the TEMkn315 DNA fragment into C. rodentium, including the use of 
longer homology extensions in the PCR primers and increasing the concentration of 
the insert DNA, we were unable to isolate any positive transformants, as verified by 








Figure 3.2.6 Overview of a chromosomally encoded effector fusion using 
pCX315. To construct a chromosomal effector fusion with TEM-1, the TEMkn315 
region from the pCX315 was PCR-amplified using primers with flanking DNA 
homologous to the chromosomal effector site. The resulting PCR product was 
electroporated into a λ Red recombinase expressing C. rodentium strain and selected 





                                 
Figure 3.2.7: PCR product (TirTEMkn315) for homologous recombination. 
PCR amplification of the TEMkn315 region (1.850 kb) from pCX315 plasmid using 
primers TirTEMkn315 (fw) and TirTEMkn315 (rv).  
 
 
Figure 3.2.8: Verification of the chromosomally encoded TirTEMkn315 fusion. 
Colony PCR using primers pCX340 (fw) and pCX340 (rv) of overnight cultures 
grown from the electroporation of TEM-kn315 into Citro pKD46. The presence of a 
1.045 kb band size would indicate that successful homologous recombination had 
taken place. Therefore, the absence of this band confirms our inability to generate the 








3.2.2.3 Homologous recombination with nled 
Facilitated by the C. rodentium genome sequence (www.sanger.ac.uk) bioinformatics 
analysis comparing the AE pathogens revealed the presence of many novel and 
putative effectors in C. rodentium. Additional studies using proteomics and genetic 
screens have determined that some of these potential effectors are translocated into 
host cells by the LEE-encoded TTSS, but not encoded within the LEE (Gruenheid et 
al, 2004; Deng et al, 2004; Marches et al, 2005; Li et al, 2006; Garcia-Angulo et al, 
2008). 
The non-LEE-encoded D (nleD) gene, present in pathogenicity islands (PAIs) 
outside the LEE (Deng et al, 2004), was shown to encode NleD, which is highly 
translocated into HeLa cells (Marches et al, 2005) through the LEE-encoded T3SS 
(Deng et al, 2010). Although a signature-tagged mutagenesis screen showed NleD to 
be essential for the colonisation of the bovine gut by EHEC (Dziva et al, 2004), the 
role of NleD in virulence has not been established in mouse or lamb infection 
models. For example, the deletion of NleD had no effect on EHEC colonisation of 
calves or lambs (Marches et al, 2005) or on C. rodentium colonisation of mice (Kelly 
et al, 2006). The nleD gene exists as two copies in the C. rodentium genome (Kelly 
et al, 2006); this may be advantageous in the creation of chromosomal gene fusions. 
If, for example, the translational fusion with TEM-1 resulted in a gene disruption, it 
would not affect the overall phenotype of C. rodentium due to gene redundancy 
whereby the intact second copy of the chromosomal nleD would compensate. As a 
result, the NleD effector was chosen for the creation of translational fusion protiens 
with TEM-1.   
	To create a translational fusion with TEM-1, the TEMkn315 construct was PCR-
amplified from pCX315 using primers Citro nleDTEMKn315 (fw) and Citro 
nleDTEMKn315 (rv). The resulting PCR product (1850bp) contained the TEMkn315 
construct with flanking regions homologous to the nleD gene. However, upon 
electroporation of the PCR product into λ-Red recombinase-expressing C. rodentium, 
we were unable to isolate any positive transformants in which homologous 
recombination had taken place (Fig. 3.2.9).  
Despite PCR amplification of the TEMkn315 construct under optimized conditions 
and verification of its size through gel electrophoresis as well as removal of residual 




PCR product did not undergo homologous recombination at the chromosomal target 
site. Since recombineering did not occur at the tir or the nleD site of the C. 
rodentium chromosome, it may have been useful to analyze the TEMkn315 PCR 
product by DNA sequencing. In an attempt to further identify the source of the 
problem, electroporation experiments using control PCR products such as a 
kanamycin resistance cassette would be very useful. To do so, the kanamycin 
resistance cassette would be PCR amplified using primers containing flanking 
regions homologous to the nleD gene. This would generate a PCR product that is 
suitable to undergo homologous recombination at the chromosomal nleD site as well 
as enable the selection of positive transformants on kanamycin containing plates 
following electroporation into electrocompetent C. rodentium cells. Since the control 
PCR product would be the same as the TEMkn315 PCR product but without the 
TEM region, the use of such control experiments would help to identify if the source 
of the problem was associated with the pCX315 plasmid or the TEM gene. Due to 
time constraints however, we decided to explore alternative strategies to generate 




                   	 	
Figure 3.2.9. Verification of the nleDTEMkn315 chromosomally encoded fusion. 
Colony PCR of overnight C. rodentium cultures (electroporated with TEMkn315) 
using primers (A) pCX340endTEM (fw) and pCX340endTEM (rv), (B) 
pCX340endTEM(fw) and Kn315 (rv), and (C) nleDTEMkn315 (fw) and 




                                 
 
Figure 3.2.10: Cloning using pJETkn315. BglII restriction digestion of pJETkn315 
resulting in 2.928 kb and 1.063 kb DNA fragments (lane 2-4). Undigested 
pJETkn315 plasmid with a band size of 3.991 kb (lane 5) is shown for comparison. 
Although the TEM-kn315 was successfully cloned into the pJET cloning vector, 
subsequent PCR amplification of this region resulted in a PCR product that did not 





3.2.2.4 The xylE locus 
 
An alternative strategy to generate a chromosomally encoded fusion was explored 
using the xylE locus. A housekeeping gene expressed in most bacterial cells, xylE 
encodes the XylE protein, which is involved in xylose transport in E. coli K12 but is 
not essential for bacterial survival. In previous studies, the xylE locus was 
manipulated to insert a gene of interest into the C. rodentium chromosome, such that 
the disruption of the xylE gene did not change bacterial virulence. For example, the 
disruption of the xylE gene to insert an antibiotic resistance cassette and a LUX 
transposon reporter gene into the xylE locus caused no effect on the virulence of C. 
rodentium (Wiles et al, 2004).  
Similarly, Girard et al (2009) created a chromosomally encoded insertion of TccP (a 
T3SS effector also known as EspFU) in the xylE locus of C. rodentium. This was 
done by sequentially cloning the 5’ and 3’ ends of the xylE gene into the Asel and 
XmnI sites of the pACYC184 plasmid, thus generating the plasmid pICC440 from 
which the cloning of tccP into the EcoRV/BamHI sites produced the plasmid 
pICC441. PCR amplification of the pICC441 plasmid construct—containing 5’ xylE, 
the tetracycline promoter tccP, the chloroamphenicol resistance cassette, and 3’ 
xylE—was subsequently used for homologous recombination of tccP into the xylE 
locus (Girard et al, 2009). Using this strategy, we wanted to create a chromosomally 
encoded effector-TEM fusion in the xylE locus (Fig. 3.2.11). One advantage of this 
strategy is the increased efficiency of homologous recombination, due to the 
presence of longer homology extensions (150 bp) compared to the 50 bp homologies 
used in the previous strategy with plasmid pCX315. In addition, the creation of the 
gene fusion in the xylE locus should ensure that the effector-TEM fusion is encoded 
chromosomally without disrupting the organisation of effector genes in their native 







Figure 3.2.11 Overveiw of the chromosomally encoded nleDTEM fusion at the 
xylE locus. To construct a gene insertion within the xylE locus, the pICC442 plasmid 
was first created by cloning the nleDTEM gene fusion at the BamHI and EcoRV site 
of the pICC440 plasmid. The resulting pICC442 plasmid was subsequently PCR 
amplified from the xylE5’ to xylE3’ region containing the nleDTEM gene fusion, and 
electroporated into λ Red recombinase-expressing C. rodentium. Homologous 
recombination between the PCR product and the bacterial chromosome should result 
in the disruption of the xylE gene and insertion of the nleDTEM fusion construct into 





3.2.2.5 Construction of pCXnleD 
To create the nleDTEM gene fusion, we needed to clone the nleD gene into the 
pCX340 plasmid containing TEM-1 (Fig. 3.2.12). This was done by PCR-amplifying 
a 776bp fragment containing the nleD gene from C. rodentium genomic DNA using 
the primer pair nleDNdeI (fw) and nleDEcoRI (rv). The primers contained homology 
extensions to the restriction sites NdeI and EcoRI, which are located within the 
multiple cloning site (MCS) upstream of TEM-1 in the pCX340 plasmid. The PCR 
product was then purified and TA cloned into the TOPO cloning vector to generate 
the plasmid pCR2.1nleD. The pCR2.1nleD plasmid, following confirmation by 
colony PCR and sequence analysis, was digested with NdeI and EcoRI restriction 
enzymes and ligated into the cut pCX340 (Fig. 3.2.13). The resulting pCXnleD 
plasmid, containing the nleDTEM construct (1505bp), was electroporated into C. 
rodentium to generate the strain Citro pCXnleD, which was verified by colony PCR 










Figure 3.2.12. Overview of pCXnleD plasmid construction. To create a gene 
fusion between the effector and TEM-1, the nleD gene was PCR amplified using 
primers containing restriction site overhangs. The resulting PCR product was 
digested using restriction enzymes NdeI and EcoRI, and ligated into the pCX340 











                 
 
 
Figure 3.2.13 Construction of plasmid pCXnleD. EcoR1 and Nde1 restriction 
digestion of NleD insert (lane 1) and pCX340 vector (lane 2).   
 
 
          
 
Figure 3.2.14 Verification of pCXnleD. Colony PCR using primers 94 (fw) and 95 
(rv) to confirm the insertion of nleD into pCXnleD (lane 2-5) and its absence in 
pCX340 (lane 1). Primers 94 and 95 are located just outside the nleD insert in 
pCXnleD, and hence the resulting PCR products would have a fragment size of 0.9 
kb in pCXnleD and 0.2 kb in  pCX340. EcoRl digestion confirms the presence of 






3.2.2.6 Construction of pICC140 
To construct plasmid pICC442, the nledTEM gene fusion was cloned from plasmid 
pCXnleD and into plasmid pICC440 containing the 3’ and 5’ ends of the xylE gene. 
This was done by PCR-amplifying the nleDTEM region from pCXnleD using the 
primers EcoRV-rbs-nleD (fw) and BamHI-stopTEM (rv). The PCR product was TA-
cloned, (Fig. 3.2.15), cut using EcoRV/BamHI restriction enzymes, and ligated into 
the EcoRV/BamHI sites located between the 3’ and 5’ ends of the xylE gene (Fig. 
3.2.16). Subsequent PCR of the plasmid pICC442 using the primers aseI-N-xylE 
(fw) and xmnI-C-xylE (rv) produced a PCR construct (5.527kb) containing 5’ xylE, 
nleDTEM, the chloramphenicol resistance cassette, and 3’ xylE. However, several 
difficulties were encountered in obtaining the PCR product. For example, PCR 
amplification produced a strong band at 1kb and a very weak band at the required 
5.5kb size (Fig. 3.2.17 - 3.2.18). One possible reason for this that the efficiency of 
the Taq polymerase enzyme is reduced when it amplifies DNA fragments larger than 
4kb. The 5.5kb PCR product may have been produced at the right size, purified, and 
electroporated into C. rodentium for homologous recombination at the xylE locus; 
but no colonies were observed the following day (Fig. 3.2.21). Consequently, PCR 
optimisation experiments were carried out using different polymerase enzymes 
(PFU, phusion and deepvent), different PCR conditions, and various thermocycler 
programmes, including the use of a Tm gradient (Fig 3.2.17-1.2.21). Eventually this 






Figure 3.2.15 Verification of plasmid pCR2.1TOPOnleDTEM. EcoRI restriction 
digestion of pCR2.1TOPOnleDTEM (lane 1-5) and pCR2.1TOPO empty vector 
(lane 6).  Undigested pCR2.1TOPOnleDTEM (lane 7) is shown for comparison. The 
EcoRI restriction sites are located on either side of the insert region in the TOPO 
vector. 
 
                                                   
Figure 3.2.16 Construction of plasmid pICC442 in various stages. Gel 









Figure 3.2.17 PCR optimisation I. PCR amplification of pICC440 (lane 1) and 
pICC442 (lane 2) using PCR programme 1, as well as pICC440 (lane 3) and 
pICC442 (lane 4) using PCR programme 2. The primer pair XmnI-C-xylE (fw) and 
AseI-N-xylE (rv) was used. 
 
Figure 3.2.18 PCR optimisation II. PCR amplification of pICC442 using the above 







                 
Figure 3.2.19 PCR optimisation III. PCR amplification of pICC442 using primers 
XmnI-C-xylE (fw) and AseI-N-xylE (rv) under various different PCR programmes.  
 
 
Figure 3.2.20 PCR optimisation IV. PCR amplification of pICC442 using primers 
XmnI-C-xylE (fw) and AseI-N-xylE (rv) with various polymerases including Taq 









Figure 3.2.21 Generating PCR product (5’xylE-nleDTEM-3’xylE) for 
homologous recombination. (A) PCR product (5.572kb) from the amplification of  
pICC442 using the primer pair XmnI-C-xylE (fw) and AseI-N-xylE (rv) under two 
different thermocycler programmes. (B) PCR product (pooled from 10 tubes for 
increased concentration of DNA) using the same PCR conditions as (2) from (A) 
prior to electroporation. (C) Colony PCR of transformed C. rodentium to verify the 
chromosomal insertion of 5’xylE-nleDTEM-3’xylE following homologous 






3.2.3 Construction of a plasmid encoded reporter fusion  
Having tried and failed with several cloning strategies to generate a chromosomally 
encoded fusion, we decided to construct the nleDTEM gene fusion on a plasmid. 
Although we had previously generated the pCXnleD plasmid encoding the 
NleDTEM fusion protein, we needed to use a more stable plasmid suitable for in vivo 
studies in mice. The pACYC184 plasmid has been used previously for in vivo studies 
involving C. rodentium (Mundy et al, 2003; Mundy et al, 2004; Kelly et al, 2006). 
The plasmid pACYC184 (Fig 3.2.22) is an E. coli cloning vector that contains a p15 
origin of replication, has a low copy number at about 15 copies per cell, and carries a 
gene encoding resistance to tetracycline (TcR) and another encoding resistance to 
chloramphenicol (CmR) (www.neb.com).  
To clone the nleDTEM gene fusion into plasmid pACYC184 (3.2.23), a 1.5kb region 
containing the nleDTEM construct was amplified by PCR from plasmid pCXnleD 
using the primers Ecorv-rbs-nleD (fw) and BamHI-stop-TEM (rv). The PCR product 
was TA-cloned into pCR2.1TOPO, digested, and ligated into pACYC184 at the 
EcoRV/BamHI site (Fig 3.2.24). The resulting pACYCnleD plasmid construct 
(5.579kb) was verified and transformed into C. rodentium to generate the strain Citro 
pACYCnleD. Overnight colonies were selected on chloroamphenicol plates and 
confirmed by colony PCR (Fig. 3.2.25).  
To ensure plasmid transformations occur with efficiency, various control 
experiments can be useful. For instance, the transformation of uncut plasmid vectors 
into competent cells can enable the verification of competent cell viability and the 
antibiotic resistance of the plasmid, provided that the corresponding antibiotic is used 
in the agar media.  Additionally, the transformation of cut plasmids without an insert 
can help to determine the amount of background due to undigested plasmid, since 
efficient restriction digestion should produce only digested plasmids that cannot 
circularize and grow into colonies. A third control experiment could include the 
transformation of a cut plasmid vector that has undergone ligation reaction to 
determine if the plasmid can re-ligate in the absence of the insert. In the case where a 
single restriction enzyme has been used, the ends of the vector DNA should be 
compatible and easily joined during the ligation reaction resulting in the growth of 




restriction enzymes, two incompatible ends would be generated that are unable to re-
ligate and produce colonies. The use of such control experiments would have greatly 
improved the reliability of the plasmid transformations carried out in this study and 
may have provided good insight into where things have gone wrong in case plasmid 







Figure 3.2.22 Map of the pACYC184 plasmid. This is a low-copy plasmid 
encoding resistance to chloroamphenicol and tetracycline. The presence of numerous 
restriction sites enables the cloning of a gene of interest into the desired location in 





Figure 3.2.23 Overview of the pACYCnleD plasmid construction. To create a 
plasmid-encoded fusion, the nleDTEM construct was PCR-amplified using primers 
containing the restriction sites EcoRV and BamHI, and the PCR product was cut and 
ligated into the EcoRV-BamHI site of the pACYC184 plasmid vector. The resulting 
pACYCnleD plasmid was transformed into C. rodentium, which was subsequently 
used for in vivo and in vitro infection studies.  
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Figure 3.2.24 Construction of plasmid pACYCnleD. (A) Restriction digestion of 
pACYC184 using EcoRI and EcoRV restriction enzymes (lane 1), EcoRI (lane 2), 
and EcoRV (lane 3) along with undigested plasmid (lane 4-5). (B) EcoRV and 
BamHI digestion of pACYC184 (lane 2) and pCR2.1TOPOnleDTEM (lane 1) to 







Figure 3.2.25 Verification of plasmid pACYCnleD. Colony PCR of pACYCnleD 
(lane 1-5) and pACYC184 empty vector (lane 6) using primers NleD-rbs-EcoRV 
(fw) and BamH1-stop-TEM1 (rv). Positive transformants produced a band at 1.504 






Figure 3.2.26: Verification of the presence of pACYCnleD in the reporter strain 
and the control mutant strain. PCR product of pACYCnleD using primer pair 
pACYCtc (fw) and pACYCtc (rv) in various cultures of Citro pACYCnleD (1-4)  
and Citro ΔescNpACYCnleD (5-8). These primers are located just outside the 
nleDTEM insert within the pACYCnleD plasmid, such that strains containing the 





The aim of this study was to generate a reporter C. rodentium expressing the ß-
lactamase fusion protein to allow visualisation of in vivo effector translocation into 
immune cells. Having first tried and failed with several methods to create a 
chromosomally encoded effector fusion, we constructed the gene fusion on a low-
copy pACYC184 plasmid. The results of this study confirm that Citro pACYCnleD 
is able to encode the fusion proteins NleDTEM, which is translocated into murine 
cells in a type 3-dependent manner by C. rodentium. 
Our inability to generate a chromosomally encoded effector fusion may be associated 
with the use of the λ Red recombinase system in C. rodentium. The λ Red 
recombinase system, mostly described in E. coli (Marches et al, 2003; Garmendia et 
al, 2004; Nadler et al, 2006; Hemrajani et al, 2008; Jaeger et al, 2004; Umanski et al, 
2002; Creuzberg et al, 2005; Dahan et al, 2005; Tu et al, 2003; Baba et al , 2006; 
Zhang et al, 2004; Kang et  al, 2004), where it was originally developed to disrupt 
and replace chromosomal genes with an antibiotic selection marker (Datsenko and 
Wanner, 2000), has only rarely been described in C. rodentium (Kelly et al, 2006; 
Angulo et al, 2008; Dong et al, 2009). It is possible that the efficiency of λ Red-
mediated homologous recombination, which varies across bacterial species, may be 
reduced in C. rodentium in comparison to E. coli. A recent study demonstrated that 
mutations in the bacterial host replication machinery can reduce the efficiency of λ 
Red mediated recombination with electroporated DNA species (Poteete, 2013). 
Although the presence of such mutations has not been reported in C. rodentium, the 
study by Poteete et al. (2013) does suggest the possibility of host interference with λ 
Red-mediated homologous recombination. However, the use of the λ Red 
recombinase system to replace the escN gene with a kanamycin resistance cassette 
proved successful for the creation of the Citro ΔescN mutant. This indicates that the 
process of λ Red-mediated homologous recombination in C. rodentium is not 
affected by the host cell machinery, and therefore this does not explain why we were 
unable to obtain C. rodentium colonies that had undergone homologous 






In this study, an alternative strategy to create a chromosomally encoded fusion was 
investigated using the xylE locus. A PCR product containing 5’ xylE, a tetracycline 
promoter, nleDTEM, a chloramphenicol resistance cassette, and 3’ xylE was 
generated and electroporated into λ Red-expressing C. rodentium cells to enable the 
insertion of  an nleD-TEM fusion within the chromosomally encoded xylE gene. 
However, as we were unable to obtain any positive transformants, it is possible that 
homologous recombination of the PCR product occurred with the chromosomal copy 
of the nleD gene rather than with the xylE gene. Although the growth of positive 
transformants in media containing chloroamphenicol and tetracycline should have 
selected the C. rodentium cells, which had recombined at the xylE gene and not the 
nleD gene, the lack of colonies observed on the plates containing antibiotics suggests 
that the C. rodentium cells probably did recombine at the nleD gene and not the xylE 
gene. The fact that the PCR product contained another C. rodentium chromosomal 
gene (nleD) in addition to xylE was not discovered until the end of this study. This 
problem was not encountered by previous studies (Wiles et al, 2004) because the 
genes used to disrupt the xylE locus were not present in the genome of wild type C. 
rodentium. In the future, such factors must be taken into consideration when using 
similar strategies to integrate DNA at specific locations in bacterial chromosomes.  
Regarding the initial strategy to create a chromosomally encoded Effector-TEM 
fusion, the lack of homologous recombination between the PCR product (containing 
TEMkn315) and the chromosomal effector may be explained by the size of the insert 
DNA, which may have reduced the efficiency of the recombineering process by λ 
Red. According to the Datsenko and Wanner (2000) strategy, λ Red-mediated 
recombination usually occurs between the chromosome and a small PCR fragment 
containing a single selectable marker and flanking regions homologous to the 
sequence of the desired insert site. In our study, however, the PCR fragment 
contained more than one gene, including a kanamycin resistant marker (kn315) and 
the β-lactamase reporter gene (TEM-1). Perhaps the presence of two genes resulted 
in a large insert fragment, which may have reduced the efficiency of the homologous 
recombination. Indeed, a recent study demonstrated a significant decrease in the 
efficiency of transformation and integration of DNA fragments with increasing size 




plates reduced as the size of the insert DNA increased (Kuhlman & Cox, 2010), as 
shown in Fig. 3.3.1. As a result, no recombinants were obtained from the 
homologous recombination of insert DNA beyond the size of  2.5kb. In our study, we 
used an insert size of 1.9kb, which, according to the above study, should produce just 
over one hundred recombinants, though with very low efficiency of recombination. 
In comparison, the kanamycin gene (kn315) used to disrupt the chromosomal escN 
locus in this study was approximately 0.7kb in size and successfully produced many 
recombinants, thereby corroborating the finding by Kuhlman & Cox (2010) that 
success of homologous recombination improves with smaller insert fragments.  
Further work is necessary to develop the Datsenko and Wanner (2000) method of λ 
Red-mediated gene disruption for the chromosomal integration of large DNA 
constructs. Kuhlman and Cox (2010) demonstrated the use of a 'landing pad' for the 
insertion of large DNA fragments at specific locations in the bacterial chromosome. 
The 1.3kb ‘landing pad’ is a tetracycline resistance gene flanked by I-SceI 
recognition sites. I-SceI recognition sites do not exist naturally within the bacterial 
chromosome and are cut by I-SceI homing endonucleases encoded in the yeast 
mitochondrial DNA. By introducing helper plasmids that express I-SceI 
endonuclease genes and by inserting I-SceI recognition sites in the desired 
chromosomal location, it is possible via homologous recombination to insert large 
DNA fragments in the bacterial chromosome. To use this method, the bacterial cell is 
first transformed with a helper plasmid carrying the genes encoding λ–Red enzymes 
and I-SceI endonuclease. Expression of the λ–Red genes facilitate the recombination 
of the landing pad (tetracycline resistance gene) into the desired  chromosomal 
location. Following tetracycline selection of successful landing pad integrants, the 
bacterial cell is transformed with a donor plasmid carrying the insert fragment (also 
flanked by I-SceI recognition sites). The I-SceI recognition sites in both the insert 
fragment and the landing pad are cleaved and via homologous recombination, the 
insert DNA is incorporated into the landing pad. After successful chromosomal 
integration of the insert fragment, the I-SceI recognition sites are eliminated from the 
landing pad. In this manner, large constructs can be inserted at any desired location 
in the chromosome, which can be explored for future studies to generate a reporter C. 




An alternative strategy to create a chromosomally encoded fusion may utilise a 
mutant strain of C. rodentium carrying a lacZΔM15 deletion to insert TEM-1 in a 
two-step, λ Red-mediated homologous recombination process. The first step would 
require the insertion of a LacZα gene adjacent to the effector in its native site in the 
chromosome. This would enable the selection of positive transformants (blue 
colonies) on agar plates containing x-galactose (x-gal). The second step would 
involve the disruption of the LacZα gene to insert the TEM-1 adjacent to the effector 
in its native site. Positive transformants (white colonies) would be selected on agar 
plates containing x-gal. A chromosomally encoded fusion would thus be constructed 
between the effector and TEM-1 using a smaller DNA fragment (containing a single 
gene) without the need of an antibiotic selection marker.  
 
Figure 3.3.1 Representative recombineering efficiency as a function of insert 
size. Taken from Kuhlman and Cox (2010). 
 
Although the chromosomally encoded reporter fusion is generally more 
physiologically relevant due to expression of the effectors under its native regulation, 
the use of a plasmid can also be advantageous for three reasons. First, a plasmid-
encoded reporter fusion results in the constitutive expression of the fusion proteins, 
leading to increased activity of the reporter enzyme and thereby enabling stronger 
fluorescence to be detected by flow cytometry. Secondly, the dispensable nature of 
the plasmid allows the manipulation of bacterial genes without compromising host 
function. For example, a plasmid-encoded fusion would ensure that the chromosomal 
copy of the effector genes remained intact and would compensate for the loss of 




manipulation (such as gene fusion). Thirdly, the use of a low-copy plasmid, such as 
one with a pACYC origin, would mean that the effector proteins are produced at 
physiological levels rather than at abnormal levels, as is the case with high copy 
plasmids where the proteins are over expressed. Moreover, the use of a low-copy 
plasmid ensures that the plasmid does not impose a metabolic burden on the host and 
may be more likely to remain stable even in the absence of antibiotic selection.  
 
Indeed, our findings support previous studies wherein the majority of the 
experiments utilising the ß-lactamase reporter system to monitor effector injection in 
pathogens containing T3SS employed plasmid-encoded fusions. For example, 
Marketon et al. (2005) constructed the plasmid pHSG576 to carry the translational 
fusions of YopM-Bla in Y. pestis, while Koberle et al. (2009) used pAYCYC plasmid 
derivatives to construct YopE-Bla fusion proteins to study Y. enterocolitica. More 
recently, the low-copy vector pHSG576 was used to create translational fusions 
YopH-Bla, YopN-Bla, and YopJ-Bla in Y. pestis (Dewoody et al, 2011), which is 
similar to the plasmids pYopH-Bla and pYopJ-Bla that were constructed to study Y. 
pseudotuberculosis (Zhang et al, 2011). Similarly, β-lactamase (TEM-1) fusions with 
effectors NleC, NleD (Marches et al, 2005), and NleE (Vossenkaemper et al, 2010) 
were constructed on pCX340 plasmid derivatives to study EPEC effectors. 
 
Nevertheless, the use of chromosomally encoded fusions of type 3 effector genes 
with ß-lactamase has been reported in E. coli (Mills et al, 2008). In the study by 
Mills et al. (2008), the chromosomally encoded fusion was created by first cloning 
the effectors EspF, EspG, EspH, EspZ, Map, and Tir, along with native promoters, 
into the pCX340 plasmid containing the TEM-1 gene. The resulting pCX340 plasmid 
derivatives were propagated in permissive strains and transformed into conjugation-
competent permissive strains, where bacterial conjugation enabled the transfer and 
chromosomal integration of gene fusions to recipient cells when crossed with EPEC 
strains. Successful transconjugants contained the chromosomally integrated effector-
blaM fusions placed under native regulation via homologous recombination (Mills et 
al, 2008). Therefore, for future studies it may be beneficial to explore the use of 
bacterial conjugation systems to generate a reporter strain of C. rodentium expressing 
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4. In vitro visualisation of mouse cells targeted for protein 
translocation by C. rodentium 
4.1 Introduction 
The β-lactamase enzyme provides antibiotic resistance against antibiotics containing 
β-lactam, such as ampicillin, penicillin, and cephalosporin. It is encoded by the 
TEM-1 gene in many gram-negative bacteria, including Escherichia coli. β-
lactamases work by catalysing the hydrolysis of the four-atom β-lactam ring, 
breaking it open and deactivating the antibiotic. The nucleotide sequence of β-
lactamase enzyme was first determined by Sutcliffe et al. (1978), who identified a 
signal sequence made of the first 23 amino acids necessary for the secretion and 
maturation of the β-lactamase enzyme. Kadonaga (1984) further demonstrated that 
this enzyme is normally secreted into the periplasmic space, and deletion of the 
signal sequence prevents the protein secretion across the inner membrane, resulting 
in accumulation of β-lactamase within the bacterial cytoplasm. Hence, by mutating 
the signal sequences of the TEM-1 gene, it is possible to retain the β-lactamase 
enzyme inside the cell where it can carry out its activities against β-lactam 
antibiotics. Due to the increasing rise of antibiotic resistance across bacterial strains, 
β-lactamase-mediated cleavage of antibiotics has been studied extensively in the 
clinical setting. 
However, the usefulness of β-lactamase as a reporter system was not appreciated 
until Zlokarnik et al. (1998) described the design and synthesis of a fluorescent 
substrate molecule containing a β-lactam ring, known as 7-hydroxycoumarine-3-
carboxamide cephalosporin flourescin (CCF2). By linking a donor fluorophore 
(coumarine) and an acceptor fluorophore (fluorescin) to a cephalosporine bridge, a β-
lactamase substrate molecule capable of carrying out efficient Fluorescence 
Resonance Energy Transfer (FRET) was created. This substrate was further esterified 
by acetoxymethylation (AM) to form CCF2-AM, which is lipophilic and readily 
enters the cell without causing any damage to it. Inside the cell, endogenous esterases 
convert CCF2-AM back to the free acid CCF2, which becomes negatively charged at 
physiological pH and trapped within the cell cytoplasm. Excitation of coumarine at a 
wavelength of 408 nm (UV) leads to a FRET between the coumarine and the 
fluorescin, producing a green fluorescence at 530 nm. However, in the presence of β-




the coumarine to produce a blue fluorescence at 460 nm instead. By measuring the 
fluorescence signals in the green and blue channels, the presence of β-lactamase in 
single cells can be detected with fluorescence microscopy and FACS analysis 
(Zlokarnik 2000).  
Additional studies confirmed a lack of toxicity associated with substrate loading into 
mammalian cells. For example, the viability and proliferation of Jurkat cells 
remained unaffected after staining with CCF2, and zebrafish embryos were reported 
to have no developmental abnormalities after microinjection of CCF2 at the single-
cell stage (Zlokarnik 1998). Therefore, the β-lactamase reporter system provides a 
very simple, sensitive, and accurate approach for the detection of gene expression in 
live systems. 
Charpentier and Oswald (2004) were the first to modify and use the β-lactamase 
reporter system to detect effector injection by bacteria, carried out via the type three 
secretion system (T3SS). By creating translational fusion proteins between effectors 
and the β-lactamase gene (TEM-1), the study identified the secretion and 
translocation domain of an EPEC effector protein known as Cif (Charpentier and 
Oswald, 2004). The technology became popular and subsequently used to study the 
effects of protein injection by many T3SS-containing pathogens, including Yersinia 
pestis and its effects on host innate immunity (Marketon et al, 2005); Yersinia 
enterocolitica and its evasion of the host innate and adaptive immune system 
(Koberle 2009, Autenrieth 2010); and Salmonella and Shigella and its ability to 
rupture the host cell membrane for entry into host cytoplasm (Ray, 2010; Nothelfer 
2014).  
In addition to the study of invasive pathogens, the fluorescent-based reporter system 
has been useful in the study of type III-mediated secretion by non-invasive pathogens 
such as EPEC, EHEC, and Citrobacter rodentium. From characterising novel 
effectors (Marches 2005; Dahan 2005; Li 2006; Echtenkamp 2008) and defining new 
EPEC strains (Bulgin 2009) to elucidating the role of EPEC effectors in the 
manipulation of host cellular dynamics (Garmendia, 2004; Whale, 2007) and 
dampening pro-inflammatory immune responses (Vossenkaemper et al., 2010), the 
β-lactamase reporter system has proved to be an invaluable tool. In view of this, the 
aim of this chapter is to determine the usefulness of the β-lactamase reporter system 














Figure 4.1.1: β-lactamase reporter system. A graphic representation of the β-
lactamase reporter system used to visualise effector translocation in host cells by 





 4.2 Results 
4.2.1 Translocation of NleD-TEM fusion proteins into murine cell lines 
Having generated the deletion mutant Citro ΔescNpACYCnleD and the reporter 
strain Citro pACYCnleD expressing the NleD-TEM fusion proteins, the usefulness 
of the β-lactamase system for assaying NleD injection into various host cells was 
investigated. In the first set of experiments, swiss 3T3 fibroblasts were infected with 
either the deletion mutant or the reporter strain of C. rodentium for 6 hours. This 
was followed by an hour-long incubation with CCF4-AM and analysis by 
fluorescence microscopy. In cells infected with the reporter strain, 50% to 70% of 
cells were blue, indicating that translocation of NleD into the fibroblasts had 
occurred. In contrast, only green fluorescence was observed in cells infected with the 
ΔescN mutant, indicating the absence of translocated NleD proteins.  These results 
confirm that translocation of NleD-TEM fusion protiens is type III-dependent and 
requires a functional T3SS ATPase (Fig. 4.4.1). Similar observations were made in 
the CMT93 mouse colonic epithelial cell line, where 10% to 15% of cells were blue 
(Fig. 4.4.2), and in the J774 macrophage cell line, where 20% to 40% of the cells 
were blue (Fig. 4.4.3).  
Although microscopic analysis enabled the visualisation of host cells in which 
protein translocation had occurred, it was difficult to quantify. As a result, 
translocation of the NleDTEM fusion proteins into colonic epithelial cells and 
macrophages was detected by flow cytometry (Figs. 4.4.2 and 4.4.3). However, 
preparing adherent cells for analysis by flow cytometry proved difficult as the cells 
formed into clumps following cell detachment, the process of which may have 
damaged and compromised the physical properties of the cells. In contrast, the 
mouse thymoma T cell line BW5157, which is grown in suspension, proved more 





4.2.2 Detection of NleD translocation into T cell lines by flow cytometry  
To detect NleD translocation into T cells, the T cell line was infected with wildtype 
(WT) Citrobacter rodentium, reporter Citro pACYCnleD and mutant Citro 
ΔescNpACYCnleD. CCF4 labelled over 95% of the cells. As expected, blue 
fluorescence was not observed in T cells infected with wildtype strain or the ΔescN 
mutant strain. In contrast, T cells infected with reporter C. rodentium strain 
fluoresced blue in over 40% of the cells (Fig 4.4.4 A-B). The latter experiment was 
repeated 5 times under identical conditions and the percentage of blue cells ranged 
from 40% to 65%. To enhance bacterial attachment to the host cells during our 
experiments, the 12-well plates containing the inoculated cells were centrifuged 
briefly at the start of the infection. 
 
4.2.3 Effect of time on NleD translocation  
To determine whether NleD translocation into host cells increases with time, T cells 
were infected with Citro pACYCnleD (Fig 4.4.5B) and the ΔescN mutant (Fig. 
4.4.5C) at various time-points (1, 2, 4, and 6 hours). Cells were incubated with 
CCF4-AM substrate and analysed by flow cytometry. It is evident from the FACS 
data that β-lactamase activity increases from 20% to 70% between 4 and 6 hours post 
infection (Fig. 4.4.6). This shows that effector translocation is time-dependent and 
the bacteria require sufficient time to interact with and translocate effector proteins 
into host cells. In contrast, blue fluorescence was detected in 0.3% of the cells at 6 
hours after infection with the ΔescN mutant (Fig 4.4.5), confirming that effector 
delivery into host cells is not possible without a functional T3SS. 
 
4.2.4 Multiplicity of infection (MOI) and NleD translocation 
Next, the relationship between NleD translocation and the number of bacteria per 
target cell—or the multiplicity of infection (MOI)—was investigated. T cells were 
infected with increasing doses of reporter C. rodentium, stained with CCF4, and 
analysed by flow cytometry (Fig. 4.4.7). Initially, a positive relationship between the 
percentage of blue cells and the number of bacteria was observed. For instance, at 
MOI 102, approximately 10% of the viable T cells had undergone translocation, 
which increased to 40% at MOI 103 and 75% at MOI 104 (Fig. 4.4.8). However, at 




cell death (Fig. 4.4.7A). This experiment was repeated using the mutant strain, Citro 
ΔescNpACYCnleD, as a negative control (Fig. 4.4.7B).  
 
4.2.5 Detection of NleD translocation in primary immune cells 
Having established the translocation of NleD into cell lines, I aimed to use the β-
lacatamase translocation assay to monitor NleD injection into primary immune cells. 
To do so, single cell suspensions were prepared from the spleen, MLN, and PP of 
Balb/c mice and infected with either the reporter C. rodentium or the ΔescN mutant 
with a MOI of 103 bacteria per cell. For FACS analysis, lymphocytes were gated 
and analysed for green and blue fluorescence (Figs. 4.4.9- 4.4.11). 
As seen previously with cells lines, NleD translocation into primary cells also 
required a functional T3SS. In addition, the highest number of blue cells were 
observed in the spleen with over 10% of its cells targeted for NleD injection (Fig. 
4.4.9), followed by 5% in the MLN (Fig. 4.4.10) and 2.1% in PP cells (Fig. 4.4.11). 
 
4.2.6 Effect of MOI on NleD translocation into primary immune cells 
Analogously to the studies using cell lines, I examined the relationship between MOI 
and NleD translocation into primary cells. After infection of cells isolated from the 
mouse spleen, MLN, and PP with Citro pACYCnleD in varying doses, it was 
clear that the optimum MOI for primary cells was 103 bacteria per cell, an 
order of magnitude lower than that for T cells (Figs. 4.4.12 and 4.4.13). At 
this optimum MOI, the highest percentage of blue cells observed was 12.5% for the 
spleen, followed by 8.5% for the MLN and 6.4% for the PP. As with T cells, 
infection of primary cells with bacteria above the optimum MOI led to an 
increase in cell toxicity and death.	
 
4.2.7 Concanavalin A (ConA) stimulation of primary immune cells and its effect 
on NleD injection 
To further explore the susceptibility of primary cells to protein injection, the 
cells were stimulated with Con A, a lectin that interacts directly with T cell 
receptor (TCR) to trigger T lymphocyte activation and stimulation for cytokine 
synthesis. I hypothesised that stimulation of primary cells with Con A prior to 
bacterial infection may increase the cell surface area, enabling more bacterial 




As described in chapter 2, primary cells from the spleen, MLN, and PP were 
stimulated with Con A (1µg/ml) for 3 days and subsequently infected with Citro 
pACYCnleD (MOI 103) for 6 hours. An increase in the size of lymphocytes in the 
gated population occurred after stimulation (Figs. 4.4.14-4.4.16). A nearly 3-fold 
increase was observed in the number of blue cells from 9% in unstimulated 
splenocytes to 29% in stimulated splenocytes (Fig. 4.4.14). Similarly, there was a 2-
fold increase in the percentage of blue cells from before and after stimulation in 
MLN from 6% to 14% (Fig. 4.4.15) and in PP from 5% to 10% (Fig. 4.4.16). The 
data were summarized from 5 independent experiments (Fig. 4.4.17).  
The results were further confirmed by splenocyte infection with Citro pACYCnleD 
at various MOI for 6 hours following Con A stimulation. The number of blue cells 
increased significantly for each MOI after stimulation (Figs. 4.4.18 and 4.4.19). This 
may have been due to the increase in cell size, which may have resulted in a larger 
surface area for the bacteria to attach and inject its proteins; or it may have been the 
result of the cells' activated state.  
 
4.2.8 Distribution of NleD injection into splenocyte sub populations in vitro 
Having established the ability of Citrobacter to inject proteins into lymphocytes  
isolated from the spleen, MLN, and PP, I next examined whether there might be a 
preferential injection into certain immune cell types. To characterise the splenocyte 
populations injected with NleD, splenocytes were infected with Citro pACYCnleD, 
then stained with CCF4 and antibodies against CD3, CD19, and CD11c. Flow 
cytometry analysis determined the composition of spleen cells and confirmed that B 
and T cells are the most abundant cell sub populations in the spleen (Fig. 4.4.21A). 
This finding is in agreement with previous studies in Yersinia (Marketon et al, 2005; 
Koberle et al, 2009). In addition, after analysing the cells for various surface 
expression markers, I found that the highest percentage of blue cells belonged to B 
cells (6-7%), followed by dendritic cells (5-7%) and then T cells (4-5%) (Figs. 
4.4.20B and 4.4.21C). However, this difference is not statistically significant. These 





4.2.9 Gating strategies and controls used for flow cytometry  
For cell analysis by flow cytometry, the violet laser was used for excitation of the 
flurochromes at 405nm in the BD FACSCanto II flow cytometer (BD Biosciences). 
The voltages were set using unstained samples and the forward and side scatter 
adjusted so that the cell population is clearly delineated. Following the acquisition of 
cells in the forward and side scatter plots, CCF2-AM stained cells were gated for 
blue and green fluorescence using the AmyCyan (green) and Pacific blue (blue) 
filters. Propidium iodide was not used to stain dead cells since CCF2-AM loaded 
cells that did not fluoresce green were considered dead. Dead cells cannot load with 
CCF2-AM because retention of the CCF2-AM dye requires active cell processes 
such as endogenous esterification that convert esterified CCF2-AM in to CCF2-free 
acid that becomes negatively charged at physiological pH and trapped within the host 
cell cytoplasm (Zlokarnik et al, 1998). In the absence of active esterification, dead 
cells are unable to retain CCF2-AM, which readily leaves through the cell 
membrane. Therefore CCF2-AM staining was sufficient to exclude dead cells from 
the flow cytometry analysis during this study. Nonetheless, it may have been 
advisable to confirm this using propidium iodide staining.  
For the cell characterisation experiments, the surface markers CD11c, CD19 and 
CD3e were used to identify dendritic cells, B cells and T cells respectively. Since the 
emission peaks of the various fluorophors were close together, there was spectral 
overlap between the channels. Compensation was performed manually based on 
single antibody staining of splenocytes and unstained samples for all the channels. 
Although the antibody markers were selected based on their expression on the 
specific cell types as well as manufacturers recommendations, these antibodies 
stained more than one cell type. For instance, CD19 is a typical B cell marker but is 
also expressed by some follicular dendritic cells. In addition, CD11c is expressed 
mostly on dendritic cells but can also be found on the surface of monocytes, 
macrophages, neutrophils and some B cells. Similarly, CD3e is expressed on 
thymocytes, mature T lymphocytes and NK T cells. The overlap of cell surface 
markers between the different cell types may explain why the total percentage of 




           
 
Figure 4.2.1: Fluorescence spectrum showing the excitation (dashed peaks) and 
emission (filled peaks) wavelengths (nm) of the various flurochromes used in the 






The T3SS-mediated delivery of effector proteins into host mammalian cells is an 
important strategy of enteropathogens to manipulate host cellular processes and 
immune responses. Although the T3SS and its effectors have been studied 
extensively in the recent years, very little has been reported on the types of cells 
targeted for effector injection by attaching effacing (AE) pathogens. In this chapter, 
the β-lactamase reporter system was applied to C. rodentium to investigate its 
usefulness for visualisation of target cells for effector delivery in vitro.  
Translocation assays were designed so that the number of blue cells containing the 
CCF4 hydrolysis product indicated the presence of translocated fusion protiens 
inside the host cell cytoplasm. In addition, the use of the EscN mutant confirmed that 
β-lactamase reporter activity is dependant on translocation of the fusion proteins by 
the bacterial T3SS, as reported in previous studies (Marches et al, 2005; 
Vossenkaemper et al, 2010). Moreover, green or blue fluorescent signals from the 
infected cells following the uptake of CCF4-AM dye substrate reflected cell 
viability, as dead cells were unable to retain the CCF4-AM dye.  
This study found that infection of T cell lines with Citro pACYCnleD resulted in a 
time-dependent increase in the percentage of blue cells. An initial lag phase was 
seen, followed by an exponential increase between 4 and 6 hours with the maximum 
number of cells turning blue at 6 hours post inoculation. These results are consistent 
with previous studies wherein real-time analysis of effector translocation in EPEC 
showed that translocated effectors follow simple Michaelis-Menten enzyme kinetics 
(Mills et al, 2008; Zlokarnik, 2000). The effector proteins eventually reach a stable 
steady state at which the rate of accumulation of the CCF2 hydrolysis product 
becomes constant. The accumulation rate then slows once the enzyme reaches its 
maximum velocity, thereby indicating the maximum concentration of effectors in the 
infected host cells (Mills et al, 2008).  
These results are further confirmed by studies in Yersinia enterocolitica in which 
over 50% of the host cells reached a steady state after 1 hour of bacterial incubation 
(Koberle et al, 2009). Similarly, in EPEC most translocated effectors reached a 
steady state within the first hour of bacterial inoculation, with Tir reaching this state 




demonstrated that Tir reached its maximum velocity (Vmax) at 60 minutes post-
infection, at which point 70-85% of the cells had turned blue. In comparison, 
according to the translocation assays in our study, 70-80% of the T cells had turned 
blue at 6 hours post-inoculation, indicating that nleD had reached its maximum 
velocity at this time-point. These findings suggest that translocation kinetics in C. 
rodentium are slower than in the other T3-containing pathogens, although more 
studies are required to confirm this. The variation in translocation efficiency between 
the different pathogens can probably be explained by the species differences, which 
can influence factors such as the efficiency of bacterial attachment to the host cell, 
the number of T3SS present per bacterium, effector concentration inside the 
bacterium, their interaction with chaperon proteins, the coordinated expression of the 
T3 genes, and the regulation of T3SS assembly.  
This study further demonstrated a positive correlation between the percentage of blue 
cells and the multiplicity of infection (MOI). The percentage of translocated cells 
increased from 10% to 75% as the MOI increased from 102 to 104. This supports 
previous findings in Yersinia in which the number of injected cells followed a 
hyperbolic regression curve with increasing MOI (Koberle et al, 2009). However, 
our observation of an increase in cell death associated with a very high MOI has not 
been described previously. It is possible that this increase in cell death was due to 
effector-induced apoptosis of target cells, which has been widely reported in many 
T3SS pathogens. For example, Shigella flexeneri (Zychlinsky 1994), Salmonella 
typhimurium (Jiang et al, 2004) and Yersinia pseudotuberculosis (Zhang et al, 2011) 
are able to translocate the effectors Invasin plasmid antigen B (IpaB), Salmonella 
outer protein D (SopD), and Yersinia outer protein J (YopJ), respectively, to induce 
apoptosis in host macrophages. Similarly, the translocation of effectors EspF, Cif, 
and EspH by AE pathogens induced apoptosis in epithelial cells and HeLa cells 
(Wong et al, 2011; Raymond et al, 2013). However, other effectors also belonging to 
AE pathogens, such as NleH, NleD, NleF, EspZ, and NleB (Hemrajani et al, 2010, 
Baruch et al, 2011; Shames et al, 2010; Blasche et al, 2013; Pearson et al, 2013), 
have an anti-apoptotic effect, and hence without further evidence it is difficult to 





Another possible explanation for the host cell death observed at high MOI is related 
to cell toxicity as a result of effector overdose. According to Mills et al (2008), 
however, this may not be possible due to translocation auto-inhibition, whereby 
'early-attaching' EPEC translocated effectors send signals to initiate changes in host 
cells—for example by inducing modification of the cell membrane—and thereby 
reducing the capacity of 'late-attaching' EPEC to inject further proteins into the same 
cells. More recently, studies using typical strains of EPEC showed that the effector 
EspZ inhibited effector translocation following superinfection of HeLa cells, and this 
was described as a 'translocation stop' (Berger et al, 2012). Taken together, these 
findings suggest that host cells are only susceptible to effector translocation during 
the first wave of infection, which then inhibits effector translocation by the second 
wave, and hence it is not possible for these cells to receive an effector overdose.  
An alternative explanation may be that at high MOI, the buffering capacity of the 
growth medium becomes exhausted through the consumption of nutrients and build-
up of metabolic waste products, resulting in a low (acidic) pH and making it very 
difficult for cells to survive. Indeed, at high MOI the growth medium was observed 
to have changed colour from red to yellow, indicating a drop in pH toward the end of 
the experiment.  
The present study, designed to determine the ability of C. rodentium to target cells of 
the immune system, found that C. rodentium can indeed inject effectors into immune 
cells in vitro. For example, our results showed that C. rodentium can inject effectors 
into BW5157 T cells, J774 macrophages, and primary lymphocytes harvested from 
the mouse spleen, MLNs, and PPs. Although the experiments using primary cells 
isolated from the GALT are physiologically more relevant than those using cell lines, 
the translocation efficiency—indicated by a high percentage of blue cells—appeared 
to be greater in the murine cell lines. This may be due to differences in cell size; that 
is, cells from the cell lines were larger and had a larger surface area than the primary 
cells.  
Due to the many generations of cell passage, cell lines exhibit several alterations in 
morphology, chromosomal variations, and cell functions relative to the primary cells. 
For example, when comparing the proteome of a Hepa1-6 cell line with primary 
hepatocytes, it was found that the former had lost many of its functions, such as 




switched its resources to other cellular activities associated with proliferation and the 
maintenance of cell signalling pathways (Pan et al, 2009). This may help to explain 
the increased susceptibility of cell lines to effector injection in comparison to 
primary cells observed in our experiments. 
To identify factors influencing the translocation efficiency in lymphocytes, cells 
from the spleen, MLN, and PP were activated with Concanavalin A (Con A) prior to 
infection with C. rodentium. Con A is a mitogen known to stimulate the mouse T cell 
subset, giving rise to distinct effector T cell populations (Dwyer and Johnson, 1981). 
According to our data, C. rodentium can inject stimulated cells more efficiently than 
non-stimulated cells. Upon observation by microscopy, these stimulated cells 
appeared to be larger than non-stimulated cells. The increase in surface area may 
have facilitated more bacterial attachment.  
Moreover, it is possible that the upregulated expression of surface markers on the 
stimulated cells have led to the increased susceptibility of these cells to effector 
injection. Indeed, previous studies have described a positive relationship between the 
expression of cell surface molecules and bacterial invasion of T3SS-containing 
pathogens. For example, entry by Shigella into epithelial cells is facilitated by the 
interaction of the IpaB effector with host receptor CD44 and α4β1 integrins, which 
are cell surface molecules upregulated upon lymphocyte activation and recruited to 
the bacterial entry site, where they localise at the plasma membrane of the cellular 
protrusions induced by Shigella (Watarai 1996; Skoudy 2000; Kinashi 2007). In 
addition, previous studies demonstrated that activation of T cells resulted in the β1 
integrin-mediated adhesion of these cells, while resting T cells displayed limited 
adhesive activity (Miron et al, 1992), and that Shigella invaded activated primary 
human CD4+T cells rather than inactivated CD4+T cells (Konradt et al, 2011).  
Further studies examining the role of surface integrins have revealed that they are 
involved in the initiation of T3SS-mediated protein transloction. Studies in Yersinia 
have shown that β1 integrins are very important for Yop injection, as these surface 
molecules mediate adhesion of Yersinia and its subsequent internalisation into host 
cells (Schulte et al, 2000; Eitel & Dersch et al, 2002). β1 integrin-mediated signal 
transduction is also required for the initiation of Yop effector translocation in Y. 
pseudotuberculosis infection (Mejia et al, 2008). Fibroblasts lacking the expression 




reduction in the percentage of blue cells compared to fibroblasts expressing β1 
integrins (Koberle et al, 2009). Similarly, intimin, the outer membrane protein in 
EPEC, was also shown to bind to β1 integrins (α4β1 and α5β1) for adhesion to host 
cells (Frankel, 1996). Activation of CD4+T cells by PMA also induced β1 integrin-
mediated adhesion of these cells to laminin and fibronectin (Frankel, 1996). Taken 
together, such studies suggest that stimulated cells have increased expression of 
surface integrins, resulting in greater bacterial adhesion to host cells, which in turn 
may switch on the assembly of the T3SS and its subsequent translocation of effector 
proteins. 	
Finally, the use of β-lactamase translocation assays in this study enabled us to 
demonstrate NleD injection in all immune cell types characterised from the mouse 
spleen, including CD19+B cells, CD3e+ T, cells and CD11c+ DCs. Our findings 
show that splenocytes are composed mostly of B cells and T cells, in agreement with 
previous studies in which the mouse splenocyte population consisted of 40-60% 
CD19+ B cells, 30-40% CD3+T cells, and 3-5% CD11c+ dendritic cells (Marketon 
et al, 2005; Koberle et al, 2009). Despite the abundance of T and B cells in the 
spleen, NleD-TEM injection seemed to occur more frequently in B cells and 
dendritic cells and less frequently in T cells. However, since the differences in 
effector injection between the various immune cells are not statistically significant, it 
is difficult to conclude whether there is preferential selection of certain immune cells 
for T3 injection by these bacteria.  
On the contrary, previous studies have reported preferential selection of B cells and 
DCs in vitro by Y. pestis (Marketon et al, 2005). In vivo studies using the same 
bacterial strain (Y. pestis) also demonstrated significant T3 injection in DCs, 
macrophages, and neutrophils at day 2 after infection, followed by effector injection 
into all immune cell types, including T and B cells, by day 3. The observation that T 
and B cells, which constitute the majority of the splenic immune cell population, 
were not injected on day 2 led the authors to conclude that selection mechanisms 
must exist for bacterial type III injection of target cells whereby innate immune cells 
are early targets for injection (Marketon et al, 2005).   
Further studies in Y. enterocolitica demonstrated that injection of Yops occurs 
randomly into all immune cells in vitro including DCs, granulocytes, NK cells, T 




comprised, in order of proportion, B cells, dendritic cells, and macrophages in vivo 
upon infection of mice (Koberle et al, 2009). Effector injection into innate immune 
cells has also been reported for AE pathogens, for which EPEC was shown to inject 
effectors into DCs (Vossenkamper et al, 2010) and macrophages (Marches et al, 
2008). Taken together, these studies support the notion that the pathogens 
preferentially select certain immune cells for type III injection in vivo. Their 
targeting of innate immune cells in particular suggests that these pathogens use the 
T3SS to destroy cells that are important for the first line of defence, thereby 
preventing adaptive responses and causing disease.  
To obtain further evidence for this hypothesis, more in vivo studies will need to be 
conducted. For example, analysis of immune cells isolated from mice infected with 
reporter C. rodentium can enable us to determine whether C. rodentium preferentially 
selects certain immune cell types for effector injection in vivo. If this were indeed the 
case, it would be interesting to further investigate the effects of C. rodentium 
injection on immune cell functions, including the proliferation of CD4+ T cells, 
uptake and presentation of antigen to naïve lymphocytes by DCs, activation and 
maturation of various immune cells, production of cytokines, and migration of 
migratory immune cells. Such studies would demonstrate the consequences of 
protein translocation for host immune cells and provide insight into the immune 











Figure 4.4.1 NleD injection in Swiss fibroblasts (3T3 cell line). Fibroblasts 
infected with either reporter Citro pACYCnleD  or Citro ΔescNpACYCnleD (mutant 
strain lacking the T3SS) for 6 hours. The multiplicity of infection (MOI) was 1000. 
Subsequently, the cells were washed and incubated in CCF4-AM substrate for 1hour. 
NleD injection was visualised (blue cells) by fluorescence microscopy as described 




















                                                                                                                
Figure 4.4.2 NleD injection in murine colonic epithelial cells (CMT93 cell line). 
Epithelial cells infected with either Citro pACYCnleD or Citro ΔescNpACYCnleD 
(MOI = 1000) for 6h followed by CCF4-AM substrate incubation. A) NleD injection 
(blue cells) was visualised by fluorescence microscopy and B) detected by flow 











                                  
 
         
 
Figure 4.4.3 NleD injection in murine macrophages (J774 cell line).  A) 
Macrophages infected with either Citro pACYCnleD or Citro ΔescNpACYCnleD 
(MOI = 1000) for 6h followed by CCF4-AM substrate staining. NleD injection was 
visualised by fluorescence microscopy. Representative of 5 independent 
experiments. B) The experiments were repeated using different MOI and 









Figure 4.4.4 Detection of NleD injection in T cells in vitro. T cells were infected 
with different strains of C. rodentium for 6 hours (MOI=100), incubated with CCF4-
AM and analysed by flow cytometry. A) FACS plots show the presence of green and 
blue cells. B) The data are depicted as histograms where the upper panel shows 
uptake of CCF4-AM by cells (green) while the lower panel shows the cleavage of 
CCF4-AM substrate by cells positive for β-lactamase activity (blue). The vertical bar 
indicates the gating used to determine the number of cells positive for either intact 
CCF4-AM substrate or cleaved products of CCF4-AM respectively. Representative 















Figure 4.4.5: Timecourse of NleD injection in T cells. A) Uninfected T cell 
control. B) T cells infected with Citro pACYCnleD for various time durations: 1, 2, 4 
and 6 hours (MOI= 1000) followed by CCF4-AM substrate incubation. NleD 
injection was detected as blue fluorescence by flow cytometry. The data are depicted 
as histogram where the vertical bar indicates the gating used to show the number of 
β-lactamase positive cells revealing NleD injection (blue).  C) The experiment was 






Figure 4.4.6: Timecourse of NleD injection in T cells. T cells were infected with 
Citro pACYCnleD for 1, 2, 4 and 6 hours (MOI= 1000) followed by CCF4-AM 
substrate staining. NleD injection was detected as blue fluorescence by flow 









Figure 4.4.7 Detection of NleD injection in T cells with increasing MOI. T cells 
infected with varying MOI of A) Citro pACYCnleD or B) Citro ΔescNpACYCnleD 
for 6h and subsequently stained with CCF4-AM.  NleD injection is indicated by the 







Figure 4.4.8: Detection of NleD injection in T cells with increasing MOI. 
Summarized data from the previous figure showing mean +SEM of 12 experiments 
with Citro pACYCnleD (open squares) and 5 experiments with Citro 
















Figure 4.4.9: Detection of NleD injection in primary lymphocytes from the 
spleen. Single cell suspensions were prepared from the mouse spleen and infected 
with the reporter C. rodentium or the escN deletion mutant for 6 hours at MOI 103. 
Cells were subsequently stained with CCF4-AM and analysed by flow cytometry. 










Figure 4.4.10: Detection of NleD injection in primary lymphocytes from the 
MLN. Single cell suspensions were prepared from the mouse mesenteric lymph 
nodes and infected with the reporter C. rodentium or the escN deletion mutant for 6 
hours at MOI 103. Cells were subsequently stained with CCF4-AM and analysed by 
flow cytometry. The lymphocytes were gated as shown. Representative data from  3 









Figure 4.4.11: Detection of NleD injection in primary lymphocytes from the PP. 
Single cell suspensions were prepared from the mouse Peyer’s patches and infected 
with the reporter C. rodentium or the escN deletion mutant for 6 hours at MOI 103. 
Cells were subsequently stained with CCF4-AM and analysed by flow cytometry. 
















Figure 4.4.12: Detection of NleD injection in primary lymphocytes with varying 
MOI. Single cell suspensions were prepared from the spleen, MLN and PP and 
infected with different doses of Citro pACYCnleD for 6 hours. Subsequently, cells 
were stained with CCF4-AM and analysed by flow cytometry. Representative data 










Figure 4.4.13: Detection of NleD injection in primary lymphocytes with varying 
MOI. Summarized data from the previous figure showing mean +SEM of 5 








Figure 4.4.14: Detection of NleD injection in splenocytes following ConA 
stimulation. Single cell suspensions were prepared from the spleen, stimulated with 
Concanavalin A (1µg/ml) for 3 days and subsequently infected with reporter C. 
rodentium (MOI 103) for 6 hours. Cells were stained with CCF4-AM and analysed 










Figure 4.4.15: Detection of NleD injection into MLN cells following ConA 
stimulation. Single cell suspensions were prepared from the mesenteric lymph 
nodes, stimulated with Concanavalin A (1µg/ml) for 3 days and subsequently 
infected with reporter C. rodentium (MOI 103) for 6 hours. Cells were stained with 
CCF4-AM and analysed by flow cytometry. Representative data from 5 experiments 









Figure 4.4.16: Detection of NleD injection into PP cells following ConA 
stimulation. Single cell suspensions were prepared from the Peyer’s patches, 
stimulated with Concanavalin A (1µg/ml) for 3 days and subsequently infected with 
reporter C. rodentium (MOI 103) for 6 hours. Cells were stained with CCF4-AM and 











Figure 4.4.17: Comparison of NleD injection into primary lymphocytes before 
and after conA stimulation. Summarized data from Fig. 4.4.14-16 showing mean 







Figure 4.4.18: NleD injection in splenocytes following ConA stimulation under 
various MOI. Isolated splenocytes were stimulated with ConA (1ug/ml) for 3 days 
followed by in vitro infection with various  MOI of Citro pACYCnleD for 6 hours. 
After subsequent CCF4 staining, cells were analysed by flow cytometry. 














Figure 4.4.19: Comparison of NleD injection in splenocytes before and after 
ConA stimulation. Mean +SEM of 5 independent experiments showing percentage 







Figure 4.4.20: Distribution of NleD injection in splenocytes in vitro. Single cell 
suspensions from the mouse spleen were infected with Citro pACYCnleD (MOI 
1000) for 6h. Subsequently cells were analysed by flow cytometry for surface 
expression of CD3e+ T cells, CD19+ B cells and CD11c+ dendritic cells following 
staining with CCF4-AM and antibodies. A) Gated population of splenocytes 
containing lymphocytes. B) Representative histogram showing percentage of blue 
cells expressing each surface marker. C) Histogram showing percentage blue cells 









Figure 4.4.21: Distribution of NleD injection in splenocytes in vitro. A) Bar chart 
showing the percentage of splenocytes expressing the indicated surface markers. B) 
Bar chart showing the percentage of blue cells of the indicated subpopulations. C) 
Bar chart showing percentage of blue cells expressing one of the indicated surface 
markers. Data are summarised as the mean + SEM of 3 independent experiments. 
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5. In vivo visualisation of cells targeted for protein translocation by 
C. rodentium 
5.1 Introduction  
The gut-associated lymphoid tissue (GALT) sample antigens directly from mucosal 
surfaces to initiate protective immune responses in the gastrointestinal tract 
(described in detail in section 1.1.6). This occurs mainly through M cells present in 
the follicle-associated epithelium (FAE) of the GALT, where the active uptake and 
presentation of bacteria and antigens from the gut lumen to the immune cells of the 
lymphoid follicles helps to generate effective immune responses against enteric 
pathogens. Many of these enteric pathogens, however, are able to colonise GALT 
structures and manipulate the host antigen sampling system to gain access to the 
lymphoid follicles, where they can target immune cells and subvert host immune 
responses.  
 
5.1.1 Bacterial colonisation of GALT structures  
It is becoming increasingly clear that some enteric pathogens containing the T3SS 
exploit M cells to gain entry into and invade the host epithelium. For example, 
Shigella infects its host by translocating into M cells, where it invades macrophages 
and DCs residing within the M cell pocket. Inside macrophages, Shigella disrupts the 
vacuolar membranes and replicates within the cytoplasm, which eventually results in 
macrophage cell death. Shigella released from dying macrophages, invade and 
multiply within the surrounding epithelial cells and subsequently spread from cell to 
cell, causing shigellosis (Ashida et al., 2011).  
Similarly, Salmonella preferentially adhere to and enter the epithelium through M 
cells of the PP (Jones et al., 1994). After crossing the intestinal epithelium in 
Salmonella-containing vacuoles (SCVs), Salmonella encounter several different 
types of phagocytes, such as neutrophils, macrophages, and DCs (Fabrega & Vila, 
2013). The migration of these infected phagocytes further facilitate the dissemination 
of Salmonella via the bloodstream to the spleen and liver, where this pathogen 
preferentially replicates (Worely et al., 2006). Studies show that Salmonella from the 
GALT are able to reach the MLN via DC transportation through the intestinal lymph 
(Niess & Reinecker, 2006). In addition, DCs can directly take up Salmonella from 
the intestinal lumen by opening tight junctions and sending dendrites into the lumen 
	 191	
(Rescigno et al., 2001). Moreover, infected macrophages accumulate predominantly 
in the PPs and MLNs of infected mice (Rydstrom & Wick, 2007). Taken together, 
these studies provide evidence that invasive pathogens can enter the GALT and 
target immune cells to facilitate bacterial spread into systemic tissue.  
Attaching effacing pathogens, despite being non-invasive and colonising the surface 
of the epithelium, also show tropism for GALT structures. For example, EHEC was 
shown to colonise the follicle-associated epithelium of distal ileal PP (Chong et al., 
2007). Similarly, rabbit EPEC (REPEC) was observed exclusively in the ileal PP 48 
hours after infection and was followed by the formation of an AE lesion in the ileal 
PP and the proximal colon 3 days after infection (Heczko et al., 2000). In addition, 
bioluminescent in vivo imaging has further demonstrated the localisation of AE 
pathogens, including EPEC and EHEC in the caecum and colon of infected mice 
(Rhee et al., 2011). These observations were further confirmed in mice infected with 
C. rodentium in which the primary site of bacterial colonisation was the caecum, 
followed by the distal colon and rectum (Wiles et al., 2004; Wiles et al., 2006). 
Although AE pathogens colonise GALT structures, they do not promote bacterial 
entry in to the GALT tissue via M cells. Rather, evidence suggests that AE pathogens 
may use the T3SS to actively prevent their uptake by M cells (Tahoun et al., 2011). 
 
5.1.2 Targeting immune cells for T3SS-mediated effector translocation 
Bacterial pathogens containing T3SS can inject effectors directly into the cytoplasm 
of host immune cells to alter their function. Salmonella typhimurium can inject a 
multitude of T3SS effectors into macrophages to facilitate intracellular survival and 
subsequent spread to host tissues. For example, injection of AvrA can dampen the 
host proinflammatory response inside macrophages (Wu et al., 2012), while 
translocation of MgtCB can promote the intracellular survival of bacteria (Blanc-
Potard et al., 1997) alongside SopD, enabling Salmonella to replicate within the 
Salmonella-containing vacuoles of macrophages (Jiang et al., 2004). The 
translocation of SScI further promotes macrophage motility and accelerates the 
systemic spread of Salmonella (Worley et al., 2006). Eventually, the injection of 
SipB induces early macrophage pyroptosis and macrophage autophagy (Santos et al., 
2001), which enables bacterial systemic dissemination throughout the infected 
organs (Guiney, 2005).  
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Similarly, Yersinia pestis, another invasive enteric pathogen, was shown to target 
neutrophils, macrophages, and DCs for injection of T3SS effectors directly into the 
host cell cytoplasm (Marketon et al., 2005). By injecting YopM, Y. pestis was able to 
deplete the host natural killer cell population (Kerschen et al., 2004). Y. pestis was 
also shown to target DCs for Yop injection, resulting in the inhibition of IL-12 and 
TNFα production in DCs (Brubaker, 2003). Similarly, Y. enterocolitica was shown 
to inject Yops into neutrophils, macrophages, and DCs but preferentially target 
follicular B cells, increasing the expression of the cell activation marker CD69 
(Koberle et al., 2009). Injection of Yops directly into splenic DCs resulted in the 
negative regulation of the stimulatory capacity of DCs to induce T cell proliferation 
by Y. enterocolitica (Autenrieth et al., 2010). Moreover, by targeting adaptor 
molecules of the TCR signalling pathway, injection of YopH and YopP inhibited T 
cell activation (Gerke et al., 2005) and CD8+T cell priming (Trulzsch et al., 2005), 
respectively, in a mouse infection model. Similarly, for Shigella the injection of 
IpgD directly into T cells resulted in the inhibition of T cell migration in vitro and 
impaired T cell dynamics in vivo (Salgado-Pabon et al., 2014). Collectively, these 
studies provide strong evidence for the ability of enteric pathogens to target cells of 
both the adaptive and innate immune system for effector injection and subsequent 
suppression of the host immune responses, thereby facilitating their own survival. 
However, very few studies have reported similar immune-targeting capabilities 
among non-invasive pathogens. An early study by Inman and Canty (1983) reported 
that rabbit EPEC can adhere to the surfaces of antigen-sampling M cells without 
forming pedestals or being taken up by these cells. This was later confirmed by 
subsequent studies in EPEC and EHEC, where the EspF effector was shown to 
inhibit E. coli translocation through human- and bovine-derived M cells in vitro and 
in co-culture systems (Martinez-Argudo et al., 2007; Tahoun et al., 2011). It is 
possible that EspF-mediated inhibition of M cell transcytosis allows E. coli to 
prevent its own internalisation early during infection, thereby delaying the initiation 
of the immune response.  
Further studies have reported the ability of EPEC to interact with macrophages and 
inhibit phagocytosis through the T3SS-mediated translocation of EspA, EspB, EspD, 
EspF, and EspJ into macrophages (Goosney et al., 1999; Quitard et al., 2006; 
Marches et al., 2008; Tahoun et al., 2011). In particular, the effector EspJ was shown 
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to block opsono-phagocytosis, including the phagocytosis of C3b- and IgG-
opsonised particles mediated through FcyR and CR3, respectively (Marches et al., 
2008). These studies suggest that the inhibition of macrophage phagocytosis may 
allow AE pathogens to prevent their own uptake by host immune cells, thereby 
bypassing the first line of host defence presented by professional phagocytes and 
facilitating survival in the gastrointestinal tract.  
In a more recent study, Vossenkamper et al. (2010) demonstrated the ability of 
EPEC to translocate effectors directly into DCs by sending dendrites through a 
model gut epithelium in a transwell system. This was also shown in myeloid DCs 
isolated from human PP biopsies. Effector translocation into DCs resulted in the 
inhibition of NFκB activation and the subsequent production of proinflammatory 
cytokines IL8, TNFα, and IL6. These effects were attributed to the T3-translocated 
effector NleE. Dendritic cells cultured with EPEC in the absence of NleE showed 
high secretion of IL8, TNFα, and IL6, as well as a strong nuclear translocation of 
p65 required for NFκB activation. In contrast, cytokine secretion and translocation of 
p65 were markedly lower in DCs cultured with EPEC in the presence of NleE. NleE 
injection into DCs further resulted in the reduced expression of co-stimulatory 
molecules CD80 and CD86, impairing the ability of these DCs to activate T cells. T 
cell activation was indicated by the production of IL2, a marker of lymphocyte 
activation (Vossenkamper et al., 2010). DCs prime naïve T cells and initiate adaptive 
immunity against bacteria, and hence by interfering with and suppressing DC 
function, EPEC promotes its own survival. The study by Vossenkamper et al. (2010) 
was the first of its kind to demonstrate the ability of AE pathogens to inject effectors 
that have an immunomodulatory role in host immune cells.  
Given that Citrobacter rodentium is an in vivo model of AE pathogens, it is fair to 
speculate that C. rodentium can also target immune cells for effector injection. The 
finding that subepithelial DCs can extend dendrites into the lumen to sample gut 
antigens (Rescigno et al., 2001; Niess et al., 2005; Chieppa et al., 2006) and EPEC 
can inject effector proteins into DCs of intact PP as well as cultured DCs 
(Vossenkamper et al., 2010), strongly suggest that C. rodentium also has the capacity 
to inject effectors into DCs residing in the epithelium and the mouse PP in vivo.  
Interaction of C. rodentium with immune cells can also be facilitated by M cell-
mediated entry into the PP during bacterial sampling of the gut lumen. Inside the 
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subepithelial dome of the PP, C. rodentium can interact with naïve DCs, T cells, and 
B cells to target these cells for effector injection. Immune cells containing the 
translocated effectors may subsequently drain into the MLN and spleen, where their 
initiation of mucosal immune responses may be impaired. The impaired functions of 
immune cells can give pathogens such as C. rodentium the advantage of prolonged 
colonisation in the gut before protective immunity can initiate bacterial clearance. 
This may explain why AE pathogens show tropism for the follicle-associated 
epithelium (FAE) overlying the GALT: it contains M cell gateways and a dense 
population of immune cells, which these pathogens can manipulate to facilitate their 
own survival. 
The aim of this study is to visualise the cells targeted for protein translocation in vivo 
by C. rodentium. In previous chapters, we generated a reporter strain of C. rodentium 
containing a plasmid-encoded fusion between the effector protein (NleD) and the β-
lactamase reporter enzyme. The reporter strain was subsequently used to infect 
murine cell lines and primary cells to visualise cells targeted for protein translocation 
in vitro. In this chapter, the reporter strain will be used to infect Balb/c mice to 




5.2.1 Colonisation of mice by reporter Citro pACYCnleD strain  
To investigate the ability of the reporter strain to colonise mice, 5- to 7-week-old 
female Balb/c mice were orally inoculated with 1-5x109 cfu of Citro pACYCnleD. A 
separate group of mice were inoculated with the control strain Citro 
ΔescNpACYCnleD. As described in section 2.8 in chapter 2, the infected 
mice were monitored over a period of 8-12 days post-inoculation (p.i). 
Viable counts of Citrobacter cfu were recovered from mice faeces at various 
days p.i. 	
The results (Fig. 5.4.1) show an initial increase over time in bacterial numbers in 
mice infected with Citro pACYCnleD. This peaks to approximately 109 cfu per 
gram of stool by day 6 p.i. In comparison, the number of bacteria in mice inoculated 
with the EscN mutant strain decreased rapidly until no bacteria were detected by day 
6 p.i. This confirms that without the EscN protein, Citrobacter is unable to express a 
functional T3SS and hence cannot colonise mice. During further infection studies 
comparing the reporter strain with wildtype C. rodentium, stool counts showed both 
strains following similar colonisation dynamics and peaks of infection (Fig. 5.4.2). 
The transformation of wildtype bacteria with pACYCnleD plasmid thus confers no 
changes in the ability of Citrobacter to colonise the mice gut mucosa.  
The hyperplasic responses of mice infected with various strains of C. rodentium were 
also compared (Fig. 5.4.3). Hyperplasia, indicated by an increase in mucosal 
thickness in the distal colon, was observed in both groups of mice infected with 
either wildtype C. rodentium or the reporter strain, with an average of 220 µm and 
240 µm colonic thickness, respectively. The average mucosal thickness in uninfected 
mice and mice infected with the mutant strain were approximately 150 µm, 
indicating no hyperplasia. As no changes in other characteristics such as weight (data 
not shown) or loose stool consistency were seen in the infected mice, bacterial 
shedding in faeces and mucosal thickness were the only reliable observations for 
establishing the progression of Citrobacter infection in this study. 
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5.2.2 Plasmid stability of pACYCnleD in vivo 
Having confirmed the competency of the reporter strain for colonising mice, the 
stability of the pACYCnleD plasmid in vivo was investigated. Mice were infected 
with the reporter strain as described previously, and bacteria were then isolated from 
infected mice faeces and grown in antibiotic-containing media to select those that 
either lost or retained the pACYCnleD plasmid. This was done by growing the 
bacteria in LB plates containing nalidixic acid and in LB plates containing nalidixic 
acid combined with chloramphenicol. Resistance to nalidixic acid indicated the 
presence of all C. rodentium strains, while resistance to both nalidixic acid and 
chromamphenicol indicated strains containing the plasmid only. By quantifying the 
number of colonies that grew on the plates containing both nalidixic acid and 
chloroamphenicol and comparing this to the number of colonies that grew on the 
plates containing only nalidixic acid, we determined the percentage of bacteria that 





The subsequent data (Fig. 5.4.4B) reveal that approximately 45% of bacteria 
(equivalent to ~50 cfu/g of stool) lost the plasmid by day 9. This confirms that the 
majority of Citro pACYCnleD strains retained the plasmid at least until day 9 p.i. 
PCR analysis further confirmed the ability of this reporter C. rodentium strain to 
express NleD-TEM fusion proteins in the mouse gut (Fig. 5.4.5). 
 
5.2.3 In vivo visualisation of NleD injection into immune cells of C. rodentium-
infected mice  
To determine whether NleD injection can be detected in vivo, Balb/c mice were 
orally gavaged with Citro pACYCnleD or Citro ΔescNpACYCnleD. The bacterial 
burden of mice, regularly monitored over the course of infection, confirmed the 
ability of the reporter strain to successfully colonise the mice gastrointestinal tract 
(Fig. 5.4.11).  Subsequently, after 7 to 11 days, immune cell suspensions were 
prepared from the spleen, MLN, and Peyer’s patch, stained with CCF4-AM for an 
hour, and subjected to flow cytometry analysis (Figs. 5.4.6-5.4.9). Contrary to our 
expectations, the flow cytometry data revealed no distinct population of blue cells 
No. of nalidixic acid & chloramphenicol resistant CFU   
No. of nalidixic acid resistant CFU	
Percentage of bacteria  





from any of the lymphoid organs or tissues. Despite cell analysis at various days 
including day 7, 8, 9, 10, 11, 12 and 14 post-infection, the results failed to show any 
blue cells from the infected mice. Representative data for days 7, 9, and 11 are 
summarised in Figs. 5.4.6-5.4.9.  
As a control, epithelial cells were analysed for β- lactamase activity following the 
above infection protocol. Epithelial cells lining the gut wall are most exposed to 
bacteria residing in the lumen, and hence if C. rodentium injects proteins into host 
cells, epithelial cells are most likely to be targeted first. Unfortunately, analysis by 
fluorescence microscopy showed blue cells in both positive and negative controls; 
that is, in cell preparations infected with wild-type and reporter strains of C. 
rodentium. These blue epithelial cells also appeared to be in clumps (Fig. 5.4.10). 
The blue fluorescence in wild-type C. rodentium-infected cells cannot be attributed 
to the enzymatic activity of β-lactamase, as these cells do not express β-lactamase 
fusion proteins. Instead, the CCF4 substrate must somehow have been cleaved in the 
absence of β-lactamase activity. Enterocytes are filled with digestive enzymes, such 
as peptidases, sucrase, maltase, lactase, and intestinal lipase, and it is possible that 
these were cleaving the CCF4 substrate; however, further experiments would be 
necessary to confirm this. As a result, epithelial cells isolated from the colon of 
infected mice were not analysed by microscopy.   
 
5.2.4 Ability of immune cells to remain ‘injectable’ after in vivo infection with 
Citro pACYCnleD 
To explore whether the lack of β-lactamase activity in vivo was due to the gut cells 
being resistant to NleD injection in vivo, immune cell preparations from the spleen, 
MLN, and PP of infected mice were inoculated with Citro pACYCnleD for 6 hours 
and incubated with CCF4 AM (Figs. 5.4.12-5.414). Flow cytometry analysis 
confirmed that β-lactamase activity occurred in a dose-dependent manner and mouse 
cells were not resistant to nleD injection following oral inoculation in vivo.  
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5.2.5 Ability of Citro pACYCnleD to inject NleD into host cells after passage 
through the mouse gut 
Next, we investigated the ability of the host-passaged Citro pACYCnleD to inject 
murine cells in vitro. Citro pACYCnleD was recovered from mouse stool at day 9 
post-infection, isolated, grown overnight, and used for subsequent infection of T 
cells in vitro. As expected, normal β-lactamase activity was observed in T cells 
infected with the host-passaged bacteria (Fig. 5.4.15) In addition, NleD injection 
increased with increasing MOI of the host-passaged bacteria, confirming that the 
reporter strain retained its ability to inject murine cells in vitro. 
 
5.2.6 In vivo infection of mice using hyperinfectious bacteria 
In a final attempt to visualise blue cells from the mice gut in vivo, infection studies 
using hyperinfectious bacteria were conducted. Following inoculation of mice with 
Citro PACYCnleD, hyperinfectious bacteria were isolated from the stool at day 6 
post-infection, resuspended in sterile PBS, and orally gavaged to a new group of 
mice. Mice infected with the hyperinfectious bacteria were sacrificed at day 3 p.i and 
the epithelial cells from the colon and rectum were analysed for blue cells (Fig. 
5.4.16). Unfortunately, no β-lactamase activity was observed.  
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5.3 Discussion  
The aim of this study was to visualise host cells targeted for protein translocation by 
C. rodentium in vivo. In previous chapters we generated the reporter strain Citro 
pACYCnleD and demonstrated its ability to inject into murine cell lines and primary 
cells in vitro, and in this chapter we investigated the ability of reporter strain to inject 
NleD fusion proteins into host cells in vivo. 
Bacterial shedding in mouse stool throughout the infection period confirmed that C. 
rodentium followed the classical growth curve reported in earlier studies (Wiles et 
al., 2004; Wiles et al., 2006; Collins et al., 2013). Following an oral gavage, the CFU 
counts indicated an initial increase in bacterial numbers (~5x10 8-9 cfu/g) within 24 
hours post-inoculation (p.i) followed by a sudden dip (~5x106-7 cfu/g) in day 2 p.i 
(data not shown). After day 2, bacterial shedding began to increase again, until day 6 
when bacterial numbers peaked to ~5x10 9-10 cfu/g. Following the peak, bacterial 
numbers declined from day 8 until the end of the experiment.   
These observations corroborate previous studies in which bioluminescence was used 
to indicate bacterial colonisation of the mouse GI tract (Wiles et al., 2004; Wiles et 
al., 2006). Both studies showed that in mice orally gavaged with C. rodentium, 
bacteria reached the caecum and the colon within 1 hour p.i. and began to clear the 
colon with some remaining in the caecum within 5 hours p.i until the bioluminescent 
signal was lost due to bacterial numbers falling below 103 cfu/g. These studies 
indicate that the majority of inoculated C. rodentium does not colonise the mouse 
initially but rather passes straight through the gastrointestinal tract, which accounts 
for the initial increase and subsequent decrease in bacterial shedding within the first 
24 hours p.i. According to these studies, only a few bacteria remain in the caecal 
patch, where they adapt to the gastrointestinal environment and activate virulence 
genes necessary for subsequent colonisation of the distal colon and rectum. Indeed, 
the bioluminescent signal was detected again after 24-72 hours p.i when bacteria had 
increased in number and began to colonise the mouse gastrointestinal tract (Wiles et 
al., 2004; Wiles et al., 2006).  
Although the initial colonisation dynamics observed in previous studies (Wiles et al., 
2004; Mundy et al., 2004; Wiles et al., 2006; Girard et al., 2009) are consistent with 
this study, C. rodentium colonisation during the later stages of infection seems to 
differ slightly. In our study, bacterial numbers reached a peak at day 6 followed by 
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bacterial clearance from day 8, which is earlier than previous reports in which 
bacterial numbers peaked from day 8 and started to decline after day 10. The slight 
difference in bacterial clearance may be due to use of a different strain of mice: we 
used BALB/c mice, whereas the previous studies used C57Bl/6 mice. Studies 
comparing mouse strains have suggested that C57Bl/6 mice exhibit increased 
susceptibility to C. rodentium-induced colitis in comparison to BALB/c (Vallance et 
al., 2003). C57Bl/6J mice infected with C. rodentium exhibited a lower survival rate, 
higher CFU count at day 4 and 6 p.i, and higher colon weight and crypt height at day 
6 p.i than infected BALB/c mice (Vallance et al., 2003). Additional studies found 
that acute colitis induced by dextran sulfate sodium (DSS) progressed to chronicity 
in C57Bl/6 mice but not in BALB/c mice (Melgar et al., 2005). Such findings 
suggest that in comparison to C57Bl/6 mice, the BALB/c mice may have reduced 
susceptibility to C. rodentium-mediated colitis, which in turn may help to explain the 
results observed in this study. 
Having established the ability of C. rodentium to colonise and infect mice, we 
monitored the ability of the reporter strain, containing pACYCnleD plasmid, to also 
establish infection in comparison to the wild-type C. rodentium strain. It was 
assumed that the reporter strain may take longer to colonise, as the presence of a 
plasmid requires the bacteria to synthesise additional the nucleic acids and proteins 
necessary to perform plasmid-encoded functions, which may impose an energetic 
burden on the reporter strain and make it an inferior competitor relative to its wild-
type counterpart (DaSilva and Baily, 1986). However, after comparing the viable 
colony forming untis (CFU) counts and crypt lengths, we found no significant 
difference in the level of colonisation and colonic hyperplasia between the two 
strains at any given time. Thus the plasmid pACYCnleD conferred little or no fitness 
burden on the C. rodentium host strain.  
Next, the plasmid stability of pACYCnleD within the mouse gut was investigated. 
The pACYCnleD plasmid was maintained under lab conditions by growing the host 
strain in LB containing chloramphenicol, due to the presence of the chloramphenicol 
resistance gene in the plasmid. However, in the absence of antibiotic selection in the 
mice gut in vivo, there was a risk that the reporter strain would revert back to its 
original plasmid-free form. Without the plasmid, which encodes the reporter enzyme, 
visualisation of protein translocation would not be possible even if bacterial 
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colonisation did occur as normal, thus defeating the purpose of this study. 
Nonetheless, our data confirm that the plasmid-bearing strain was stably maintained 
in the mouse gut, as the pACYCnleD plasmid was successfully prepared from mouse 
faecal samples as late as day 10 p.i.  
The plasmid vector pACYC184, from which the pACYCnleD was derived, is present 
at a low copy number in the bacterial cells. Past studies using a pACYC184-
transformed strain of E. coli grown in antibiotic-free media found that the plasmid-
bearing strain was competitively inferior to its plasmid-free counterpart (Bouma and 
Lenski, 1988). However, when the same strain was propagated for 500 generations 
(75 days) in media containing chloramphenicol antibiotics, genetic adaptation 
occurred in the bacterial chromosome such that subsequently the ‘evolved’ strain 
was superior to the ‘naïve’ strain even in the absence of antibiotic selection (Bouma 
and Lenski, 1988). Not only was the cost of plasmid carriage eliminated, but the 
plasmid benefitted the bacteria that had evolved with the plasmid present. This may 
partly explain why the pACYC184 is commercially available and is used routinely as 
an expression vector for cloning. Evidence from this study, along with findings from 
previous studies (Mundy et al., 2003; Mundy et al., 2004; Kelly et al., 2006), 
confirms the stability of the pACYC184 plasmid (and its derivatives) in vivo and 
hence its utility for mouse infection studies.  
The current study found that host-adapted reporter C. rodentium, isolated from 
freshly shed stool samples, was able to inject effectors into T cell lines in vitro. In 
other words, the ability of C. rodentium to translocate proteins was retained after 
passage through the mouse gut. This is in line with earlier studies describing the 
ability of host-adapted C. rodentium to efficiently adhere to and trigger actin 
polymerisation and microcolony formation on cultured epithelial cells (Bishop et al., 
2007). In fact, such studies observed a higher expression of LEE genes from the 
host-adapted bacteria in comparison to bacteria grown in LB broth (Bishop et al., 
2007). These findings support the ‘hyperinfectious’ state of C. rodentium first 
observed by Wiles et al. (2005); these authors reported the enhanced ability of host-
adapted C. rodentium to infect mice in low doses, which bypassed the initial tropism 
for the caecum and colonized the colon directly. This is further supported by a recent 
study that describes the host-adapted bacteria as a ‘hypervirulent-host-associated’ 
Citrobacter rodentium strain (Smith & Bhagwat, 2013). However, since the 
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hyperinfectious state of C. rodentium is removed with one overnight passage of 
bacteria in LB broth (Wiles et al., 2005), the host-adapted C. rodentium used in this 
study was not hyperinfectious, as it was grown in LB broth overnight following 
isolation from mouse stool. Nonetheless, the host-adapted bacteria were able to 
translocate proteins in vitro and their passage through the mouse gut did not reduce 
the bacteria’s ability to subsequently colonise in vitro.  
Since C. rodentium is a non-invasive pathogen that adheres to the epithelial lining of 
the gut, IECs are the primary targets of C. rodentium effector translocation. Upon 
contact with host epithelium, Tir is translocated through the T3SS, which inserts 
itself back into the host cell membrane and acts as a receptor for bacterial intimin 
where Tir-intimin binding causes intimate attachment of C. rodentium to its host cell 
(described in Chapter 1). For this reason, isolated IECs were the first cells to be 
analysed for effector translocation by C. rodentium in this study. Contrary to 
expectations, IECs prepared from control mice and incubated with CCF4-AM 
fluoresced blue rather than green. The presence of blue cells in the absence of β-
lactamase activity suggests that these epithelial cells were auto-fluorescing, perhaps 
because of enzyme activity within these cells arising from their role in the digestive 
system. Indeed, the enterocyte brush border in BALB/c mice is filled with enzymes 
such as lactase, gamma-glutamyltransferase, alkaline phosphatase, and sucrase 
(Kozakova et al., 2002). Although further studies are required to confirm cleavage of 
CCF4 by these enzymes, epithelial cells isolated from the colons of infected mice 
were excluded from this study.  
Since the β- lactamase translocation assay did not appear to work in the isolated 
epithelial cells due to autofluorescence, further research is necessary to explore 
alternative methods to isolate IECs in order to minimise/diminish autofluorescence. 
Alternative isolation procedures may involve (1) mechanical shaking (vortex), (2) 
enzymatic separation using low trypsin concentration or (3) chelating agents using 
EDTA. Previous studies show that the microscopic appearance of IECs and the level 
of brush border enzyme activity changes according to the method of isolation used 
(Mac Donal et al, 2008). Therefore it is recommended to optimise the IEC isolation 
procedure to ensure its suitability for the β- lactamase translocation assay, so that 
visualisation of effector injection into isolated IECs (positive control) is enabled 
prior to analysis of isolated immune cells during future study. 
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Less anticipated, however, was our inability to visualise effector translocation in 
vivo. This finding was disappointing given the ability of these reporter bacteria to 
successfully colonise the mouse gut, express T3SS machinery, express the plasmid 
encoded reporter fusion, and inject the fusion proteins into mouse gut cells in vitro. 
The fact that the in vivo infection studies were carried out several times and always 
produced the same result, suggests that there may be underlying factors.  
One possible explanation is that C. rodentium entering the PP was killed by the 
alternative pathway of the complement system. The alternative pathway of the 
complement system can be activated by spontaneous hydrolysis of serum C3 into 
C3b, which binds to bacterial cell wall components of gram-negative bacteria 
(Goldsby et al., 2003). This initiates the complement cascade, leading to the 
formation of the membrane attack complex (MAC), which mediates cell lysis of the 
bacteria. Bacterial phagocytosis can also be enhanced by C3b acting as an opsonin 
and coating the surfaces of bacteria. Initiation of the complement cascade can 
additionally produce anaphylatoxins, including C3a, C4a, and C5a, which enhance 
inflammation by increasing vascular permeability, inducing extravasation and 
chemotaxis of leukocytes at the site of inflammation, and increasing expression of 
complement receptors on neutrophils (Goldsby et al., 2003). The increase in 
inflammation can further contribute to phagocytic killing of C. rodentium by 
complement. Evidence for the presence of complement proteins in the PP is provided 
by a previous study in which complement components related to the alternative 
pathway were localised within human lymphoid tissues, including the appendices, 
PP, and tonsils (Yamakawa & Imai, 1992). Hence, it is possible that the activation of 
complement by the alternative pathway, which serves as an important innate immune 
defence against many bacterial pathogens, may have reduced C. rodentium numbers 
in the PP.  
Even if some C. rodentium in the PP did survive and inject into immune cells, this 
could have been below the level of detection. It is possible that the number of events 
in which these bacteria encountered, interacted with, and targeted immune cells for 
protein translocation was too small to be visualised via the β-lactamase reporter 
system. Koberle et al. (2009) were unable to detect blue cells following orogastric 
infection of mice with Yersinia because the number of bacteria attached to a single 
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host cell was too low for detection of the β-lactamase reporter system; however, 
following tail vein infection the authors detected blue cells in the spleens of the mice. 
If effector injection did occur, it is possible that the effector proteins were degraded 
by proteosome activities inside the host cells. Studies using Salmonella enterica have 
previously reported a difference in the cellular levels of two effectors, SopE and 
SptP, inside host cells resulting from differential regulation by the host proteosome 
(Kubori & Galan, 2003). Although both effectors were delivered into host cells in 
approximately the same amounts, SopE was rapidly degraded by the host 
proteosome, while SptP exhibited much lower degradation kinetics and remains 
stable for longer. The half-life of these effector proteins was determined by their 
secretion and translocation domains (Kubori & Galan, 2003; Buttner 2012). These 
findings suggest the possibility that following their injection into host cells, NleD 
fusion proteins may have been subjected to host proteosome degradation. However, 
this would require the degradation to occur after 6 hours p.i, otherwise visualisation 
of injected cells in vitro would not be possible.  
Another factor underlying the lack of blue cells may be a loss of cells during 
isolation procedures. Although an average of 105 to 108 live cells were routinely 
isolated from the spleen, MLN, and PP for analysis in this study, this number does 
not necessarily reflect their original numbers in the tissue. It is thus possible that our 
isolation techniques did not pick up the injected cells, which may have been low in 
number from the outset. Recently, the use of multi-photon confocal microscopy in 
transgenic mice allowed the visualisation of a dense network of approximately 1 
million DCs and macrophages in the small intestinal LP, a number which no current 
isolation methods can produce (Pabst and Bernhardt, 2010). The use of multi-photon 
confocal microscopy to visualise cells in transgenic mice following a β-lactamase 
translocation assay may be an important strategy for future studies. 
Koberle et al (2009) found that the efficiency of the ß-lactamase reporter system in 
Yersinia is strain-dependent; the system worked highly efficiently when expressed in 
the E40(09) strain of Yersinia but not the WA-314(08) strain. It may be possible that 
the ß-lactamase reporter system did not work efficiently in the C. rodentium strain 
used in this study. Future studies should investigate the efficiency of the ß-lactamase 
reporter system in various strains of C. rodentium via transformation of the 
pACYCnleD plasmid.  
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Since the reorganization of actin filaments on the surface of IECs are crucial for C. 
rodentium pathogenesis, and this process is dependent on the T3SS mediated 
translocation of Tir into host cells, it may have been advisable to carry out 
immunofluorescence staining of Tir-actin in the colonic tissues of infected mice prior 
to β-lactamase translocation assay. This would ensure that the infecting C. rodentium 
is indeed injecting effectors into host cells. If the actin filaments cannot be 
visualised, this would indicate that C. rodentium is not injecting into host cells and 
that further studies would be required to optimise mouse infection procedures.   
An alternative explanation for the inability to visualise effector injected-host cells 
may be due to the thick, two layer of mucus present on the surface of epithelium in 
the mice distal colon, which may have prevented bacterial contact with epithelial 
cells and the subsequent injection of C. rodentium effectors. Having said that, C. 
rodentium colonisation of the distal colon can cause a depletion in goblet cell 
numbers, which in turn, may reduce the level of mucus present in the colon, thus 
enabling bacterial contact with the epithelium. In addition, C. rodentium mediated 
inflammation of the mice colon triggers a loss of epithelial barrier integrity, which 
enables the bacteria to enter the sterile lamina propia, thereby increasing bacterial 
contact with immune cells. But most importantly, C. rodentium, like other attaching 
effacing pathogens, has the ability to breach the mucosal barrier and bind intimately 
to IECs in the host epithelium. Future studies should focus on the visualisation of 
this intimate binding between C. rodentium and host IECs, using procedures such as 
immunolfluorescence staining of Tir-actin (mentioned previously), to confirm that 
bacterial translocation of effectors into epithelial cells has indeed occurred prior to 
analysis by β- lactamase translocation assay.  
Although isolated immune cells were analysed from the MLN, PP and the spleen, 
future studies may consider the analysis of immune cells from other lymph nodes. 
Recently, the caudal lymph node has been described to drain immune cells migrating 
from the descending colon and the rectum in addition to the MLN, which drains 
immune cells arriving from the jejunum, ileum, caecum and the ascending colon 
(Mowat & Agace, 2014). Although the MLN was thought to drain the entire small 
and large intestine at the time of this study, the possibility of the C. rodentium 
injected immune cells draining into the caudal lymph node should be explored for 
further study.  
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Additionally, the thoracic duct is the largest lymphatic vessel of the lymphatic 
system, collecting most of the lymph in the body, including intestinal immune cells 
migrating from the MLN, and draining into the systemic blood circulation. Mice, 
which have undergone the removal of MLN from the lymphatic circulation in a 
procedure known as mesenteric lymphadenectomy (MLNx), the thoracic duct lymph 
contains a population of immune cells that are normally present in the MLN 
(Rhodes, 1985). Another procedure known as thoracic duct cannulation allows the 
collection of all MLN-bound immune cells in sufficient numbers over a long period 
of time (Cerovic et al, 2013). The isolation and analysis of such cells for β- 
lactamase activity following the infection of mice with reporter C. rodentium is an 
important study for future research.  
Bacterial shedding during C. rodentium infection peaks around day 6-7 p.i, so it is 
reasonable to assume that effector injection may also peak during this time-point 
where the highest number of bacteria passes through the colon. However since we 
were unable to observe bacterial injection during this time, it may be a consideration 
for future studies to isolate cells during earlier time points. It is known that during 
the early stages of C. rodentium infection, bacteria pass through the colon at day 0-1 
p.i. Even though these bacteria do not colonise, there may be a possibility that they 
may be injecting effectors into the intestinal cells. Bacteria may also be injecting 
effectors into target cells during early colonisation at days 2-6 p.i when bacterial 
numbers increase until the peak of infection.   
C. rodentium is an extracellular pathogen that colonises the epithelial surface of the 
caecum, colon, and rectum. As a result, the majority of cells targeted for protein 
translocation are epithelial cells. However, CX3CR1+DCs extend transepithelial 
processes through the epithelium to sample luminal bacteria (Rescigno et al., 2001; 
Neiss et al., 2005) and EPEC inject effectors into myeloid-derived DCs to shut down 
NFκβ; in view of this, we hypothesised that DCs may also be targeted for protein 
translocation by C. rodentium. In addition we hypothesised that target cells 
containing effectors may migrate to surrounding draining lymph nodes and lymphoid 
tissue, such as the spleen, MLN, and PP, where the effectors may exert an 
immunomodulatory effect on the host immune response.  
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Recently the identity of CX3CR1+ cells has come into question. Schulz et al (2009) 
showed that CX3CR1+ cells did not express the chemokine receptor CCR7 required 
for their migration to the MLNs and were inefficient at priming naïve T cells, 
which—in addition to the observation that CX3CR1+ cells displayed macrophage-
like characteristics, including a vacuolar cytoplasm (Bogunovic et al., 2009)—led 
many researchers to classify these cells as macrophages (Denning et al., 2007; 
Schulz et al., 2009; Bogunovic et al., 2009; Pabst & Bernhardt, 2010; Farache et al., 
2013).  
Another population of LP cells associated with the epithelium, CD103+DCs, were 
recently shown to migrate between the LP and the intraepithelial compartment of the 
small intestine (Farache et al., 2013). After entering the epithelium, these DCs 
migrated above the basal membrane, extended thick finger-like projections which 
could capture luminal Salmonella, upregulated the expression of CCR7, migrated 
back to the LP, and entered draining MLNs. There, they presented antigens to T 
cells, resulting in the proliferation of antigen-specific CD8 T cells that were later 
imprinted for gut homing (Farache et al., 2013). Hence, CD103+DCs are considered 
major players in presenting antigens to T cells and thereby inducing adaptive 
immunity in the intestine.  
Although CX3CR1+ cells are more efficient than CD103+ cells at sending dendrites 
into the lumen and capturing luminal bacteria and/or antigens, the latter express 
CCR7, migrate to MLN, and are more efficient at presenting antigens to T cells 
(Farache et al., 2013). A recent study demonstrated a functional cooperation between 
these two phagocytes to establish oral tolerance (Mazzini et al., 2014). CX3CR1+ 
cells were found to take up soluble fed antigens and transfer them to CD103+DCs by 
a mechanism that was dependent on the gap junction protein connexin 43. Deletion 
of connexin 43 prevented CD103+ DCs from acquiring antigens and presenting them 
to T cells to drive T regulatory cell differentiation and induce oral tolerance 
(Mazzani et al., 2014).  
A slightly different role for CX3CR1+ cell-mediated phagocytosis of luminal bacteria 
has been demonstrated in C. rodentium infection (Manta et al., 2013). Upon infection 
of transgenic CX3CR1-GFP mice, C. rodentium was associated closely with and 
within CX3CR1+ cells during the peak of infection, suggesting that luminal C. 
rodentium had been phagocytosed by CX3CR1+ cells in the colonic LP (Manta et al., 
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2013). Phagocytosed C. rodentium may provide signals to CX3CR1+ cells, which 
help to facilitate IL22 expression by innate lymphoid cells (ILCs) (Manta et al., 
2013); IL22 regulates expression of the antimicrobial molecules RegIIIγ and 
REGIIIβ as well as increasing epithelial cell proliferation and promoting wound 
healing. Uptake of C. rodentium by CX3CR1+ cells and subsequent initiation of the 
IL22 mediated immune response may thus serve as a host defence mechanism 
against enteric pathogens (Manta et al., 2013). Although such findings suggest that 
C. rodentium may not actively support its uptake by CX3CR1+ cells, experiments 
using C. rodentium lacking the T3SS will need to be conducted in order to clarify 
this.   
For future studies, intravital two-photon microscopy may provide an alternative 
method to visualise cells targeted for effector translocation by C. rodentium. 
Intravital two-photon microscopy enables live imaging of immune cells deep within 
lymphoid tissues and organs in real time (Farache et al., 2013). Application of this 
technology to the β-lactamase reporter system could provide three dimensional 
information about the identity, location, and motility or migration of live immune 
cells targeted for effector injection by C. rodentium in live mice, generating valuable 
insight into the modulation of host immune responses by bacterial effectors and 






Figure 5.4.1 Bacterial shedding in mice infected with reporter C. rodentium or 
ΔescN deletion mutant. Balb/c mice (x12) were orally gavaged with 1x109 colony 
forming units  (CFU) of Citro pACYCnleD (closed squares) or Citro 
ΔescNpACYCnleD (open squares) as described in Materials & Methods. Infected 
mice were monitored for bacterial shedding for 8 days post inoculation (p.i). Viable 
counts were made by quantification of CFU shed per gram of stool from individual 
mice. Error bars indicate the mean+ SEM of 6 individual mice.  Representative data 







Figure 5.4.2 Bacterial shedding in mice infected with wildtype C. rodentium or 
reporter C. rodentium. Mice (x12) were orally gavaged with 1x109 CFU of 
Citrobacter rodentium (closed squares) or Citro pACYCnleD (open squares) and 
monitored for 11 days.  Viable counts were made by quantification of CFU shed per 































Figure 5.4.3 Comparison of mucosal thickness in mice infected with various 
strains of C. rodentium. Mice infected with CitroΔescN pACYCnleD, Citrobacter 
rodentium and CitropACYCnleD were sacrificed at day 7 p.i and sections of the 
distal colon were stained with Haematoxylin and Eosin (H&E).  A) H&E staining of 
colonic sections showing crypt hyperplasia. B) Hyperplasia is indicated by an 
increase in crypt length (µm) in the distal colon. Data expressed as mean of 6 













   
       
 
 





Figure 5.4.4:  Plasmid stability in infected mice over time. Mice were infected 
with Citro pACYCnleD and monitored over 10 days. A) Viable counts of Citrobacter 
(cfu/G of stool) observed on LB plates containing either nalidixic acid (closed 
squares) or nalidixic acid with chloramphenicol (open squares).  Error bars indicate 
the mean+ SEM of 7 individual mice. Statistical analysis revealed no significant 
difference between the datasets Nalidixic acid and Nalidixic acid & chlorampenicol 
as the P values were all greater than 0.05. B) Segmented column chart showing the 
percentage of bacteria that have either lost or retained the plasmid. Representative 













Figure 5.4.5:  PCR analysis confirming plasmid stability. PCR was carried out 
using various preparations of plasmids, which were obtained from bacteria grown 
from mouse faeces at various days post inoculation (p.i). PCR using primers 
pACYCtc (fw) and pACYCtc (rv) produced 1680bp and 345bp fragments from 
plasmid pACYCnleD and pACYC184 respectively. The lanes are labelled as follows 
(1) DNA ladder (-2 log), (2) pACYCnleD  from frozen stock (positive control), (3) 
pACYCnleD from  day 5  p.i, (4) pACYCnleD from day 6 p.i, (5) pACYCnleD from  






Figure 5.4.6 β-lactamase activity in splenocytes in vivo. Splenocytes were isolated 
from mice infected with either wild type CitroΔescN pACYCnleD or Citro 
pACYCnleD  and sacrificed at days 7, 9 and 11 p.i. The isolated cells were 
subsequently stained with CCF4-AM substrate for 1h as described in Materials & 
Methods. β -lactamase activity was A) visualized by fluorescence microscopy (x10 
objective) and B) detected by flow cytometry. The FACS plots show firstly, the 
gated live lymphocytes within the total spleen cell population (FSC x SSC), and 
secondly, the percentage of β-lactamase activity in cells within the gated population 
(green/blue).  Results are representative of approximately 150-210 mice from 15 








Figure 5.4.7 β-lactamase activity in mesenteric lymph node (MLN) cells in vivo 
MLN cells were isolated from mice infected with either CitroΔescN pACYCnleD or 
CitropACYCnleD at days 7, 9 and 11 p.i and CCF4 stained. β-lactamase activity was 
A) visualized by fluorescence microscopy (x10 objective) and B) detected by flow 
cytometry. The FACS plots show the gated live lymphocytes within the total MLN 
population (FSC x SSC), and the percentage of green/blue cells.  Results are 








Figure 5.4.8 β-lactamase activity in Peyer’s patch (PP) cells in vivo. PP cells were 
isolated from mice and infected with either CitroΔescN pACYCnleD or 
CitropACYCnleD  at days 7, 9, 11 p.i and CCF4 stained . Protein translocation was 
A) visualized by fluorescence microscopy (x10 objective) and B) detected by flow 
cytometry. The FACS plots show the gated live lymphocytes and the percentage of 
green/blue cells. Results are representative of approximately 150-210 mice from 15 







Figure 5.4.9 β-lactamase activity in colonic epithelial cells in vivo. Colonic 
epithelial cells were isolated from individual mice (x12) infected with either 
CitroΔescN pACYCnleD or Citro pACYCnleD and incubated with CCF4-AM 
substrate for 1h. β-lactamase activity was A) visualized by fluorescence microscopy 
(x10 objective) and B) detected by flow cytometry. The FACS plots show the gated 
live epithelial cells and the percentage of green/blue cells. Cell isolates were 
prepared from mice at days 7, 9 and 11 p.i. Results are representative of at least 5 








    
 
Figure 5.4.10: Autocleavage of CCF4-AM in colonic epithelial cells in vivo. 
Green and blue cells observed in colonic epithelial cells isolated from uninfected 
mice that have been stained with CCF4-AM and visualized using A) x10 objective 
B) x20 objective of fluorescent microscope. These cells are displaying autocleavage 
of CCF4-AM even in the absence of β-lactamase activity. Images are representative 







Figure 5.4.11 Bacterial shedding in mouse faeces overtime. Mice were inoculated 
with Citro pACYCnleD and the bacterial burden monitored regularly over the course 
of infection. Viable counts were made by quantification of CFU per gram of stool 
from individual mice. Error bars indicate the mean+ SEM of an average of 50 mice 






Figure 5.4.12 β-lactamase activity in infected splenocytes isolated from infected 
mice. Mice (x10) were orally infected with WT C. rodentium or CitropACYCnleD  
and monitored  regularly until they were sacrificed at day 7 p.i and analysed for β-
lactamase activity. A) Representative FACS plot showing lymphocyte gate. B) 
Percentage of blue cells after CCF4-AM staining for 1 hour.  C) The isolated 
splenocytes were further re-infected with either Citrobacter rodentium (control) or 
CitropACYCnleD with increasing MOI for 6 hours in duplicate wells and 
subsequently analyzed by flow cytometry. D) Summarized data from infected mice 
experiments compared to previous data from uninfected mice. Error bars indicate the 






Figure 5.4.13 β-lactamase activity in infected MLN cells isolated from infected 
mice. A) FACS plot showing lymphocyte gate. B) Cells after CCF4-AM staining.  
C) The MLN cells were re-infected with either Citrobacter rodentium (control) or 
CitropACYCnleD with increasing MOI for 6 hours in duplicate wells and 
subsequently analyzed by flow cytometry. D) summarized data from infected mice 
experiments compared to previous data from uninfected mice. Error bars indicate the 


















Figure 5.4.14 β-lactamase activity in infected PP cells isolated from infected 
mice. A) FACS plot showing lymphocyte gate. B) Cells after CCF4-AM staining.  
C) The PP cells were re-infected with either Citrobacter rodentium (control) or 
CitropACYCnleD with increasing MOI for 6 hours in duplicate wells and 
subsequently analyzed by flow cytometry. D) Summarized data from infected mice 
experiments compared to previous data from uninfected mice. Error bars indicate the 



























Figure 5.4.15: T cell infection with host-passaged bacteria. T cells infected with 
varying MOI of Citro pACYCnleD recovered from mice stool at day 7 p.i. A) 
Representative FACS plot and histograms of uninfected cells showing the gating of 
live cells and the percentage of CCF4 labelled cells.  B) Representative FACS plot of 
infected T cells. C) Data are summarised as the mean SEM of 3 independent 
experiments, compared with previous data using Citro pACYCnleD grown overnight 















Figure 5.4.16: In vivo infection of mice with hyperinfectious bacteria. Mice were 
orally gavaged with CitropACYCnleD and the infection monitored for 11 days.  
Bacteria was isolated from mice faeces at day 7 p.i and used to inoculate new mice 
(x5).  A) Bacterial load in faeces of mice infected with hyperinfectious bacteria for 3 
days, compared with mice infected with non-hyperinfectious bacteria. B) 
Representative FACS plots of isolated and stained epithelial cells from the colon and 





Chapter 6. Final discussion & Future work 
In this thesis, Citrobacter rodentium infection in mice was used as a model to study host 
cells targeted for effector translocation by T3SS-containing bacteria. First, we generated 
a reporter C. rodentium expressing ß-lactamase fusion proteins, to allow visualisation of 
host cells targeted for effector translocation by C. rodentium. We determined that the 
most convenient method for introducing the β-lactamase reporter gene into the C. 
rodentium strain was a pACYC-derived plasmid. Although a chromosomally encoded 
reporter fusion is physiologically more relevant, due to the expression of the effector in 
its native context, a plasmid-encoded reporter fusion also has its advantages. 
Constitutive expression of fusion proteins from the plasmid facilitates the detection of 
reporter activity inside host cells that have been targeted for protein translocation. In 
addition, the dispensable nature of the plasmid allows for manipulation of bacterial 
genes while keeping chromosomal genes intact. Low-copy plasmids, such as those 
derived from pACYC184, enable the production of fusion proteins at physiological 
levels, making the experiments physiologically more relevant. Our results demonstrate 
that the pACYCnleD plasmid remains stable throughout the mouse infection period, 
thereby confirming its suitability for subsequent infection studies in mice. 
In contrast, the λ-Red-mediated homologous recombination in this study was 
unsuccessful in the integration of β-lactamase into the bacterial chromosome. This may 
have been due to the large size of the insert DNA (~2kb PCR product), which may have 
reduced the efficiency of the recombineering process by λ Red. Further work is 
necessary to explore methods for increasing the efficiency of λ Red-mediated 
homologous recombination between the β-lactamase reporter gene and the C. rodentium 
chromosome. Alternative methods to integrate the β-lactamase reporter gene into the 
bacterial chromosome, such as bacterial conjugation or the use of a LacZ gene, could be 
pursued in future studies. 
A key part of our research involved using the reporter C. rodentium to investigate the 
utility of a β-lactamase translocation assay in vitro. Our results show that C. rodentium 
is capable of injecting effectors into various types of murine cell lines, including Swiss 
3T3 fibroblasts, J774 macrophages, CMT93 colonic epithelial cells, and BW715 T 
cells. In addition, we have observed C. rodentium-translocated effectors in primary cells 
isolated from mouse lymphoid tissues, including the spleen, MLN, and PP. To our 
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knowledge, we are the first to demonstrate the ability of C. rodentium to target cells of 
the host immune system. Analysis of these cells by flow cytometry has revealed that the 
cells targeted for effector translocation were B cells, DCs, and T cells. This confirms 
previous findings in which E. coli was shown to inject effectors into macrophages 
(Marches et al., 2008) and DCs (Vossenkaemper et al., 2010). The findings from our 
study support the notion that if reporter C. rodentium were to encounter immune cells in 
vivo, effector translocation would probably occur.  
A natural progression from this work will be to understand the biological significance 
of the effectors translocated into immune cells in vitro by C. rodentium. This could be 
achieved by examining the ability of immune cells injected with bacterial effectors to 
carry out immune functions, such as presentation of antigens to lymphocytes, 
production of chemokines and cytokines, and migration to effector sites throughout the 
lymphatic system. Such studies would provide valuable insight into the consequences of 
protein translocation for host immune cells and thereby determine to what extent these 
pathogens can impair host immune responses in a type 3 manner.  
In this study, our observation that effector translocation occurs more efficiently in 
stimulated cells supports previous findings in which stimulated cells exhibited increased 
expression of surface integrins (Miron et al., 1992; Kinashi et al., 2007). Increased 
integrin expression facilitates bacterial adhesion to host cells (Frankel et al., 1996; 
Schulte et al., 2000), which leads to the enhanced translocation of effectors in the 
stimulated cells (Mejia et al., 2008: Koberle et al., 2009). As the present study has 
shown that the activated state of a cell can increase the probability of protein 
translocation, it would be informative to examine conditions that can reduce the 
likelihood of protein translocation. Additional future work could identify molecules and 
compounds that inhibit effector translocation by the T3SS for potential treatments 
against T3SS containing pathogens.  
Another key part of this research comprised in vivo studies of the reporter C. rodentium 
in mouse models. We infected Balb/c mice with reporter C. rodentium and used the 
escN mutant encoding a non-functional T3SS as a control. Although the mice were 
successfully colonised by the reporter bacteria, we were unable to detect any reporter 
activity inside mice cells, despite several attempts. This was unexpected, in view of our 
success in demonstrating the ability of the reporter strain to express plasmid-encoded 
fusion proteins throughout the infection period, as indicated by plasmid preparations 
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from faecal bacteria. We postulate that the reporter C. rodentium was destroyed by host 
innate defences following its entry into the mouse PP, or alternatively that the number 
of cells injected was below the level of detection by the β-lactamase reporter system.  
The success of the β-lactamase reporter technology in visualising bacterial injection in 
vivo may have been limited by the non-invasiveness of C. rodentium. Non-invasive 
bacteria, such as the AE pathogens, only colonise the surface of the epithelium, where 
the likelihood of having direct contact with an immune cell is rare. Although certain 
subsets of monocytes and DCs have been shown to associate with the gut epithelium, 
extend their dendrites into the gut lumen, and be injected with effector proteins by 
T3SS-containing pathogens, these interactions may simply be too rare for detection by 
β-lactamase reporter technology. Although small numbers of live bacteria can be 
recovered from mouse MLNs and the spleen during infection (Goncalves et al., 2001), 
whether these bacteria are fit enough to inject effectors into host cells at these sites—
and whether this is detectable by flow cytometry—is a subject for further study. Non-
invasive bacteria cannot survive in intracellular space; instead, upon entry into 
lymphoid tissues they are subjected to bacterial clearance by the host innate defence 
mechanisms. These factors may contribute to the lack of reported in vivo visualisation 
of host cells targeted for effector translocation using the β-lactamase translocation assay 
in AE pathogens to date.  
In contrast, invasive pathogens are able to penetrate the epithelial barrier and enter 
lymphoid tissues and organs, where they encounter various types of immune cells. 
Invasive pathogens have mechanisms to defend themselves against the host immune 
response and hence can survive and multiply in the intracellular space. β-lactamase 
translocation assays carried out on cells isolated from the lymphoid organs of mice 
infected with such pathogens are likely to reveal more immune cells that have been 
targeted for protein translocation, in comparison to non-invasive pathogens. This may 
be why the ability to inject proteins into immune cells and subsequently subvert host 
immune responses is well-established for invasive pathogens such as Salmonella, 
Shigella, and Yerisinia. 
Fukuda et al. (2011) used a PP intestinal loop assay to assess bacterial uptake of 
fluorescent Salmonella by M cells in mice. Based on this method, a future study could 
employ a ligated intestinal loop assay to evaluate effector translocation by C. rodentium 
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into intestinal immune cells. This would involve ligation of the distal colon while the 
mouse is anaesthetised, followed by the injection of bacterial suspension containing 
reporter C. rodentium directly into the ligated intestinal loop. After a few hours, the 
ligated loop would be removed, the mice immediately euthanised, and the intestinal 
immune cells analysed for effector translocation using the β-lactamase translocation 
assay. Further research might also explore the use of intravital-2-photon microscopy for 
live imaging of immune cells within the lymphoid tissues of mice in real time. Analysis 
with this technology of mice infected with reporter C. rodentium would provide three-
dimensional information about the phenotype, location, and migration of immune cells 
targeted for effector translocation by C. rodentium in vivo.   
Taken as a whole, this study has demonstrated the utility of the β-lactamase 
translocation assay as a reporter system to monitor effector injection into host cells in 
vitro by C. rodentium. To our knowledge, we are the first to show that C. rodentium can 
target immune cells for effector injection in vitro. Our findings corroborate previous 
studies that have characterised the ability of T3SS-containing pathogens to inject 
effectors into immune cells and subsequently subvert host immune responses. Although 
further work will be necessary to visualise host cells targeted for effector injection in 
vivo, we conclude that the Citrobacter rodentium model of infection is a useful system 
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Appendix A: Cells and molecules of the host immune system that facilitate 















Key adaptor molecule in immune signaling downstream of 
TLR and ILIR. MYD88 signaling controls infection by 
recruiting neutrophils, DC and macrophages to the mucosa, 
expressing iNOS and triggering the proliferation of epithelial 
cells  (colonic hyperplasia). 
 
 
Vallance et al, 2004 
Gibson et al, 2008 
Lebeis et al, 2007 







TLR2 and TLR4 are activated infection, which induces the 
up-regulation of iNOS and the production of proinflammatory 
cytokines KC, TNF and IL6. 
TLR2 signaling in stromal cells induces tissue protective 
responses, which are especially required in the presence of 
TLR 4 signaling. TLR2 mediated signaling limits tissue 
damage which is associated with the production of 
cytoprotective cytokines IL-11 by subepithelial mesenchymal 
cells. IL-11 is essential for STAT 3 phosphorylation in colonic 
crypt epithelial cells, which promote epithelial cell health and 
proliferation. This may also protect against TLR 4 driven 
damage.  
TLR4 expressing hematopoietic cells drive infection induced 
mucosal damage and may facilitate C.rodentium colonization 
by helping to remove competing commensals. 
 
 
Lupp et al, 2007 
Gibson et al,  2008 




NOD1 and NOD2 signaling are activated by C.rodentium, 
which protects against pathogen induced damage by limiting 
bacterial translocation and promoting mucosal integrity. This 
occurs through the production of IL17A by ILC3 cells which 
are responsible for early IL17A mediated production of IL22 
and RegIIIy. NOD2 signaling also leads to the recruitment of 
cd11c+ inflammatory monocytes to the site of infection, 
which also promote pathogen killing.   
  
 
Geddes et al, 2011 








Caspase I mediated mucosal responses are crucial for host 
resistance to C.rodentium. Caspase 1 proteolytically cleaves 
the precursor forms of IL1b and IL18 into active mature 
peptides.  
Caspase 11 is required for C.rodentium mediated NLRP3 
dependent caspase 1 maturation and IL-1 responses.  Caspase 
11 is regulated by TRIF (an adaptor molecule downstream of 
TLR 4).  
Caspase 12 is a negative regulator of caspase 1 and 
inflammasome function. Caspase 12 directly interferes with 
NOD signaling required for NF-κB activation and the 
production of the NOD regulated B-defensin-2.  By doing so, 
caspase 12 dampens  NF-κB activation thus inhibiting NOD 
activation and the resulting antimicrobial peptide production. 
 
 
Liu et al, 2012  
Kayagaki et al, 2011 









Macromolecular scaffolds in the cytosol of immune cells that 
are responsible for the proteolytic maturation of caspase 1 and 
the IL-1 family of cytokines including IL1b and IL18. 
 
 
Kayagaki et al, 2011 
Gurung et al, 2012 
Liu et al, 2012 







ILC3 are an important source of IL22 and IL17 in the early 
stage of C.rodentium infection. ILC3 are induced early in the 
caecum and is dependent on NOD1 and NOD2 signaling as 
well as imprinting by the intestinal microbiota.   
 
O’Quinn et al, 2008 
Torchinsky et al, 2009 
Song et al, 2011 
Collins et al, 2014 





Compliment protein C3b and complement fixing IgG enter the 
gut lumen during infection and bind to adhering C.rodentium. 
Opsonization of C.rodentium leads to increased phagocytosis, 
neutralization of bacterial adhesins and bacterial lysis. 
 
 







Reactive nitrogen species are generated by Inducible nitric 
oxide synthase (iNOS) in neutrophils, macrophages and 
epithelial cells. Infection results in a strong expression of 
iNOS by epithelial cells and thus increased nitric oxide (NO) 
in the lumen of the gut.  NO is bacteriostatic against 
C.rodentium but seems to play a minor role in host defense 
against C.rodentium.  
 
 
Simmons et al, 2002 





CX(3)CR1(+) mononuclear phagocytes produce IL23 and IL-
1beta which support IL22 production by ILC3s in response to 
infection. IL22 production induces the expression of the 
antimicrobial peptides RegIIIb and RegIIIy.  
 
 
Longman et al, 2014 




During infection, NK cells are recruited to the mucosal tissue 
where they express a diverse array of immunomodulatory 
factors such as TNFa and IFNγ, which provide protection 
against C.rodentium. NK cells reduce C.rodentium burden in 
the colon, modulate infiltration and cytokine (such as IL17) 
profiles of MLN immune cells (such as neutrophils), recruit 
colonic effector cells (T and B cells), prevent extracolonic 
dissemination of C.rodentium (by stimulating macrophages 
and neutrophils to produce ROS) and are directly cytotoxic 
(by producing a-defensins) to C.rodentium.  
 
 





Murine B defensins (mBD1 and mBD3) are upregulated in 
colonic tissue of infected mice. Defensins have antimicrobial 
activity against C.rodentium by disrupting bacterial membrane 
and causing cell death.  
Murine cathelicidin-related antimicrobial peptide (mCRAMP) 
also play a role in limiting C.rodentium colonization early 
during infection. 
RegIIIy and RegIIIb expression are induced by the production 
of IL22 and have antimicrobial activity against C.rodentium. 
 
 
Simmons et al, 2002 
Limura et al, 2005 
Manta et al, 2013 
 







CD4+T cells elicit a Th1 cell response that is characterized by 
the production of IFNγ and TNFa. CD4+T cell dependent IgG 
response is required to overcome C.rodentium infection.   
CD8 T cells increase in the submucosa of infected tissue but 
do not have a major role in the resolution of infection. 
Th22 cells are an important source of IL22 which induce the 
production of Reg III antimicrobial peptides and promote 
epithelial barrier integrity. Development of Th22 cells is 
dependent on IL6 and the transcription factor T bet and Ahr.  
Th17 are an important source of IL17 which increases 
chemokine and cytokine production in various tissues to 
recruit monocytes and neutrophils to the local site of infection.  
Foxp3+ T regulatory cells induce a strong Th17 response in 
the colon which helps to clear the pathogen. Th17 cell 




Simmons et al, 2003 
Bry & Brenner 2004 
Zheng et al, 2008 
Basu et al, 2012 
Li et al, 2014 
Wang et al, 2014 





The functions of B cells are mainly mediated by serum IgG, 
which is crucial for the resolution of C.rodentium infection.  
B cells also play an important role in the development and 
formation of intestinal lymphoid tissue.  
B cells are potent APC and facilitate the development of 
effective T cell responses.  
B cells can also secrete chemotactic cytokines which are 
important for immune cell recruitment.  
 
 
Simmons et al, 2003 
Maaser et al, 2004 
Bry & Brenner 2004 
Uren et al, 2005 









IL-12 plays an important role in limiting bacterial infection of 
the colonic epithelium. 
 
 




IFNγ enhances macrophage phagocytic activity against 
C.rodentium and induces the activation of antigen specific T 
cells. Drive goblet cell depletion and IEC proliferation. IFNγ 
produced by antigen specific CD4+Tcells play an important 
role in defense against C.rodentium. 
 
 
Shiomi et al, 2010 




TNFa downregulates mucosal pathology and Th1 immune 
responses by dampening down IL12 and IFNγ. TNFa might 
limit intestinal colonization through enhancing innate immune 
responses through neutrophil recruitment and defensin 
production. Thus, TNFa has a role in controlling bacterial 
burden and limiting mucosal immune mediated pathology but 
does not contribute to pathogen clearance.  
 
 









Produced by ILC3s and CD4 Th17 cells. ILC3 responses 
occur mainly in the caecum and is dependent on NOD1 and 
NOD2 signaling, imprinting by the intestinal microbiota, IL6 
induction and is associated with C.rodentium induced 
apoptosis of IECs. The phagocytosis of infected apoptotic 
cells by DCs can induce the simultaneous production of IL6 
and TGFb which lead to the polarization of Th17 cells.  
Blocking apoptosis during infection, impairs the Th17 cell 
response in the lamina propia. IL17 increases chemokine and 
cytokine production in infected tissue to recruit innate cells 
including monocytes and neutrophils to the site of infection. 
 
 
O’Quinn et al, 2008 
Torchinsky et al, 2009 
Song et al, 2011 
Brereton & Blander 
2011 
Liu et al, 2009 




Produced by Th17cells, Th22 cells and ILC3s. DC derived 
IL23 and macrophage derived IL1b facilitates IL22 production 
by ILCs. IL22 induces the production of Reg III antimicrobial 
peptide and promote epithelial barrier integrity.  IL22 also 
facilitate host responses by modulating the expression of 
various chemokines including CXCL1, CXCL5 and CXCL9. 
STAT 3 is required for IL22 production in both innate and 
adaptive immune cells.  
 
 
Zheng et al, 2008 
Basu et al, 2012 
Manta et al, 2013 





Produced by C.rodentium mediated activation of Nlrp3 
inflammasome. IL-1b and IL-18 play a critical role in host 
defense against enteric infection. IL1b controls the production 
of IL22 by RORgt+ILC cells.  
 
 
Lebeis et al, 2009 
Liu et al, 2012 




Inflammatory cytokine required for the differentiation and 








Infection induced macrophage and DC production of IL10 is 
associated with diminished anti bacterial host defenses.  
 
 






















Mice suffer from bacteremia, 
gangrenous mucosal necrosis, 
severe colitis and death. 
 
 






Delayed inflammatory cell 
recruitment, reduced iNOS 
and abrogated production 
of TNFa and IL6 from 
macrophages and colons. 
Unable to promote 
epithelial cell turnover and 
repair. 
 
Mice develop lethal colitis with 
colonic mucosal ulcerations and 
bleeding associated with high 
bacterial burden, bacterial 
invasion of colonic crypts and 
intestinal barrier dysfunction. 
 








Mice are unable to clear 
infection, exhibit reduced influx 
of immune cells into infected 
colonic tissue and increased 
levels of mucosal hyperplasia, 
IFNγ and TNFa.  Also show 
higher levels of anti 
C.rodentium IgG and IgM. 
 
 
Dennis et al, 2008 
 




expression in IECs. 
 
Mice suffer from a sustained 
bacterial burden and fail to 
recruit CD4 T cells into colonic 
mucosal lesions due to impaired 
chemokines expression in IECs. 
 
 
Kang et al, 2010 
 
Compared to Casp1-/-, there 
was a delayed onset of body 











maturation of caspase 1 
required for the production 
of  IL1b and IL18 
 
Infected mice developed severe 
colitis. Treatment of infected 
mice with IL-1B reduced 
bacterial colonization, abrogated 
bacterial translocation to 
mesenteric lymph nodes and 
protected epithelial integrity. 
 
 







Defective  production of 
IL-1 family of cytokines 
(IL1b and IL18) 
 
Mice were highly susceptible to 
C.rodentium infection. There 
was significant loss of body 
weight, increased colon 
inflammation, increased 
inflammatory cytokine 









Reduced CCL2 chemokine 
production by stromal cells, 
inflammatory monocyte 
recruitment and Th1 cell 
responses. 
 
Impaired clearance of C. 
rodentium, due to reduced 
CCL2 chemokine production 
(by colonic stromal cells or 
CD11b+ phagocytic cells in a 
NOD2-dependent manner), 
reduced inflammatory 
monocytes recruitment ( which 
produces IL12 required for 
inducing adaptive immunity)  
and a reduced TH1 cell response 
in the intestine. 
 
 





Loss of function of NOD2 
and reduced activation NF-
kB and MAPKs. 
 
 
Less induction of cytokines 
after engagement of NOD2 and 


















Increase in innate cells 
Gr1(+), F4/80(+), 
CD11c(+) and MHCII(+); 
CD11c(+) and Th1 
adaptive (CD4) immune 
cells 
Severe colitis and greater bacterial 
colonisation. MTG16 is a transcriptional 
corepressor that regulates inflammatory 
recruitment and is critical for colonocyte 
survival and regeneration 
Williams et al, 2013 
ASK-/- 




Inability of macrophages 
to kill bacteria  
Increased susceptibility to colonic 
inflammation by C.rodentium in vivo. In 
vitro, ASK-/- macrophages are impaired 
in their ability to kill bacteria and had 
increased susceptibility to bacteria-
induced apoptosis. Ant apoptotic genes 
were greatly reduced in ASK-/- 
macrophages.  





Inability to recruit innate 
immune cells such as 
neutrophils and 
macrophages to site of 
inflammation. 
More pronounced morbidity associated 
with higher bacterial load, elevated IL-
12p70, TNF-a, IFNγ, MCP-1 and IL-6 
production, more severe inflammation and 
higher leucocyte infiltration in the guts.  






macrophages and DCs 
Delayed clearance of C.rodentium, 
associated with reduced IL-22 expression. 
Without CX3CR1, there is reduction of 
IL22 production by lymphoid tissue 
inducer (Lti) cells. This also correlates 
with the decreased expression of 
antimicrobial peptides RegIIIβ and 
RegIIIy. 








recruitment and survival in 
the mucosa due to failure 
of epithelial cells to 
upregulate production of 
DC attractant CCL22. 
Had fewer mucosal CD11c (+) DCs, 
greater bacterial burden, increased 
mucosal inflammation and systemic 
spread of infection, decreased antibody 
responses, and delayed pathogen 
clearance.  
Hirata et al, 2010 
Nfil3-/- Impaired development of 
Peyer's patches and ILC2 
and ILC3 subsets. 
Highly susceptible to infection due to 
reduced PP formation and impaired 
recruitment and distribution of 
lymphocytes within the patches. In Nfil3 
defecient mice, ILC3s including LTi cells 
are severly diminished in number and 
function. 
 
Seillet et al, 2014 
Geiger et al, 2014 




There is increased 
apoptosis of 
RORgammat(+) ILCs and 
less production of IL-22. 
Infected mice succumb to C.rodentium 
infection. Without Ahr, RORγt(+) ILCs 
have increased apoptosis and less 
production of IL-22 which mediates 
innate gut immunity.  
Qiu et al, 2012 
Ltbr-/- 
 
Impaired development of 
secondary lymphoid 
tissues. Also defective 
LTbr signaling in gut 
epithelial cells fail to 
produce CXCL 
chemokines that recruit LT 
producing neutrophils and 
RORgt+ innate cells 
Mice lost weight and died of 
overwhelming infection within two weeks 
post infection. There were multiple 
defects in the development and 
maintenance of secondary lymphoid 
tissue and sever epithelial cell damage 
with edema, ulceration and bacterial 
abscesses in the colon.  
Wang et al, 2010 
LTβR-/-  NCR22 cells in gut cryptopatches 
function through IL22 mediated 
production of antibacterial peptides after 






Inability of infected, 
damaged cells to undergo 
autophagy.  
 
Greater clinical evidence of disease and 
higher expression levels of pro-
inflammatory cytokine mRNA in the large 
intestine and reduced bacterial clearance.  
Inoue et al, 2012 
NK1.1 cell 
depletions 
Loss of NK cells resulting 
in lower colonic IFNγ, 
TNFa and IL-12, and a 
delay in homing of 
IFNγ+CD4+ T cells to the 
gut, resulting in a reduced 
IgG response.  
Higher bacterial load, intestinal pathology 
and crypt hyperplasia at the peak of 
infection due to a reduced IgG response 
against C.rodentium.  
Reid-Yu et al, 2013 







Present in neutrophils, 
macrophages and epithelial 
cells which generate 
reactive nitrogen species. 
Significant induction of IFNγ, IL-1 and 
TNFa mRNA expression in colitis tissue 
 




Deficient in cathelicidin 
(mCRAMP), an important 
antimicrobial peptide. 
Increased bacterial colonization, epithelial 
damage and systemic dissemination  
Limura et al, 2005 
Core3-/- 
 
Defective in mucin 
secretion. 
Mice exhibited significant colitis in 
response to C.rodentium. Restoring 
signaling via the Notch and Wnt/B-
catenin pathways promoted crypt 
regeneration and replenished the mucus 
layer leading to amelioration of bacterial 
colitis.  




Impaired IL22 production 









Immune phenotype Response to infection Reference 
RAG-/- 
 
Mice develop severe pathology in colon 
and internal organs and deteriorate rapidly 
during acute infection.  




Mice do not display a reduction in the 
number of goblet cells or in mediators 
(Muc2 and tff3) expression as observed in 
infected wild type. 
Bergstrom et al, 
2008 
RAG1-/- Mice gradually lost weight and eventually 
died around 3–4 weeks post infection 
Wang et al , 2010 
RAG-/- 
 
Heavily infected with high bacterial load 
which are often fatal. Surviving mice 
display reduced tissue pathology and 
disease. 
Vallance et al, 2002 
RAG-/- 
 
RAG -/- knockout 
(KO) mice have 
undergone a targeted 
deletion in the 
recombination-
activating gene and are 
unable to perform 
V(D)J recombination 
of the immunoglobulin 
and T cell receptor 
genes. As a result, 
these mice lack both 
mature T and B 
lymphocytes and thus 




Infected mice suffer high mortality rates 
but do not display goblet cell depletion. 
Reconstitution of RAG-/-mice with 
CD8(+) T cells, leads to colonic ulcers but 
not goblet cell depletion. RAG-/- mice 
receiving CD4(+) T cells show goblet cell 
depletion as well as exaggerated IEC 
proliferation.  




Adaptive immunity: T cells 
Knockout 
mice 
Immune phenotype Response to infection Reference 
TCR-/- 
 
Non functional T cells   
CD4-/- 
 
Defecient in CD4+T cells, unable to 
activate B cells for antibody production 
Mice are highly susceptible to 
infection and develop severe colitis. 
Reduced IgG and IgA response to 















Costimulatory molecules on the surface 
of naïve CD4 T cells, essential for 
activating B cell antibody responses 





Costimulatory molecules on the surface 
of activated CD4 T cells that bind to 
APC, necessary for B cell antibody 
response. 
Over 50% mice failed to clear 
infection resulting in progressive 
mucosal destruction, polymicrobial 





Adaptive immunity: B cells & Antibody response 




B cell defecient 
Severe epithelial hyperplasia with ulcerations 
and mucosal inflammation later on in infection 





B cell defecient 
Highly susceptible to C.rodentium infection. 
Systemic immunity can be restored by adoptive 
transfer of convalescent immune sera and 





B cell defecient 
Mice develop severe pathology in colon and 






IgA defecient Same as wild type 







Same as wild type 








secretory IgA and 
IgM in the mucosa.  
Same as wild type 








secretory IgA and 
IgM in the mucosa.  
Lack secretory antibodies, Clear infection in the 
same way as WT mice although higher bacterial 
load initially.  
Uren et al, 
2005 
J chain-/-            
 
Defecient in 
secretory IgA and 
IgM in the mucosa. 
Same as wild type 
Maaser et al, 
2004 
 
TNF-a and iNOS 
deletions in B cells  
 
B cells unable to 
produce TNFa and 
iNOS 
Reduction in IgA production, altered gut 
microbiota, and poor clearance of C.rodentium.  






center formation and 
humoral immune 
responses. 
Infected mice exhibit prolonged colonization 
with C.rodentium, associated with higher 
bacterial burden in the gastrointestinal tissue and 
spread into systemic tissues. Germinal center 
formation and humoral immune responses are 
severely impaired.  












impaired IL1 signalling 
via MyD88 adaptor 
resulting in a reduced 
proinflammatory response 
Increased bacterial burden and exacerbated 
histopathology 




Impaired IL1 signalling 
via MyD88 adaptor 
resulting in a reduced 
proinflammatory response 
Increased bacterial burden and exacerbated 
histopathology 
Liu et al, 2012 
IL1R-/-  
 
Impaired IL1 signalling 
via MyD88 adaptor 
resulting in a reduced 
proinflammatory response 
Exhibit increased mortality and severe colitis 
characterized by intramural colonic bleeding 
and intestinal damage including gangrenous 
mucosal necrosis similar to MyD88-/- mice. 
Mice also have increased predisposition to 
intestinal damage caused by C.rodentium. 




Deficient in TNFa 
Higher colonic bacterial burden although 
bacterial clearance was the same as WT. 
Markedly enhanced pathology with increased 
mucosal weight and thickness, increased T cell 





Deficient in IL12 and IL23 
cytokine 
Significantly more susceptible to C.rodentium 
with a proportion of mice dying. Gut mucosa of 
infected mice displayed an influx of CD(+) T 
cells and a local IFNγ response. Infected mouse 
mounted IgA response and expressed iNOS. 
Expression of the mouse beta defensin (mBD-
3) was attenuated. 
Simmons et al, 
2002 
IFNy-/- Deficient in IFNγ Mice are more susceptible to C.rodentium 
infection and mounted IgA responses, 




expressed iNOS and the expression of mBD-3 
was attenuated. 





Induces differentiation of 
naïve CD4+T cells in to 
Th2 cells and B cell class 
switching to IgE 






Impaired development of 
IL-22-producing CD4(+) T 
cells 
Mice are more susceptible to C.rodentium Li et al, 2014 
IL23-/-  
 
Impaired IL22 production 
by ILCs.  
Mice exhibit elevated bacterial loads and 
succumb to infection at high doses (109 CFU).  
At low doses (107 CFU) however, mice are able 
to recover from infection.  
Mangan et al, 
2006 
IL23-/-  
Very high bacterial load from the beginning 
and all mice succumbed day 8-12 p.i. Severe 
multifocal ulcerations of the descending colon 
with translocation of dense colonies of bacteria 
as well as multifocal transmural inflammation. 
IL-6 was attenuated which led to defective IL-
22 production, may be due to the significant 
reductions in IL-1B, TNFa, IFNγ.  





production by epithelial 
cells 
Increased intestinal epithelial damage, systemic 
bacterial burden and mortality associated with 
inability to induce the Reg family of 
antimicrobial proteins in colonic epithelial 
cells. 




Lower levels of innate 
antibacterial molecules.  
Receptor for IL17C, without which there is 
lower expression of genes encoding 
antibacterial molecules, greater bacterial 
burden and early mortality during infection.  










inflammatory IL27 which 
suppresses differentiation 
of Th1 and Th17 cells.  
Infected mice had less acute infection 
associated colitis and resolved it more rapidly 
than WT.  IL10 defeciency is associated with 
downregulation of proinflammatory pathways 
and increased expression of anti inflammatory 
ctokine IL27 which suppresses Th17 and Th1 
differentiation. 






High bacterial load and majority succumbed by 
day 14. Significant increase in epithelial injury 
and ulceration associated with greater numbers 
of invasive bacterial colonies. Normal 
production of IL-1B and TNFa. 










mice Immune phenotype Response to infection Reference 
Cx43+/-  
Gap junction hemichannells 
contribute to water release during 
diarrheal disease. 
Infected mice do not suffer from 





Osteopontin contributes to pedestal 
formation, colonization, and colonic 
epithelial cell hyperplasia in response 
to bacterial infection  
Reduced colonic epithelial cell 
hyperplasia, bacterial colonization and 
colonic epithelial cell hyperplasia. 





Reduced CCL2 expression and pro-
inflammatory cytokines.  
Reduced weight loss, crypt 
proliferation, histological 
inflammatory scores, CCL2 and 
proinflammatory cytokines. This was 
due to an altered pattern of bacterial 
migration associated with attenuated 
fibronectin expression. .  




FOXO3 is a negative regulator of and 
acts downstream of epidermal growth 
factor receptor (EGFR) required for 
colonocyte proliferation.  
Increased proliferation of colonocytes 
during infection due to the elevated 
levels of EGFR.  





A key mediator for crypt cell 
proliferation 
Mice display an attenuated induction 
of Klf5 expression and a reduced 
hyperproliferative response of crypt 
cells to C. rodentium compared to 
Wild type. 
McConnell 
et al, 2008 
MMP9-/- 
Elevated levels of protective 
segmented filamentous bacteria and 
IL-17 
  
VDR-/- Increased IL22 producing ILCs and antibacterial peptides. 
Mice had fewer C.rodentium in the 
feces, kinetics of clearance was faster, 
there were more IL22 producing ILCs 
and more antibacterial peptides than 
WT mice.  




Impaired migration of CD4+ T 
lymphocytes to the intestinal mucosa 
during tissue injury and repair. 
Delayed clearance of bacteria 
associated with delayed appearance of 
CD4 T cells in the lamina propria.  








epithelial cells are impaired in their 
ability to induce the production of 
chemokines and cytokines required 
for the recruitment of  leukocytes and 
activation of effector T cells in the 
intestine. This resulted in reduced 
inflammatory responses and slower 
immune responses. 
Slower immune response to bacterial 
infection and delayed bacterial 
clearance. This is associated with 
inability to recruit leukocytes and 
activated effector T cells in the gut 
following activation of epithelial cells 
by SCFA to produce chemokines and 
cytokines.  
Kim MH et 
al 2013 




IDO inhibits tryptophan catabolism 
which suppresses T cell activation.  
Mice are more resistant to intestinal 
colonization by Citrobacter, develop 
lower levels of  serum IgM and IgG 
antibodies and significantly attenuated 
Citrobacter induced colitis.  
Harrington 
et al, 2008 
GPR15-/- 
 
Inability to control homing of 
FOXP3(+) regulatory T cells (Tregs) 
to the large intestine lamina propria 
More prone to develop severe large 
intestine inflammation due to the 
absence of FOXP3(+) Tregs homing to 
the large intestine lamina propria. This 
was rescued by the transfer of GPR15-
suffiecient T regs.  




Increased mononuclear cell 
infiltration characterized by higher 
numbers of CD3(+) T cells. Increased 
Severe clinical symptoms, unresolved 
crypt hyperplasia and marked 





levels of IFNg and IL-17 in the 
spleen.  
characterized by higher numbers of T 
(CD3+) cells.  
RELMa-/-  
 
Decreased CD4(+) T cell expression 
of the proinflammatory cytokine IL-
17A and reduced levels of serum IL-
23p19 due to macrophages deficient 
in IL-23p19 induction.  
Infected mice exhibited reduced 
infection-induced intestinal 
inflammation, characterized by 
decreased leukocyte recruitment to the 
colons and reduced immune cell 
activation. Suggests that immune 
stimulatory effects of RELMa were 
pathologic rather than host protective.  
Osborne et 
al, 2013 
 
